
<html lang="en"     class="pb-page"  data-request-id="e1620954-372c-4301-81ee-528201555e6e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b00056;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-14;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation" /></meta><meta name="dc.Creator" content="Wei  Yan" /></meta><meta name="dc.Creator" content="Xinyi  Wang" /></meta><meta name="dc.Creator" content="Yang  Dai" /></meta><meta name="dc.Creator" content="Bin  Zhao" /></meta><meta name="dc.Creator" content="Xinying  Yang" /></meta><meta name="dc.Creator" content="Jun  Fan" /></meta><meta name="dc.Creator" content="Yinglei  Gao" /></meta><meta name="dc.Creator" content="Fanwang  Meng" /></meta><meta name="dc.Creator" content="Yuming  Wang" /></meta><meta name="dc.Creator" content="Cheng  Luo" /></meta><meta name="dc.Creator" content="Jing  Ai" /></meta><meta name="dc.Creator" content="Meiyu  Geng" /></meta><meta name="dc.Creator" content="Wenhu  Duan" /></meta><meta name="dc.Description" content="Fibroblast growth factor receptor (FGFR) represents an attractive oncology target for cancer therapy in view of its critical role in promoting cancer formation and progression, as well as causing r..." /></meta><meta name="Description" content="Fibroblast growth factor receptor (FGFR) represents an attractive oncology target for cancer therapy in view of its critical role in promoting cancer formation and progression, as well as causing r..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 6, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00056" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00056" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00056" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00056" /></link>
        
    
    

<title>Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00056" /></meta><meta property="og:title" content="Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0007.jpeg" /></meta><meta property="og:description" content="Fibroblast growth factor receptor (FGFR) represents an attractive oncology target for cancer therapy in view of its critical role in promoting cancer formation and progression, as well as causing resistance to approved therapies. In this article, we describe the identification of the potent pan-FGFR inhibitor (R)-21c (FGFR1–4 IC50 values of 0.9, 2.0, 2.0, and 6.1 nM, respectively). Compound (R)-21c exhibited excellent in vitro inhibitory activity against a panel of FGFR-amplified cell lines. Western blot analysis demonstrated that (R)-21c suppressed FGF/FGFR and downstream signaling pathways at nanomolar concentrations. Moreover, (R)-21c provided nearly complete inhibition of tumor growth (96.9% TGI) in NCI-H1581 (FGFR1-amplified) xenograft mice model at the dose of 10 mg/kg/qd via oral administration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00056"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00056">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00056&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00056&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00056&amp;href=/doi/10.1021/acs.jmedchem.6b00056" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6690-6708</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01985" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00245" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Yan">Wei Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinyi++Wang">Xinyi Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Dai">Yang Dai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Zhao">Bin Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinying++Yang">Xinying Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Fan">Jun Fan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yinglei++Gao">Yinglei Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fanwang++Meng">Fanwang Meng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuming++Wang">Yuming Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Luo">Cheng Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Ai">Jing Ai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meiyu++Geng">Meiyu Geng</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenhu++Duan">Wenhu Duan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">School of Pharmacy, East China University of Science & Technology, 130 Mei Long Road, Shanghai 200237, P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Chemistry, College of Sciences, Shanghai University, 99 Shang Da Road, Shanghai 200444, P. R. China</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Drug Discovery & Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">University of Chinese Academy of Sciences, Beijing 100049, P. R. China</span></div><div class="corresp-info"><strong>*</strong>(J.A.) E-mail: <a href="/cdn-cgi/l/email-protection#1a707b735a69737777347b79347974"><span class="__cf_email__" data-cfemail="9ef4fff7deedf7f3f3b0fffdb0fdf0">[email protected]</span></a>. Phone: +86-21-50806600, ext. 2413.</div><div class="corresp-info"><strong>*</strong>(M.G.) E-mail: <a href="/cdn-cgi/l/email-protection#6b06120c0e050c2b18020606450a08450805"><span class="__cf_email__" data-cfemail="d9b4a0bebcb7be99aab0b4b4f7b8baf7bab7">[email protected]</span></a>. Phone: +86-21-50806072.</div><div class="corresp-info"><strong>*</strong>(W.D.) E-mail: <a href="/cdn-cgi/l/email-protection#6017080415010e2013090d0d4e01034e030e"><span class="__cf_email__" data-cfemail="7c0b1418091d123c0f151111521d1f521f12">[email protected]</span></a>. Phone: +86-21-50806032.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00056&amp;href=/doi/10.1021%2Facs.jmedchem.6b00056" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6690–6708</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 27, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 January 2016</li><li><span class="item_label"><b>Published</b> online</span>6 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00056" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00056</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6690%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWei%2BYan%252C%2BXinyi%2BWang%252C%2BYang%2BDai%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D14%26contentID%3Dacs.jmedchem.6b00056%26title%3DDiscovery%2Bof%2B3-%25285%25E2%2580%25B2-Substituted%2529-Benzimidazole-5-%25281-%25283%252C5-dichloropyridin-4-yl%2529ethoxy%2529-1H-indazoles%2Bas%2BPotent%2BFibroblast%2BGrowth%2BFactor%2BReceptor%2BInhibitors%253A%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6708%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00056"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2647</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00056" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Xinyi&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Dai&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Xinying&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Yinglei&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Fanwang&quot;,&quot;last_name&quot;:&quot;Meng&quot;},{&quot;first_name&quot;:&quot;Yuming&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Ai&quot;},{&quot;first_name&quot;:&quot;Meiyu&quot;,&quot;last_name&quot;:&quot;Geng&quot;},{&quot;first_name&quot;:&quot;Wenhu&quot;,&quot;last_name&quot;:&quot;Duan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6690-6708&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00056&quot;},&quot;abstract&quot;:&quot;Fibroblast growth factor receptor (FGFR) represents an attractive oncology target for cancer therapy in view of its critical role in promoting cancer formation and progression, as well as causing resistance to approved therapies. In this article, we describe the identification of the potent pan-FGFR inhibitor (R)-21c (FGFR1–4 IC50 values of 0.9, 2.0, 2.0, and 6.1 nM, respectively). Compound (R)-21c exhibited excellent in vitro inhibitory activity against a panel of FGFR-amplified cell lines. Western blot analysis demonstrated that (R)-21c suppressed FGF/FGFR and downstream signaling pathways at nanomolar concentrations. Moreover, (R)-21c provided nearly complete inhibition of tumor growth (96.9% TGI) in NCI-H1581 (FGFR1-amplified) xenograft mice model at the dose of 10 mg/kg/qd via oral administration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00056&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00056" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00056&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00056" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00056&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00056" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00056&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00056&amp;href=/doi/10.1021/acs.jmedchem.6b00056" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00056" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00056" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00056%26sid%3Dliteratum%253Aachs%26pmid%3D27348537%26genre%3Darticle%26aulast%3DYan%26date%3D2016%26atitle%3DDiscovery%2Bof%2B3-%25285%25E2%2580%25B2-Substituted%2529-Benzimidazole-5-%25281-%25283%252C5-dichloropyridin-4-yl%2529ethoxy%2529-1H-indazoles%2Bas%2BPotent%2BFibroblast%2BGrowth%2BFactor%2BReceptor%2BInhibitors%253A%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D14%26spage%3D6690%26epage%3D6708%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/jmcmar.2016.59.issue-14/20160728/jmcmar.2016.59.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fibroblast growth factor receptor (FGFR) represents an attractive oncology target for cancer therapy in view of its critical role in promoting cancer formation and progression, as well as causing resistance to approved therapies. In this article, we describe the identification of the potent pan-FGFR inhibitor (<i>R</i>)-<b>21c</b> (FGFR1–4 IC<sub>50</sub> values of 0.9, 2.0, 2.0, and 6.1 nM, respectively). Compound (<i>R</i>)-<b>21c</b> exhibited excellent <i>in vitro</i> inhibitory activity against a panel of FGFR-amplified cell lines. Western blot analysis demonstrated that (<i>R</i>)-<b>21c</b> suppressed FGF/FGFR and downstream signaling pathways at nanomolar concentrations. Moreover, (<i>R</i>)-<b>21c</b> provided nearly complete inhibition of tumor growth (96.9% TGI) in NCI-H1581 (FGFR1-amplified) xenograft mice model at the dose of 10 mg/kg/qd via oral administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fibroblast growth factor receptors (FGFRs) are a family of four receptor tyrosine kinases (RTKs), and each of the four FGFRs (FGFR1–4) consists of three extracellular immunoglobulin domains, a single transmembrane domain, and a cytoplasmic tyrosine kinase domain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon binding to fibroblast growth factors, the receptor undergoes dimerization and autophosphorylation of tyrosine residues on cytoplasmic tail, resulting in activation of downstream signaling including MEK-ERK, PLCγ, and PI3K-Akt. Physiologically, FGFR pathway plays important roles in embryogenesis, tissue repair, and wound healing.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> FGFR is an oncogenic driver of a broad panel of malignant solid tumors: FGFR1 amplification is identified in about 20% of squamous nonsmall cell lung carcinoma and about 10% of hormone receptor-positive breast cancers; FGFR2 is also amplified in about 10% of gastric cancer and 4% of triple-negative breast cancers; mutations of FGFR3 are found in about half of bladder cancers, which are strongly related to low-grade tumors; activating mutations of FGFR4 (affecting the kinase domain) are found in 6% to 8% of patients with rhabdomyosarcoma, and overexpression of FGFR4 was found in 50% of hepatocellular carcinomas.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8">(3-8)</a> Moreover, aberrant FGFR activation has been associated with poor prognosis and metastatic progression. In addition, overactivation of FGFR signaling is responsible for <i>de novo</i> and acquired resistance to anticancer therapy.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Therefore, the blockade of FGF/FGFR signaling is considered as an attractive approach for the treatment of cancers.</div><div class="NLM_p">The early examples of FGFR inhibitors were nonselective. Owing to the high degree of homology of FGFRs with VEGFRs (vascular endothelia growth factor receptors), many compounds developed as FGFR inhibitors also inhibit VEGFR family members at similar potencies, such as <b>1</b> (TKI258),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>2</b> (BIBF-1120),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and <b>3</b> (AZD2171)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Although therapies based on inhibiting VEGF/VEGFR signaling pathway have been approved for the treatment of cancers, e.g., <b>10</b> (sunitinib),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>11</b> (sorafenib),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><b>12</b> (pazopanib),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and <b>13</b> (vandetanib)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), undesired side effects such as hypertension and bleeding have been reported.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Recently, medicinal chemists tend to develop more selective FGFR inhibitors, and several orally available FGFR selective inhibitors have been reported to enter clinical trials, for example, <b>4</b> (NVP-BGJ398),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><b>5</b> (AZD4547),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><b>6</b> (CH5183284),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and <b>7</b> (LY2874455)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The 3,5-dimethoxy-phenyl moiety of <b>4</b> and <b>5</b> occupies the same hydrophobic pocket and forms a hydrogen bond with Asp641, which is identified by <b>8</b> (PD173074) to contribute to their selectivity for FGFR1;<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> similar interactions are also observed between <b>6</b> and FGFR1.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Therefore, it is possible that a common single mutation would confer resistance to these inhibitors, which is classified as a category of genetic alteration contributed to the resistance of FGFR inhibitors besides other categories of compensatory pathway activation and epithelial-to-mesenchymal transition, as revealed by limited studies.<a onclick="showRef(event, 'ref24 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref24 ref28 ref29 ref30">(24, 28-30)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative FGFR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative approved VEGFR2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As illustrated in the binding model of <b>7</b> in the ATP binding site of FGFR3,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> the indazole core binds in the ATP binding pocket and forms two hydrogen bonds with the carbonyl of Glu230 and the NH of Ala232; the vinyl pyrazole fragment extends toward solvent, making important hydrophobic interactions. Additionally, a hydrogen bond between the pyridyl nitrogen and Asn236 in hydrophobic pocket is observed; this additional hydrogen bond increases FGFR binding affinity. We envisioned that the interaction between the pyridine fragment and the hydrophobic pocket might overcome the resistance of the former three FGFR selective inhibitors (<b>4</b>, <b>5</b>, and <b>6</b>) caused by the single mutation as discussed above.</div><div class="NLM_p">McBride et al. reported compound <b>9</b> as a dual FGFR1/VEGFR2 inhibitor (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>);<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> this compound showed moderate <i>in vitro</i> and <i>in vivo</i> antitumor efficiency. To understand the ligand–protein interactions, we developed a binding model of compound <b>9</b> in the ATP binding site of FGFR1 with a known crystal structure of the FGFR1 kinase domain (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WJ6">3WJ6</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, compound <b>9</b> binds to the hinge region of the kinase and forms two hydrogen bonds with the carbonyl of Glu562 and the NH of Ala564; an additional hydrogen bond occurs between the carbonyl of Ala564 and N(1)-H of benzimidazole moiety; the benzimidazole moiety extends from the indazole 3-position toward solvent exposed region. In view of the high degree of homology of FGFR1 with FGFR3, it was reasonable to assume that <b>7</b> and <b>9</b> had similar binding patterns with FGFR in the hinge region and the solvent exposed region. In view of the importance of the interactions between the pyridine fragment and the surrounded hydrophobic pocket, we envisioned that the introduction of a pyridylalkoxy moiety to the indazole benzimidazole scaffold might form a novel series of FGFR inhibitors with improved potency and selectivity. To test our hypothesis, we designed and synthesized a series of novel 3-benzimidazole-5-pyridylalkoxy-1<i>H</i>-indazole derivatives (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), and these new derivatives displayed excellent <i>in vitro</i> and <i>in vivo</i> antitumor activities. Herein, we report the detailed synthesis and biological evaluation of these compounds.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0011.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding mode of compound <b>9</b> to FGFR1 kinase domain. The atoms of compound <b>9</b> are colored as follows: carbon orange, oxygen red, nitrogen blue, fluorine light blue, and hydrogen white. The docked protein structure of FGFR1 is shown in the cartoon and key residues are colored as follows: carbon green, oxygen red, nitrogen blue, and hydrogen white. The hydrogen bonds are colored in black.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of our compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Lead Optimization and Identification of Compound (<i>R</i>)-<b>21c</b></h3><div class="NLM_p">To evaluate the aforementioned hypothesis, we prepared compound <b>14a</b> as the proof-of-concept compound, which possessed moderate enzymatic activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In order to get a putative binding mode, a molecular docking simulation was performed. As depicted in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, <b>14a</b> maintained all the critical interactions observed in compounds <b>7</b> and <b>9</b>: the indazole core was anchored to the hinge region of kinase domain via two highly conserved hydrogen bonds with the carbonyl of Glu562 (1.8 Å) and the amino group of Ala564 (2.1 Å); an additional hydrogen bond occurred between the carbonyl of Ala564 and N(1)-H of benzimidazole moiety (2.3 Å); a hydrogen bond between pyridyl nitrogen atom and amino group of Asn568 (2.3 Å) was formed as expected, which reinforced this binding conformation.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed binding mode of compound <b>14a</b> to FGFR1 kinase domain. The atoms of compound <b>14a</b> are colored as follows: carbon orange, oxygen red, nitrogen blue, and hydrogen white. The docked protein structure of FGFR1 is shown in the cartoon and key residues are colored as follows: carbon green, oxygen red, nitrogen blue, and hydrogen white. The hydrogen bonds are colored in black.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationships of Substitutions on Racemic 5-Pyridylalkoxy Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0001.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0002.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are the mean ± SD of two independent assays.</p></div></div><div></div></div><div class="NLM_p">For initial structure–activity relationship exploration, <b>14a</b> served as a benchmark to analyze both enzymatic and cellular potency contributions from different pyridine ring substitution patterns, and compound <b>5</b> was used as the positive control. Despite its moderate potency against FGFR1, <b>14a</b> displayed a weak inhibitory effect in NCI-H1581 proliferation assay (IC<sub>50</sub> of 5016.9 nM). Incorporation of a chlorine atom at the 3-position of the pyridine ring provided <b>14b</b>, which displayed measurable increases in potencies; when an additional chlorine was introduced to the 5-position, the 3,5-dichloro derivative <b>14c</b> exhibited a 31-fold increase compared to <b>14a</b> in cellular potency with an IC<sub>50</sub> of 158.7 nM; further introduction of an α-methyl into <b>14c</b> afforded <b>15a</b>, which demonstrated a further 11-fold enhancement of cellular potency compared to <b>14c</b> (IC<sub>50</sub> of 14.1 nM) and 7- and 54-fold increases compared with compound <b>9</b> in enzymatic and cellular potencies, respectively. The increases in potency of compounds <b>14b</b>, <b>14c</b>, and <b>15a</b> might be explained by the increased lipophilicity by inclusion of the chlorine atom and the α-methyl.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The ethyl analogue <b>15b</b> retained enzymatic potency but turned out to be 27-fold less active than <b>15a</b> in the NCI-H1581 proliferation assay. Next, we assessed the importance of the position of the pyridine nitrogen by synthesizing compounds <b>14d</b> and <b>14e</b>. Interestingly, when pyridine nitrogen was moved to the 2-position, the resulting compound <b>14d</b> was more potent than the 1- or 3-pyridyl analogues (<b>14a</b> and <b>14e</b>, respectively). These results implied that the 2-pyridyl isomer interacted in a more favorable manner with the protein; however, when 3,5-dichloro and α-methyl were introduced to <b>14d</b>, the resulting compound <b>15c</b> was 8- and 2-fold less active than <b>15a</b> in enzymatic and cellular potencies, respectively. Therefore, <b>15a</b> with the 3,5-dichloro and α-methyl substitution pattern was chosen as the compound for further optimization.</div><div class="NLM_p">We next turned our attention to the benzimidazole moiety by replacing it with three other heterocyclic bioisosteres. The substituent at the 5′-position was removed for rapid evaluation of the impact of this replacement (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), which led to compound <b>16a</b> with modest cellular potency. Compared with <b>16a</b>, benzoxazole analogue <b>16b</b> displayed 3- and 8-fold decreases in enzymatic and cellular potencies, respectively. The decrease in potency of <b>16b</b> could be explained by the absence of the hydrogen bond formed between benzimidazole NH and Ala564. Replacement of the benzimidazole moiety by benzothiazole completely eroded the cellular activity (<b>16c</b>). Indole analogue <b>17</b> retained FGFR activity but was 2-fold less active than <b>16a</b> in NCI-H1581 proliferation assay. These results revealed that the benzimidazole moiety was optimal for FGFR activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationships of 3-Heterocycle Substitutions on Racemic 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazole</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0003.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0004.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are the mean ± SD of two independent assays.</p></div></div><div></div></div><div class="NLM_p">Finally, systematic structural optimization of benzimidazole of <b>16a</b> revealed that substituents on the benzimidazole dramatically impacted FGFR inhibition. As summarized in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, the 4′-methyl analogue <b>18a</b> showed a 9-fold drop in enzymatic potency compared with <b>16a</b> and had a cellular IC<sub>50</sub> greater than 10000 nM; moreover, the attachment of a 4′-piperidyl group to the benzimidazole moiety (<b>18b</b>) resulted in a significant loss of activity (FGFR1 kinase IC<sub>50</sub> greater than 1000 nM). These results revealed that substitution at 4′-position of the benzimidazole moiety was not tolerable. On the contrary, inclusion of substituents at the 5′-position of the benzimidazole had favorable impacts: derivatives bearing hydrophobic groups (such as fluoro, methyl, and methoxyl) retained enzymatic and cellular potencies (compounds <b>19a</b>–<b>c</b>); moreover, when the hydrophilic methylamino was attached to the 5′-position of benzimidazole, the resulting derivative <b>19d</b> exhibited a cellular potency with an IC<sub>50</sub> less than 10 nM in the NCI-H1581 proliferation assay. Therefore, we introduced a number of amines and alcohol to the 5′-position of the benzimidazole moiety. In general, six-membered ring analogues (<b>20</b> and <b>21b</b>–<b>e</b>) had comparable potencies; but 1-ethylpiperazine analogue <b>21d</b> was nearly 4- and 6-fold less active than methyl analogue <b>21c</b> in enzymatic and cellular potencies, respectively; the piperidinylpiperidine analogue <b>21a</b> had a FGFR1 IC<sub>50</sub> of 0.8 nM, but suffered a 12-fold enzyme-to-cell shift, resulting in a cellular IC<sub>50</sub> of 10 nM; the homopiperazine analogue <b>21f</b> was 8-fold less active compared with <b>21c</b>. The relatively low potency of <b>21a</b>, <b>21d</b>, and <b>21f</b> indicated that the larger ring substitution was less tolerable. Compounds bearing chain substituents (<b>19e</b>, <b>21g</b>–<b>h</b>, and <b>22</b>) also turned out to be very potent, and they had comparable potencies to the cyclic amines. As discussed above, a range of functional groups were tolerated at the 5′-position of the benzimidazole moiety, potentially owing to this region extending out of the kinase domain of FGFR1 into a solvent exposed region.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure–Activity Relationships of Substitutions on Benzimidazole</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0005.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0006.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values are the mean ± SD of two independent assays.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Not tested.</p></div></div><div></div></div><div class="NLM_p">Because of the undesired side-effects caused by inhibiting VEGFR2 signaling pathway, five compounds with excellent enzymatic and cellular potencies were selected to be evaluated for their VEGFR2 kinase inhibition. As listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, all tested compounds displayed 6- to 8-fold selectivity for FGFR1 over VEGFR2, while compound <b>9</b> was nearly equipotent against FGFR1 and VEGFR2. This result revealed that incorporation of 5-(1-(3,5-dichloropyridin-4-yl)ethoxyl fragment at the 5-position of the indazole-enhanced FGFR inhibitory activity and selectivity over VEGFR2. On the basis of their enzymatic and cellular inhibitory activities, compounds <b>21c</b> and <b>22</b> were chosen for further evaluation.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. FGFR Selectivity of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center" char="±">FGFR1 (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">VEGFR2 (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">VEGFR2/FGFR1 ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">9.0 ± 1.0</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">12.6 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">20.3 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">16.4 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.8 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">14.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">27.0 ± 3.4</td><td class="colsep0 rowsep0" align="char" char=".">45.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Values are the mean ± SD of two independent assays.</p></div></div></div><div class="NLM_p">Compounds <b>21c</b> and <b>22</b> were racemates; the enantiomers of <b>21c</b> and <b>22</b> were resolved to evaluate the relative FGFR activity. As illustrated in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, the <i>R</i> enantiomers were significantly more potent; the result was also consistent with the specific binding revealed in a docking model of compound (<i>R</i>)-<b>21c</b> to FGFR1 (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, <i>vide infra</i>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0014.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures and activities of the enantiomers of <b>21c</b> and <b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacokinetic Profiles of Compounds (<i>R</i>)-<b>21c</b> and (<i>R</i>)-<b>22</b></h3><div class="NLM_p">Compound (<i>R</i>)-<b>21c</b> or (<i>R</i>)-<b>22</b> was administrated to male Sprague–Dawley (SD) rats: either as a 1 mg/kg intravenous or orally by gavage at a 5 mg/kg dose, and the relevant pharmacokinetic parameters were summarized in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. Both compounds exhibited moderate and similar plasma clearance (2.0 and 1.7 L/h/kg, respectively) and oral exposure (798.6 and 663.9 ng·h/mL, respectively). Compound (<i>R</i>)-<b>22</b> had a long half-time (7.3 h) but also had a very large volume of distribution (17.6 L/kg) and relatively low oral bioavailability (22%); while (<i>R</i>)-<b>21c</b> had a moderate half-time (2.0 h), volume of distribution (5.8 L/kg), and oral bioavailability (33%). Taking all their data into consideration, we selected compound (<i>R</i>)-<b>21c</b> to further evaluate its <i>in vitro</i> and <i>in vivo</i> antitumor activities.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of (<i>R</i>)-<b>21c</b> and (<i>R</i>)-<b>22</b> in Rats<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compound</th><th class="colsep0 rowsep0" align="center">Dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0→∞</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(<i>R</i>)-<b>21c</b></td><td class="colsep0 rowsep0" align="left">1 (<i>iv</i>)</td><td class="colsep0 rowsep0" align="char" char=".">300.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">485.3</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 (<i>po</i>)</td><td class="colsep0 rowsep0" align="char" char=".">97.2</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">798.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(<i>R</i>)-<b>22</b></td><td class="colsep0 rowsep0" align="left">1 (<i>iv</i>)</td><td class="colsep0 rowsep0" align="char" char=".">735.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">582.3</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">17.6</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 (<i>po</i>)</td><td class="colsep0 rowsep0" align="char" char=".">195.3</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">663.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last"><i>C</i><sub>max</sub>, maximum concentration; <i>T</i><sub>max</sub>, time of maximum concentration; <i>T</i><sub>1/2</sub>, elimination half-life; AUC<sub>0→∞</sub>, area under the plasma concentration time curve; CL, clearance; V<sub>ss</sub>, volume of distribution; F, oral bioavailability.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Kinase Inhibition Profile of (<i>R</i>)-<b>21c</b></h3><div class="NLM_p">By use of an ELISA-based enzymatic assay, (<i>R</i>)-<b>21c</b> was distinguished for its high potency against FGFR1 kinase activity. Then we were prompted to investigate its activity against a panel of tyrosine kinases. Compound (<i>R</i>)-<b>21c</b> showed almost equal potency against FGFR2 and FGFR3, a little weaker against FGFR4, with IC<sub>50</sub> values of 2.0, 2.0, and 6.1 nM, respectively, indicating (<i>R</i>)-<b>21c</b> was a pan-FGFR inhibitor (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Compared with compound <b>5</b> (FGFR4 IC<sub>50</sub> of 165 nM, literature reported data<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>), (<i>R</i>)-<b>21c</b> was significantly more potent in inhibiting FGFR4, indicating its potential use for the treatment of FGFR4-driven cancer types, for example, hepatocellular carcinoma (HCC).<a onclick="showRef(event, 'ref8 ref33'); return false;" href="javascript:void(0);" class="ref ref8 ref33">(8, 33)</a> Furthermore, (<i>R</i>)-<b>21c</b> was extended to be profiled against a panel of 54 human kinases, including FGFR homologous PDGFR kinase family (PDGFRα, PDGFRβ). Compared to its high potency against FGFR, (<i>R</i>)-<b>21c</b> exhibited much weaker potency against these tested kinases (IC<sub>50</sub> > 100 nM, or 1000 nM) (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> and <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>), indicating that (<i>R</i>)-<b>21c</b> was a selective FGFR inhibitor.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Kinase Inhibition Profile of (<i>R</i>)-<b>21c</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Tyrosine kinase<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Tyrosine kinase<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">PDGFRβ</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR2</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.5</td><td class="colsep0 rowsep0" align="left">c-Met</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">Flt1</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR4</td><td class="colsep0 rowsep0" align="left">6.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">Flt3</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR2</td><td class="colsep0 rowsep0" align="left">7.5 ± 0.8</td><td class="colsep0 rowsep0" align="left">RET</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">c-Src</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ErbB2</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">Bcr-Abl</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFRα</td><td class="colsep0 rowsep0" align="left">781.8 ± 7.6</td><td class="colsep0 rowsep0" align="left">EPHA2</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">EGFR, epidermal growth factor receptor; PDGFR, platelet derived growth factor receptor; c-Met, mesenchymal epithelial transition growth factor; Flt, fms-like tyrosine kinase; RET, rearranged during transfection; c-Src, cellular Src kinase; Bcr-Abl, breakpoint cluster region-abelson; EPHA, erythropoietin-producing hepatocellular carcinoma receptor.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Values are the mean ± SD of three independent assays.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Inhibition on FGFR Signaling of Compound (<i>R</i>)-<b>21c</b></h3><div class="NLM_p">To further evaluate the cellular activity of (<i>R</i>)-<b>21c</b> targeting FGFR kinase, we analyzed its effects on the phosphorylation of FGFR and its major downstream signaling molecules, PLCγ and Erk. Two representative cancer cell lines with different mechanisms of FGFR activation, FGFR1-fusion protein driven human myeloid leukemia cancer cell line KG-1 and FGFR2-amplified dependent human gastric cancer cell line SNU-16, were chosen. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, (<i>R</i>)-<b>21c</b> significantly inhibited the phosphorylation of FGFR1 in a dose-dependent manner in KG1 cells. In line with suppressed FGFR1 phosphorylation, the phosphorylation of PLCγ and Erk, the main downstream molecules of FGFR, was also strongly inhibited. Similar results were observed in (<i>R</i>)-<b>21c</b> treated SNU-16 cells. These results suggested that (<i>R</i>)-<b>21c</b> exhibited an effective blockage of FGFRs signaling.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0015.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound (<i>R</i>)-<b>21c</b> effectively inhibits the phosphorylation of FGFR and the downstream effectors PLCγ and Erk in KG-1 and SNU-16 cells. KG1 (A) or SNU-16 (B) cells treated with (<i>R</i>)-<b>21c</b> for 2 h at the indicated concentrations were lysed and subjected to Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Inhibition on FGFR Signaling-Driven Cancer Cell Proliferation of (<i>R</i>)-<b>21c</b></h3><div class="NLM_p">Increased FGFR signaling promotes cancer cell proliferation. To elucidate the impact of (<i>R</i>)-<b>21c</b> on FGFR mediated cancer cell proliferation, four FGFR-driven cancer cell lines harboring the frequently occurring oncogenic forms of FGFRs were chosen: FGFR1 translocated KG1 cells, FGFR1-amplified NCI-H1581 cells, FGFR2-amplified SNU16 cells, and FGFR3-amplified RT112 cells. As shown in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>, compound (<i>R</i>)-<b>21c</b> strongly inhibited cell proliferation of KG1, NCI-H1581, SNU16, and RT112 cells, with most of the IC<sub>50</sub> values of less than 0.1 nM, which was much more potent than that of compound <b>5</b>, the most advanced pan-FGFR inhibitor in clinical studies.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These findings suggested that (<i>R</i>)-<b>21c</b> strongly inhibited FGFR-driven cancer cell proliferation via blocking FGFR signaling.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Antiproliferative Activity of (<i>R</i>)-<b>21c</b> on FGFR Addicted Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cell lines</th><th class="colsep0 rowsep0" align="center">(<i>R</i>)-<b>21c</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KG-1</td><td class="colsep0 rowsep0" align="left"><0.1</td><td class="colsep0 rowsep0" align="left">6.4 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H1581</td><td class="colsep0 rowsep0" align="left">4.2 ± 2.5</td><td class="colsep0 rowsep0" align="left">58.8 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SNU16</td><td class="colsep0 rowsep0" align="left"><0.1</td><td class="colsep0 rowsep0" align="left">13.4 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RT112</td><td class="colsep0 rowsep0" align="left"><0.1</td><td class="colsep0 rowsep0" align="left">88.4 ± 10.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Values are the mean ± SD of three independent assays.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>In Vivo</i> Antitumor Activity of Compound (<i>R</i>)-<b>21c</b></h3><div class="NLM_p">To assess the <i>in vivo</i> antitumor efficacy of (<i>R</i>)-<b>21c</b>, NCI-H1581 xenograft mouse model, which is driven by amplification of FGFR1, was used. Compound (<i>R</i>)-<b>21c</b> was orally administrated once daily at doses of 2 or 10 mg/kg for 21 consecutive days. The results showed that (<i>R</i>)-<b>21c</b> could suppress tumor growth in a dose-dependent manner, with the tumor growth inhibition rate (TGI) of 44.5% and 96.9% at the doses of 2 and 10 mg/kg, respectively, without significant body loss (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), indicating (<i>R</i>)-<b>21c</b> elicited a robust antitumor efficacy in a FGFR-dependent tumor model. Therefore, (<i>R</i>)-<b>21c</b> was a potential FGFR inhibitor candidate for further drug development.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0016.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Inhibitory effect of (<i>R</i>)-<b>21c</b> on tumor growth in NCI-H1581 xenograft model. Compound (<i>R</i>)-<b>21c</b> was administered orally once daily for 21 days. (A) The percentage of tumor growth inhibition values (TGI) was measured on the final day of the study for the drug-treated mice compared with the vehicle control mice: (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001, versus vehicle group, using Student’s <i>t</i> test. Results are expressed as the mean ± SEM (<i>n</i> = 6 for inhibitor-treated group, <i>n</i> = 12 for vehicle control group). (B) Body weight measurements during the treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Molecular Docking Study of Compound (<i>R</i>)-<b>21c</b> to FGFR1</h3><div class="NLM_p">As illustrated in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, (<i>R</i>)-<b>21c</b> had a similar binding mode with <b>14a</b>: the indazole core was anchored to the hinge region of FGFR1 kinase domain via two highly conserved hydrogen bonds with Glu562 and Ala564; a hydrogen bond between pyridyl nitrogen atom and Asn568 was formed as expected. The α-methyl in the linkage between pyridine ring and the indazole core had a favored steric effect: as indicated in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C, the <i>R</i>-methyl fit in a pocket surrounded by Asp641, Val492, and Glu485, thus compelling the pyridine ring to form a strong hydrogen bond with Asn568; on the contrary, an <i>S</i>-methyl would have an unfavored steric hindrance effect with Val492, which would destabilize the active conformation. The benzimidazole moiety was located in a narrow hydrophobic cleft that was formed by five residues (namely, Leu484, Tyr563, Ala564, Ser565, and Gly567): an additional hydrogen bond occurred between the carbonyl of Ala564 and N(1)-H of benzimidazole moiety that reinforced this binding conformation; the 4′-position of benzimidazole was surrounded by Leu484, Ser565, and Gly567; while the 5′-substitution extended out of this pocket into the solvent exposed region; this binding information explained why 4′-substitution of benzimidazole was not tolerable, but a range of functional groups was tolerated at the 5′-position.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0017.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Proposed binding mode of (<i>R</i>)-<b>21c</b> with FGFR1. (A) The atoms of (<i>R</i>)-<b>21c</b> are colored as follows: carbon orange, oxygen red, nitrogen blue, chlorine green, and hydrogen white. The docked protein structure of FGFR1 is shown in the cartoon and key residues are colored as follows: carbon green, oxygen red, nitrogen blue, and hydrogen white. The hydrogen bonds are colored in black. (B) The docked protein structure of FGFR1 is shown in surface. The surfaces of Gly485 and Glu486 are omitted for clarity. (C) The <i>R</i>-methyl fit in a pocket surrounded by three residues (Asp641, Val492, and Glu485).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, benzyl chlorides <b>23</b> or methanesulfonates <b>31</b> were reacted with 5-hydroxy-1<i>H</i>-indole to provide ethers <b>24</b> or <b>32</b>, which were transformed to 3-carbaldehyde-1<i>H</i>-indazoles <b>25</b> or <b>33</b> by treatment of dilute nitrous acid.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Nucleophilic displacement of the C-5 fluorine of <b>26a</b> with piperidine afforded <b>27</b>. Reduction of <b>27</b> with hydrogen afforded diamine <b>28</b>, which should be protected in argon atmosphere during workup and reacted immediately after workup with aldehydes <b>25</b> or <b>33</b> to afford compounds <b>14</b> and <b>15</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0018.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 5-hydroxyindole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (b) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O/dioxane, 0 °C to rt; (c) Et<sub>3</sub>N, piperidine, NMP, 120 °C; (d) H<sub>2</sub>, 10% Pd/C, MeOH, rt; (e) S<sub>8</sub>, DMF, 90 °C.</p></p></figure><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0019.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for <b>30a</b> and <b>30c</b>, LDA, acetaldehyde, THF, −78 °C; for <b>30b</b>, LDA, propionaldehyde, THF, −78 °C; (b) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (c) 5-hydroxyindole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (d) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O/dioxane, 0 °C to rt; (e) <b>28</b>, S<sub>8</sub>, DMF, 90 °C.</p></p></figure><div class="NLM_p">Compounds <b>16a</b> and <b>16c</b> were prepared by analogous methods (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>); while the stronger oxidant DDQ rather than sulfur was used in the final cyclo-condensation step in the preparation of <b>16b</b>. The indole-indazole derivative <b>17</b> was synthesized via palladium-catalyzed cross-coupling reaction of iodide <b>35</b> and boronic acid <b>36</b>; compounds <b>35</b> and <b>36</b> were prepared according to literature procedures.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a></div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0020.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for <b>16a</b> and <b>16c</b>, S<sub>8</sub>, DMF, 90 °C; for <b>16b</b>, (i) DMF, 90 °C; (ii) DDQ, CHCl<sub>3</sub>, reflux; (b) (i) Cs<sub>2</sub>CO<sub>3</sub>, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, dioxane, 90 °C; (ii) 4 N HCl in MeOH.</p></p></figure><div class="NLM_p">Compounds <b>18</b>–<b>22</b> were prepared via a similar route (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). An array of 2-nitroaniline intermediates (<b>40</b>) were prepared starting from <b>26a</b> by displacement of fluorine with commercial available amines (<b>39</b>). Acylation of amine <b>19d</b> with bromoacetyl chloride followed by displacement of the bromine with dimethylamine furnished amide <b>19e</b>. Intermediates <b>38</b> and <b>41</b> were prepared according to literature procedures.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a></div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0021.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) H<sub>2</sub>, 10% Pd/C, MeOH, rt; (ii) <b>33a</b>, S<sub>8</sub>, DMF, 90 °C; (b) for <b>26d</b>, methylammonium chloride, DIPEA, NMP, 140 °C; for <b>40</b>, DIPEA, NMP, 120 °C; (c) (i) 2-bromoacetyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt; (ii) dimethylamine, THF, rt.</p></p></figure><div class="NLM_p">The enantiomers of <b>21c</b> and <b>22</b> were resolved to evaluate the relative FGFR activities. The racemic alcohol <b>30a</b> was reacted with chiral acid <b>42</b> via kinetic resolution reaction (twice) to give (<i>S</i>)-<b>30a</b> with an enantiomeric excess (ee) of 98% (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Mitsunobu reaction of (<i>S</i>)-<b>30a</b> with acetic acid followed by hydrolysis with sodium hydroxide afforded (<i>R</i>)-<b>30a</b> in nearly complete configuration inversion (ee 97%). Compound (<i>R</i>)-<b>21c</b> was prepared starting from (<i>S</i>)-<b>30a</b> in a similar manner as described for the racemic <b>21c</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). It was noted that partial racemization was observed in the S<sub>N</sub>2 ether formation step, and the ee of (<i>R</i>)-<b>32a</b> was 89%; the corresponding aldehyde was suspended in ethyl acetate and filtered to generate enantiomerically pure (<i>R</i>)-<b>33a</b> with an ee of over 99%.</div><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0022.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DCC, 4-DMAP, toluene, 0 °C; (ii) NaOH, H<sub>2</sub>O, EtOH, rt; (b) (i) HOAc, DIAD, PPh<sub>3</sub>, THF, 0 °C to rt; (ii) NaOH, H<sub>2</sub>O, EtOH, rt.</p></p></figure><figure id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0023.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (b) 5-hydroxyindole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (c) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O/dioxane, 0 °C to rt; (d) (i) <b>40c</b>, H<sub>2</sub>, 10% Pd/C, MeOH, rt; (ii) S<sub>8</sub>, DMF, 90 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have developed a series of 3-(5′-substituted)-benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazoles as potent FGFR inhibitors. Structural optimization of <b>14a</b> led to the identification of (<i>R</i>)-<b>21c</b>, which had pan-FGFR inhibitory activities against FGFR1–4 (IC<sub>50</sub> values of 0.9, 2.0, 2.0, and 6.1 nM, respectively) and 8-fold selectivity over VEGFR2. Compared with other FGFR selective inhibitors, (<i>R</i>)-<b>21c</b> potently inhibited FGFR4, indicating its potential use for the treatment of FGFR4-driven cancer types. Western blot analysis revealed that (<i>R</i>)-<b>21c</b> suppressed FGF/FGFR and downstream signaling pathways at nanomolar concentrations. Furthermore, (<i>R</i>)-<b>21c</b> displayed potent antiproliferative effect against a number of FGFR-amplified cell lines including NCI-H1581, KG1, SNU16, and RT112. After an oral administration of compound (<i>R</i>)-<b>21c</b> at a dose of 10 mg/kg/qd, almost complete tumor stasis was observed in nude mice bearing NCI-H1581 human lung cancer xenograft after 21 days of initial administration, indicating that (<i>R</i>)-<b>21c</b> was a potential FGFR inhibitor for further drug development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p">All starting materials and reagents were either obtained from commercial suppliers or prepared according to literature reported procedures. All purchased chemicals and solvents were used without further purification unless otherwise noted. Flash chromatography was performed using silica gel (300–400 mesh). All reactions were monitored by thin-layer chromatography (TLC), using silica gel plates with fluorescence F254 and visualized under UV light. <sup>1</sup>H NMR spectral data were recorded on Varian Mercury 300 or 400 NMR spectrometer, and <sup>13</sup>C NMR was recorded on Varian Mercury 126 or 151 NMR spectrometer at ambient temperature. Chemicals shifts (δ) were reported in parts per million, coupling constants (<i>J</i>) values were in hertz, and the splitting patterns were abbreviated as follows: s for singlet; d for doublet; t for triplet; q for quartet; and m for multiplet. The low or high resolution of EI–MS was recorded on a Finnigan/MAT95 spectrometer. All tested compounds were purified to ≥95% purity as determined by high performance liquid chromatography (HPLC).</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure A: Synthesis of Target Compounds <b>14</b>–<b>15</b>, <b>16a</b>, and <b>16c</b></h4><div class="NLM_p">A mixture of the aldehyde (<b>25a</b>–<b>e</b> or <b>33a</b>–<b>c</b>) (0.3 mmol), aniline (<b>28</b>, <b>34a</b> or <b>34c</b>) (0.3 mmol), and sulfur (0.6 mmol) was heated to 90 °C for 2 h under argon atmosphere.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Ethyl acetate was added, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol + 2% aqueous ammonia, v/v, 99:1 to 97:3) to give the desired product.</div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 3-(5-(Piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-5-(pyridin-4-ylmethoxy)-1<i>H</i>-indazole (<b>14a</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>25a</b> and <b>28</b> following general procedure A. Yellow solid (56%), mp 232 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.54 (dd, <i>J</i> = 4.6, 1.6 Hz, 2H), 8.00 (d, <i>J</i> = 2.0 Hz, 1H), 7.57 (dd, <i>J</i> = 19.5, 7.6 Hz, 4H), 7.25 (dd, <i>J</i> = 9.1, 2.4 Hz, 2H), 7.08 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 5.31 (s, 2H), 3.19–3.08 (m, 4H), 1.87–1.71 (m, 4H), 1.66–1.55 (m, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 155.1, 152.1, 150.8 (2C), 150.5, 147.3, 139.9, 138.7, 137.5, 136.0, 122.7 (2C), 122.7, 120.1, 115.5, 112.3, 104.3, 103.1, 69.4, 53.2 (2C), 27.0 (2C), 25.1. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O 424.2012; found 424.2011.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 5-((3-Chloropyridin-4-yl)methoxy)-3-(5-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>14b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>25b</b> and <b>28</b> following general procedure A. Yellow solid (50%), mp 140–142 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.59 (s, 1H), 8.51 (d, <i>J</i> = 5.0 Hz, 1H), 8.03 (s, 1H), 7.76 (d, <i>J</i> = 4.9 Hz, 1H), 7.58 (d, <i>J</i> = 3.6 Hz, 1H), 7.55 (d, <i>J</i> = 3.9 Hz, 1H), 7.30–7.23 (m, 2H), 7.10 (d, <i>J</i> = 8.8 Hz, 1H), 5.37 (s, 2H), 3.22–3.13 (m, 4H), 1.85–1.75 (m, 4H), 1.67–1.58 (m, 2H). <sup>13</sup>C NMR (151 MHz, acetone-<i>d</i><sub>6</sub>) δ 154.8, 149.8, 149.2, 147.6, 144.8, 139.9, 138.8, 138.6, 137.4, 130.8, 123.9, 122.6, 120.0 (2C), 116.2, 112.4, 104.5, 100.0, 67.1, 53.4 (2C), 26.8 (2C), 24.9. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>23</sub>ClN<sub>6</sub>O 458.1622; found 458.1619.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 5-((3,5-Dichloropyridin-4-yl)methoxy)-3-(5-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>14c</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>25c</b> and <b>28</b> following general procedure A. Yellow solid (72%), mp 205 °C, <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.61 (s, 2H), 8.11 (d, <i>J</i> = 2.2 Hz, 1H), 7.64–7.50 (m, 2H), 7.30 (s, 1H), 7.19–7.09 (m, 2H), 5.45 (s, 2H), 3.26–3.14 (m, 4H), 1.89–1.75 (m, 4H), 1.68–1.57 (m, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 155.3, 149.9 (2C), 148.9, 147.7, 141.2, 138.9, 137.3, 134.3 (2C), 122.6, 120.2, 116.3, 112.5, 104.3, 98.9, 65.5, 53.5 (2C), 26.7 (2C), 24.8. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>6</sub>O 492.1232; found 492.1232.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 3-(5-(Piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-5-(pyridin-3-ylmethoxy)-1<i>H</i>-indazole (<b>14d</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>25d</b> and <b>28</b> following general procedure A. Yellow solid (54%), mp 152–154 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.72 (s, 1H), 8.51 (d, <i>J</i> = 5.0 Hz, 1H), 8.08–7.97 (m, 2H), 7.63–7.45 (m, 3H), 7.28 (s, 1H), 7.22 (dd, <i>J</i> = 9.1, 2.2 Hz, 1H), 7.12 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 5.30 (s, 2H), 3.24–3.15 (m, 4H), 1.86–1.74 (m, 4H), 1.69–1.57 (m, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 155.3, 150.5, 150.3, 150.2, 147.7, 138.6, 137.5, 136.4, 133.9, 124.3, 122.7, 120.3, 116.2, 112.3, 104.1, 102.5, 68.8, 53.2 (2C), 27.0 (2C), 25.1. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O 424.2012; found 424.2004.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 3-(5-(Piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-5-(pyridin-2-ylmethoxy)-1<i>H</i>-indazole (<b>14e</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>25e</b> and <b>28</b> following general procedure A. Yellow solid (61%), mp 159–160 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.57 (d, <i>J</i> = 4.9 Hz, 1H), 8.02 (d, <i>J</i> = 2.0 Hz, 1H), 7.90 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.70 (d, <i>J</i> = 7.9 Hz, 1H), 7.62–7.50 (m, 2H), 7.44–7.35 (m, 1H), 7.29–7.21 (m, 2H), 7.11 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 5.32 (s, 2H), 3.25–3.11 (m, 4H), 1.89–1.74 (m, 4H), 1.69–1.56 (m, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 158.4, 155.3, 150.1, 147.8, 138.6, 137.5, 137.3, 123.6, 122.8, 122.2, 120.1, 116.2, 112.3, 104.3, 101.7, 72.1, 53.5 (2C), 26.8 (2C), 24.9. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O 424.2012; found 424.2020.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>15a</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>33a</b> and <b>28</b> following general procedure A. Yellow solid (70%), mp 202 °C. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ 12.40 (s, 1H), 11.48 (s, 1H), 8.51 (s, 2H), 8.03 (s, 1H), 7.64 (s, 1H), 7.52 (d, <i>J</i> = 9.0 Hz, 1H), 7.18 (dd, <i>J</i> = 9.2, 1.9 Hz, 1H), 7.11–6.97 (m, 2H), 6.19 (q, <i>J</i> = 6.7 Hz, 1H), 3.22–3.08 (m, 4H), 1.85 (d, <i>J</i> = 6.6 Hz, 3H), 1.81–1.69 (m, 4H), 1.65–1.55 (m, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 153.3, 149.7 (2C), 145.2, 141.3, 138.5, 137.5, 136.4, 132.0 (2C), 122.7, 120.3, 120.2, 115.5, 112.2, 105.1, 99.0, 72.9, 53.1 (2C), 27.0 (2C), 25.1, 19.0. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>6</sub>O 506.1389; found 506.1390.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 5-(1-(3,5-Dichloropyridin-4-yl)propoxy)-3-(5-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>15b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>33b</b> and <b>28</b> following general procedure A. Yellow solid (57%), mp 170 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 2H), 7.84 (d, <i>J</i> = 2.1 Hz, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.25 (s, 1H), 7.16 (dd, <i>J</i> = 9.0, 1.7 Hz, 1H), 7.09 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 6.04–5.90 (m, 1H), 3.23–3.05 (m, 4H), 2.46–2.27 (m, 1H), 2.16–2.01 (m, 1H), 1.89–1.70 (m, 4H), 1.60 (d, <i>J</i> = 5.0 Hz, 2H), 1.13 (t, <i>J</i> = 7.4 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>6</sub>O 520.1545; found 520.1544.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 5-(1-(2,4-Dichloropyridin-3-yl)ethoxy)-3-(5-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>15c</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>33c</b> and <b>28</b> following general procedure A. Beige solid (40%), mp 174 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 5.3 Hz, 1H), 7.85 (d, <i>J</i> = 2.0 Hz, 1H), 7.57 (d, <i>J</i> = 8.4 Hz, 1H), 7.47 (d, <i>J</i> = 9.0 Hz, 1H), 7.39 (d, <i>J</i> = 5.1 Hz, 1H), 7.23 (s, 1H), 7.17 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.09 (d, <i>J</i> = 8.6 Hz, 1H), 6.26 (q, <i>J</i> = 6.6 Hz, 1H), 3.21–3.12 (m, 3H), 1.89–1.75 (m, 6H), 1.69–1.57 (m, 2H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 153.4, 149.6 (2C), 145.3, 145.1, 138.9, 137.5, 137.2, 136.3, 132.1 (2C), 124.6, 123.0, 122.7, 120.2, 112.1, 107.9, 107.64, 103.9, 73.9, 51.8 (2C), 26.9 (2C), 25.6, 18.6. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>6</sub>O 506.1389; found 506.1385.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 3-(1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazole (<b>16a</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>33a</b> and <i>o</i>-phenylenediamine (<b>34a</b>) following general procedure A. White solid (79%), mp 222 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.48 (s, 1H), 12.86 (s, 1H), 8.61 (s, 2H), 7.83 (d, <i>J</i> = 2.3 Hz, 1H), 7.78–7.72 (m, 1H), 7.55 (d, <i>J</i> = 9.0 Hz, 1H), 7.51–7.45 (m, 1H), 7.26–7.19 (m, 2H), 7.16 (dd, <i>J</i> = 9.0, 2.4 Hz, 1H), 6.10 (q, <i>J</i> = 6.6 Hz, 1H), 1.78 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 153.5, 149.7 (2C), 148.2, 145.6, 145.2, 138.5, 137.1, 135.1, 132.0 (2C), 123.5, 122.8, 122.4, 120.4, 120.2, 112.4, 111.9, 104.8, 72.9, 19.1. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>5</sub>O 423.0654; found 423.0653.</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Synthesis of 2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)benzo[<i>d</i>]oxazole (<b>16b</b>)</h5><div class="NLM_p last">Compound <b>33a</b> (100 mg, 0.3 mmol) and 2-aminophenol (<b>34b</b>) (36 mg, 0.3 mmol) were dissolved in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and heated to 100 °C for 2 h. The mixture was concentrated to dryness and dissolved in chloroform (2 mL). 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (150 mg, 0.66 mmol) was added and the solution was heated to reflux for 2 h.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The reaction mixture was diluted by chloroform and washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol, v/v, 98:2) to give the title product as a yellow solid (80 mg, 63%), mp 232 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 12.39 (s, 1H), 8.44 (s, 2H), 7.87–7.80 (m, 1H), 7.71 (d, <i>J</i> = 2.0 Hz, 1H), 7.65–7.60 (m, 1H), 7.57 (d, <i>J</i> = 9.1 Hz, 1H), 7.46–7.36 (m, 2H), 7.20 (dd, <i>J</i> = 9.1, 2.4 Hz, 1H), 6.17 (q, <i>J</i> = 6.7 Hz, 1H), 1.85 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 159.5, 154.2, 151.0, 149.8 (2C), 145.0, 143.0, 138.3, 133.7, 132.0 (2C), 126.1, 125.6, 123.5, 120.8, 113.0, 111.5, 103.6, 73.0, 19.0. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub> 424.0494; found 424.0503.</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)benzo[<i>d</i>]thiazole (<b>16c</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>33a</b> and 2-aminobenzenethiol (<b>34c</b>) following general procedure A. Beige solid (35%), mp 220 °C. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ 12.69 (s, 1H), 8.55 (s, 2H), 8.21 (d, <i>J</i> = 8.6 Hz, 1H), 8.07 (d, <i>J</i> = 8.0 Hz, 1H), 7.85 (d, <i>J</i> = 2.3 Hz, 1H), 7.65–7.55 (m, 2H), 7.46 (t, <i>J</i> = 7.6 Hz, 1H), 7.24 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 6.20 (q, <i>J</i> = 6.7 Hz, 1H), 1.86 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 162.9, 155.2, 154.2, 149.7 (2C), 145.1, 140.0, 138.8, 134.9, 131.9 (2C), 127.1, 126.2, 123.8, 122.7, 122.0, 121.0, 112.9, 103.6, 72.8, 19.1. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>4</sub>OS 440.0265; found 440.0262.</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Synthesis of 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(1<i>H</i>-indol-2-yl)-1<i>H</i>-indazole (<b>17</b>)</h5><div class="NLM_p last">Compounds <b>35</b> (72 mg, 0.14 mmol) and <b>36</b> (40 mg, 0.15 mmol) were dissolved in dioxane (5 mL) and cesium carbonate (91 mg, 0.28 mmol) was added. The suspension was degassed under argon bubbling for 10 min before Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (7 mg, 0.01 mmol) was added. The reaction mixture was heated to 90 °C for 2 h and then diluted with ethyl acetate. The solution was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was dissolved in a solution of hydrochloric acid in methanol (0.5 mL, 4 N) and the mixture was continually stirred overnight at room temperature. The mixture was concentrated and purified by silica gel chromatography (dichloromethane/methanol, v/v, 98:2) to give the title product as a light brown solid (34 mg, 58%), mp 216 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.96 (s, 1H), 9.05 (s, 1H), 8.45 (s, 2H), 7.71 (d, <i>J</i> = 7.5 Hz, 1H), 7.43–7.36 (m, 2H), 7.30 (s, 1H), 7.25–7.21 (m, 1H), 7.20–7.13 (m, 2H), 6.97 (s, 1H), 6.14 (q, <i>J</i> = 6.8 Hz, 1H), 1.86 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 152.5, 149.1 (2C), 144.4, 138.8, 137.7, 136.0, 131.3 (2C), 131.0, 129.2, 122.9, 120.8, 120.2, 119.9, 111.3, 111.0, 102.8, 100.9, 72.2, 18.9. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>4</sub>O 422.0701; found 422.0701.</div></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure B: Synthesis of Target Compounds <b>18</b>–<b>22</b></h4><div class="NLM_p">The substituted 2-nitroaniline (<b>26</b>, <b>37</b>– <b>38</b>, or <b>40</b>–<b>41</b>) (0.3 mmol) was dissolved in methanol (3 mL), and 10% Pd/C (0.03 mmol) was added. The mixture was stirred at room temperature under hydrogen atmosphere for 2 h. The mixture was filtered, and the filtrate was concentrated to dryness and dissolved in <i>N</i>,<i>N</i>-dimethylformamide (3 mL). Compound <b>33a</b> (0.3 mmol) and sulfur (0.6 mmol) was added. The mixture was heated to 90 °C for 2 h under argon atmosphere. Ethyl acetate was added, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol + 2% of aqueous ammonia, v/v, 99:1 to 95:5) to give the desired product.</div><div id="sec5_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(4-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>18a</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>37a</b> following general procedure B. Beige solid (51%), mp 137–139 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 2H), 7.73 (s, 1H), 7.49 (d, <i>J</i> = 9.0 Hz, 1H), 7.36 (s, 1H), 7.23–7.12 (m, 2H), 7.05 (d, <i>J</i> = 7.2 Hz, 1H), 6.21 (q, <i>J</i> = 6.7 Hz, 1H), 2.74–2.62 (m, 3H), 1.82 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec5_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(4-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>18b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>37b</b> following general procedure B. Brown solid (43%), mp 120–122 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.45 (s, 1H), 12.76 (s, 1H), 8.56 (s, 2H), 8.08 (s, 1H), 7.54 (d, <i>J</i> = 9.1 Hz, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 1H), 7.05 (t, <i>J</i> = 7.7 Hz, 1H), 6.98 (d, <i>J</i> = 7.7 Hz, 1H), 6.53 (d, <i>J</i> = 7.5 Hz, 1H), 6.20 (dd, <i>J</i> = 12.6, 6.4 Hz, 1H), 3.72–3.50 (m, 4H), 1.90–1.72 (m, 7H), 1.68–1.66 (m, 2H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 154.0, 149.7 (2C), 147.0, 146.2, 139.2, 138.3, 137.0, 132.8 (2C), 130.3, 124.5, 122.9, 120.9, 112.4, 110.7, 106.7, 74.2, 53.6 (2C), 27.1 (2C), 25.5, 18.7. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>6</sub>O 506.1389; found 506.1387.</div></div><div id="sec5_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-fluoro-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>19a</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>26a</b> following general procedure B. White solid (72%), mp > 250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.53–13.51 (m, 1H), 12.99 (s, 1H), 8.62–8.61 (m, 2H), 7.78 (s, 1H), 7.74–7.43 (m, 1H), 7.55 (d, <i>J</i> = 8.1 Hz, 1H), 7.51–7.19 (m, 1H), 7.16 (dd, <i>J</i> = 9.0, 2.4 Hz, 1H), 7.11–7.04 (m,1H), 6.10 (q, <i>J</i> = 6.7 Hz, 1H), 1.78 (d, <i>J</i> = 6.7 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>14</sub>Cl<sub>2</sub>FN<sub>5</sub>O 441.0559; found 441.0562.</div></div><div id="sec5_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>19b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>26b</b> following general procedure B. White solid (55%), mp 215 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.81 (s, 1H), 7.67–7.32 (m, 3H), 7.17 (dd, <i>J</i> = 9.0, 2.1 Hz, 1H), 7.11 (d, <i>J</i> = 7.8 Hz, 1H), 6.24 (q, <i>J</i> = 6.6 Hz, 1H), 2.50 (s, 3H), 1.83 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 154.1, 149.8 (2C), 148.5, 146.3, 139.1, 136.9, 133.7, 132.7 (2C), 125.2, 122.7, 120.9, 116.0, 112.5, 104.87, 73.65, 21.78, 18.92. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>5</sub>O 437.0810; found 437.0810.</div></div><div id="sec5_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-methoxy-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>19c</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>26c</b> following general procedure B. Yellow solid (58%), mp 150 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.81 (d, <i>J</i> = 1.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 9.0 Hz, 1H), 7.21–7.12 (m, 2H), 6.92 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.23 (q, <i>J</i> = 6.5 Hz, 1H), 3.88 (s, 3H), 1.83 (d, <i>J</i> = 6.6 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub> 453.0759; found 453.0751.</div></div><div id="sec5_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)-<i>N</i>-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-5-amine (<b>19d</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>26d</b> following general procedure B. Yellow solid (62%), mp 182 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.29 (s, 1H), 12.29 (s, 1H), 8.60 (s, 2H), 7.81 (s, 1H), 7.50 (d, <i>J</i> = 9.0 Hz, 1H), 7.41 (s, 1H), 7.12 (dd, <i>J</i> = 9.0, 2.4 Hz, 1H), 6.58 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 6.49 (s, 1H), 6.08 (q, <i>J</i> = 6.7 Hz, 1H), 5.61 (s, 1H), 2.73 (s, 3H), 1.78 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>) δ 153.3, 149.6 (2C), 147.8, 145.9, 145.3, 138.5, 137.4, 132.0 (2C), 122.5, 120.2, 118.5, 112.1, 112.0, 105.2, 94.7, 73.0, 31.4, 19.0. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>6</sub>O 452.0919; found 452.0907.</div></div><div id="sec5_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-2-(dimethylamino)-<i>N</i>-methylacetamide (<b>19e</b>)</h5><div class="NLM_p last">To a mixture of <b>19d</b> (50 mg, 0.11 mmol) and triethylamine (30 μL, 0.22 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL), 2-bromoacetyl chloride (10 μL, 0.13 mmol) was added dropwise at 0 °C. The reaction mixture was stirred at room temperature for 3 h and concentrated before a solution of dimethylamine in THF (5 mL, 2 N) was added. The mixture was stirred overnight at room temperature and was concentrated. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol + 2% of aqueous ammonia, v/v, 96:4) to give the title compound as a beige solid (26 mg, 45%), mp 185 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.45 (s, 2H), 7.83 (s, 1H), 7.73 (s, 1H), 7.56 (s, 1H), 7.50 (d, <i>J</i> = 9.1 Hz, 1H), 7.24–7.13 (m, 2H), 6.23 (q, <i>J</i> = 6.7 Hz, 1H), 3.35 (s, 3H), 3.03 (s, 2H), 2.25 (s, 6H), 1.84 (d, <i>J</i> = 6.7 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub> 537.1447; found 537.1454.</div></div><div id="sec5_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-(1-methylpiperidin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>20</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>38</b> following general procedure B. Beige solid (49%), mp 162–163 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.83 (d, <i>J</i> = 1.4 Hz, 1H), 7.58 (s, 1H), 7.56–7.44 (m, 2H), 7.23–7.13 (m, 2H), 6.23 (q, <i>J</i> = 6.6 Hz, 1H), 3.04 (d, <i>J</i> = 10.9 Hz, 2H), 2.76–2.63 (m, 1H), 2.35 (s, 3H), 2.29–2.14 (m, 2H), 2.00–1.78 (m, 7H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 154.1, 149.8 (2C), 148.9, 146.3, 142.4, 139.1, 136.8, 132.7 (2C), 123.2, 122.8, 120.9, 116.1, 112.5, 104.9, 73.7, 57.3 (2C), 46.4, 43.2, 34.7 (2C), 18.9. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>6</sub>O 520.1545; found 520.1550.</div></div><div id="sec5_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 3-(5-([1,4′-Bipiperidin]-1′-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazole (<b>21a</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40a</b> following general procedure B. Yellow solid (45%), mp 185 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.83 (s, 1H), 7.56 (d, <i>J</i> = 9.4 Hz, 1H), 7.47 (d, <i>J</i> = 9.2 Hz, 1H), 7.18–7.14 (m, 2H), 7.07 (d, <i>J</i> = 9.0 Hz, 1H), 6.24 (q, <i>J</i> = 6.7 Hz, 1H), 3.72 (d, <i>J</i> = 11.4 Hz, 2H), 2.72 (t, <i>J</i> = 12.0 Hz, 2H), 2.66–2.55 (m, 4H), 2.41 (t, <i>J</i> = 10.2 Hz, 1H), 2.00 (d, <i>J</i> = 9.9 Hz, 2H), 1.84 (d, <i>J</i> = 6.7 Hz, 3H), 1.75 (d, <i>J</i> = 11.1 Hz, 2H), 1.70–1.57 (m, 4H), 1.51–1.47 (m, 2H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>33</sub>Cl<sub>2</sub>N<sub>7</sub>O 589.2124; found 589.2121.</div></div><div id="sec5_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-((3<i>S</i>,5<i>R</i>)-3,5-dimethylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>21b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40b</b> following general procedure B. Yellow solid (44%), mp 182–183 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.82 (s, 1H), 7.59 (s, 1H), 7.47 (d, <i>J</i> = 9.2 Hz, 1H), 7.26–7.14 (m, 2H), 7.09 (d, <i>J</i> = 8.9 Hz, 1H), 6.23 (q, <i>J</i> = 6.5 Hz, 1H), 3.62 (d, <i>J</i> = 11.3 Hz, 2H), 3.28–3.13 (m, 2H), 2.45 (t, <i>J</i> = 11.4 Hz, 2H), 1.83 (d, <i>J</i> = 6.6 Hz, 3H), 1.25 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>7</sub>O 535.1654; found 535.1647.</div></div><div id="sec5_1_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>21c</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40c</b> following general procedure B. Beige solid (68%), mp 190 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 2H), 7.82 (s, 1H), 7.57 (d, <i>J</i> = 8.7 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.21–7.13 (m, 2H), 7.05 (d, <i>J</i> = 8.8 Hz, 1H), 6.21 (q, <i>J</i> = 6.7 Hz, 1H), 3.29–3.21 (m, 4H), 2.82–2.71 (m, 4H), 2.44 (s, 3H), 1.81 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (101 MHz, acetone-<i>d</i><sub>6</sub>) δ 153.3, 149.7 (2C), 145.2, 140.3, 138.5, 137.4, 135.1, 132.0 (2C), 122.7, 120.3, 120.5, 114.8, 112.3, 105.1, 98.9, 72.9, 55.8 (2C), 51.1 (2C), 45.9, 19.0. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>7</sub>O 521.1498; found 521.1493.</div></div><div id="sec5_1_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-(4-ethylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>21d</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40d</b> following general procedure B. Yellow solid (58%), mp 185–186 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.82 (s, 1H), 7.62 (s, 1H), 7.48 (d, <i>J</i> = 8.9 Hz, 1H), 7.22–7.04 (m, 3H), 6.24 (q, <i>J</i> = 6.7 Hz, 1H), 3.30–3.23 (m, 4H), 2.78–2.67 (m, 4H), 2.55 (q, <i>J</i> = 7.3 Hz, 2H), 1.84 (d, <i>J</i> = 6.6 Hz, 3H), 1.18 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>7</sub>O 535.1654; found 535.1651.</div></div><div id="sec5_1_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)morpholine (<b>21e</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40e</b> following general procedure B. Beige solid (52%), mp 185 °C. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ 12.51 (s, 1H), 8.51 (s, 2H), 8.04 (d, <i>J</i> = 2.2 Hz, 1H), 7.62 (d, <i>J</i> = 8.6 Hz, 1H), 7.53 (d, <i>J</i> = 9.0 Hz, 1H), 7.24–7.14 (m, 2H), 7.05 (dd, <i>J</i> = 8.8, 1.8 Hz, 1H), 6.20 (q, <i>J</i> = 6.5 Hz, 1H), 3.88–3.79 (m, 4H), 3.21–3.13 (m, 4H), 1.84 (d, <i>J</i> = 6.6 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> 508.1181; found 508.1179.</div></div><div id="sec5_1_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-(4-methyl-1,4-diazepan-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole (<b>21f</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40f</b> following general procedure B. Yellow solid (57%), mp 145–147 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 2H), 7.82 (s, 1H), 7.60–7.42 (m, 2H), 7.15 (d, <i>J</i> = 9.0 Hz, 1H), 6.93–6.78 (m, 2H), 6.21 (q, <i>J</i> = 6.7 Hz, 1H), 3.70–3.61 (m, 2H), 3.54 (t, <i>J</i> = 6.2 Hz, 2H), 2.93–2.85 (m, 2H), 2.77–2.69 (m, 2H), 2.45 (s, 3H), 2.16–2.04 (m, 2H), 1.81 (d, <i>J</i> = 6.6 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>7</sub>O 535.1654; found 535.1650.</div></div><div id="sec5_1_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>N</i><sup>1</sup>-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)-<i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>-dimethylethane-1,2-diamine (<b>21g</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40g</b> following general procedure B. Yellow solid (48%), mp 140–142 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 2H), 7.80 (s, 1H), 7.54–7.41 (m, 2H), 7.15 (d, <i>J</i> = 10.1 Hz, 1H), 6.81 (s, 1H), 6.73 (d, <i>J</i> = 8.7 Hz, 1H), 6.22 (q, <i>J</i> = 6.6 Hz, 1H), 3.30 (t, <i>J</i> = 6.3 Hz, 2H), 2.64 (t, <i>J</i> = 6.3 Hz, 2H), 2.33 (s, 6H), 1.82 (d, <i>J</i> = 6.7 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>7</sub>O 509.1498; found 509.1503.</div></div><div id="sec5_1_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)-<i>N</i>-(2-methoxyethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-amine (<b>21h</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>40h</b> following general procedure B. Yellow solid (55%), mp 132–133 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 2H), 7.80 (d, <i>J</i> = 1.8 Hz, 1H), 7.51–7.40 (m, 2H), 7.15 (dd, <i>J</i> = 9.0, 2.1 Hz, 1H), 6.85 (s, 1H), 6.76 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 6.22 (q, <i>J</i> = 6.7 Hz, 1H), 3.64 (t, <i>J</i> = 5.4 Hz, 2H), 3.40 (s, 3H), 3.34 (t, <i>J</i> = 5.4 Hz, 2H), 1.82 (d, <i>J</i> = 6.6 Hz, 3H). HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> 496.1181; found 496.1171.</div></div><div id="sec5_1_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 2-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)ethan-1-ol (<b>22</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>41</b> following general procedure B. White solid (77%), mp 150–151 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 2H), 7.82 (d, <i>J</i> = 2.2 Hz, 1H), 7.59 (s, 1H), 7.55–7.44 (m, 2H), 7.21–7.13 (m, 2H), 6.23 (q, <i>J</i> = 6.7 Hz, 1H), 3.84 (t, <i>J</i> = 7.1 Hz, 2H), 3.35 (s, 1H), 2.98 (t, <i>J</i> = 7.1 Hz, 2H), 1.82 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 154.1, 149.8 (2C), 148.8, 146.3, 139.1, 136.8, 135.0, 132.7 (2C), 125.0, 122.8, 120.9, 119.4, 112.5, 104.9, 73.7, 64.8, 40.6, 18.9. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub> 467.0916; found 467.0918.</div></div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Procedure C: Synthesis of Ethers <b>24a</b>–<b>e</b> and <b>32a</b>–<b>c</b></h4><div class="NLM_p last">5-Hydroxyindole (1.1 mmol) and cesium carbonate (1.2 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (10 mL) was heated to 70 °C. Benzyl chloride (<b>23a</b>–<b>e</b>) or methanesulfonate (<b>31a</b>–<b>c</b>) (1 mmol) was added, and the mixture was stirred for 2 h. Water was added, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, v/v, 90:10) to give the desired product.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Procedure D: Synthesis of Aldehydes <b>25a</b>–<b>e</b> and <b>33a</b>–<b>c</b></h4><div class="NLM_p last">5-Substituted indole (<b>24a</b>–<b>e, 32a</b>–<b>c</b>) (0.58 mmol) was dissolved in water (6 mL) and dioxane (6 mL). Sodium nitrite (5.8 mmol) was added, and the solution was cooled to 0 °C. Hydrochloric acid (3 mL, 3 N) was added dropwise over 5 min, and the resulting mixture was then stirred at room temperature for additional 3 h. Ethyl acetate was added, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (petroleum ether/dichloromethane, v/v, 90:10) to give the desired product.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> General Procedure E: Synthesis of Substituted 2-Nitroanilines <b>26d</b>, <b>27</b>, and <b>40a</b>–<b>h</b></h4><div class="NLM_p">A mixture of 5-fluoro-2-nitroaniline (<b>26a</b>) (468 mg, 3 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (1.4 mL, 7.5 mmol), and nucleophiles in <i>N</i>-methyl-2-pyrrolidone (20 mL) was heated to 120 °C for 4 h. The reaction mixture was poured into water and extracted with ethyl acetate. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol, v/v, 97:3) to give the desired product.</div><div id="sec5_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Chiral Synthesis of (<i>R</i>)-<b>21c</b></h5></div><div id="sec5_1_5_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Step 1: (<i>S</i>)-1-(3,5-Dichloropyridin-4-yl)ethan-1-ol ((<i>S</i>)-<b>30a</b>)</h5><div class="NLM_p last">A mixture of <b>30a</b> (3.6 g, 18.8 mmol), (<i>R</i>)-2-(2,4-dichlorophenoxy)propanoic acid<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (<b>42</b>) (2.2 g, 9.4 mmol), and 4-dimethylaminopyridine (114 mg, 0.94 mmol) was dissolved in anhydrous toluene (100 mL). Dicyclohexylcarbodiimide (1.94 g, 9.4 mmol) was added slowly to the mixture at 0 °C. The resulting slurry was stirred at ambient temperature for 20 min and filtered. The filtrate was concentrated in vacuum and purified by silica gel chromatography (petroleum ether/ethyl acetate, v/v, 95:5) to give the corresponding ester as a pale yellow oil (3.8 g, 49%). The resulting ester was dissolved in ethanol (40 mL), and aqueous sodium hydroxide (24 mL, 2 N) was added. The reaction mixture was stirred at ambient temperature for 2 h, then the solvent was evaporated in vacuum. The mixture was partitioned between water and dichloromethane. The organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated in vacuum to give (<i>S</i>)-<b>30a′</b> as a colorless oil (1.75 g, 98%). The aqueous layer was acidified to pH = 2 with 2 N HCl and filtered, and the filter cake was collected and dried to retrieve <b>42</b> as a white solid (2.1 g, 98%). The above-mentioned method was repeated once to give (<i>S</i>)-<b>30a</b> as a colorless oil (830 mg, 23% for two steps). [α]<sup>20</sup><sub>D</sub> = +12.07 (<i>c</i> 0.340, methanol) (98% ee, CHIRALPAK AD-H, <i>n</i>-heptane/EtOH = 90:10, flow rate 1.0 mL/min, <i>t</i><sub>R</sub> = 10.1 min, peak 2).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.44 (s, 2H), 5.59–5.46 (m, 1H), 2.82 (d, <i>J</i> = 9.6 Hz, 1H), 1.63 (d, <i>J</i> = 7.8 Hz, 3H).</div></div><div id="sec5_1_5_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Step 2: (<i>S</i>)-1-(3,5-Dichloropyridin-4-yl)ethylmethanesulfonate ((<i>S</i>)-<b>31a</b>)</h5><div class="NLM_p last">Compound (<i>S</i>)-<b>30a</b> (800 mg, 4.2 mmol) and triethylamine (0.88 mL, 6.2 mmol) were dissolved in anhydrous dichloromethane (20 mL). Methanesulfonyl chloride (0.5 mL, 6.2 mmol) was added dropwise at 0 °C. After the addition was complete, the resulting mixture was stirred at room temperature for 2 h. Water was added, and the reaction mixture was partitioned between dichloromethane and water. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum to give the title product as a white solid (1.1 g, 95%), mp 46–48 °C. [α]<sup>20</sup><sub>D</sub> = −40.06 (<i>c</i> 0.304, methanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 2H), 6.36 (q, <i>J</i> = 6.9 Hz, 1H), 2.97 (s, 3H), 1.81 (d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec5_1_5_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 3: (<i>R</i>)-5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indole ((<i>R</i>)-<b>32a</b>)</h5><div class="NLM_p last">The title compound was prepared from (<i>S</i>)-<b>31a</b> following general procedure C. Colorless oil (85%). [α]<sup>20</sup><sub>D</sub> = +47.66 (<i>c</i> 0.107, methanol) (89% ee, CHIRALPAK AD-H, <i>n</i>-hexane/<i>i</i>-prOH = 90:10, flow rate 1.0 mL/min, <i>t</i><sub>R</sub> = 18.8 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (s, 2H), 8.11 (s, 1H), 7.23 (d, <i>J</i> = 8.8 Hz, 1H), 7.14 (t, <i>J</i> = 2.8 Hz, 1H), 6.99 (d, <i>J</i> = 2.4 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.41–6.39 (m, 1H), 6.02 (q, <i>J</i> = 6.7 Hz, 1H), 1.79 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec5_1_5_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Step 4: (<i>R</i>)-5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1<i>H</i>-indazole-3-carbaldehyde ((<i>R</i>)-<b>33a</b>)</h5><div class="NLM_p last">The title compound was prepared from (<i>R</i>)-<b>32a</b> following general procedure D. The obtained solid was suspended in ethyl acetate and stirred for 30 min. The slurry was filtered, and the filter cake was dried in vacuum to give (<i>R</i>)-<b>33a</b>. Yellow solid (55%), mp 188 °C. [α]<sup>20</sup><sub>D</sub> = +76.33 (<i>c</i> 0.207, methanol) (99% ee, CHIRALPAK AD-H, <i>n</i>-Hexane/<i>i</i>-prOH = 90:10, flow rate 1.0 mL/min, <i>t</i><sub>R</sub> = 18.2 min). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.13 (s, 1H), 8.37 (s, 2H), 7.52 (s, 1H), 7.41 (d, <i>J</i> = 9.0 Hz, 1H), 7.13 (d, <i>J</i> = 9.1 Hz, 1H), 6.07 (q, <i>J</i> = 6.7 Hz, 1H), 1.78 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec5_1_5_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Step 5: (<i>R</i>)-5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(5-(4-methylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-1<i>H</i>-indazole ((<i>R</i>)-<b>21c</b>)</h5><div class="NLM_p last">The title compound was prepared from (<i>R</i>)-<b>33a</b> following general procedure B. Pale yellow solid (62%), mp 199 °C. [α]<sup>20</sup><sub>D</sub> = +229.29 (<i>c</i> 0.218, methanol) (99% ee, CHIRALPAK IE, <i>n</i>-hexane/EtOH/diethylamine = 70:30:0.1 (v/v/v), flow rate 0.8 mL/min, <i>t</i><sub>R</sub> = 20.7 min). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 2H), 7.82 (s, 1H), 7.57 (d, <i>J</i> = 8.7 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.21–7.13 (m, 2H), 7.05 (d, <i>J</i> = 8.8 Hz, 1H), 6.21 (q, <i>J</i> = 6.7 Hz, 1H), 3.29–3.21 (m, 4H), 2.82–2.71 (m, 4H), 2.44 (s, 3H), 1.81 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (101 MHz, acetone-<i>d</i><sub>6</sub>) δ 153.3, 149.7 (2C), 145.2, 140.3, 138.5, 137.4, 135.1, 132.0 (2C), 122.7, 120.3, 120.5, 114.8, 112.3, 105.1, 98.9, 72.9, 55.8 (2C), 51.1 (2C), 45.9, 19.0. HRMS (EI<sup>+</sup>) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>7</sub>O 521.1498; found 521.1493.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Kinase Profiling</h3><div class="NLM_p">The kinase profiling of (<i>R</i>)-<b>21c</b> was conducted using Elisa kinase assay and the Eurofins Kinase Profiler Selectivity Testing Service.</div><div class="NLM_p">Elisa kinase assay: The effects of indicated compounds on the activities of various tyrosine kinases were determined using enzyme-linked immunosorbent assays (ELISAs) with purified recombinant proteins. Briefly, 20 μg/mL poly(Glu, Tyr) 4:1 (Sigma, St Louis, MO, USA) was precoated in 96-well plates as a substrate. A 50-μL aliquot of 10 μM ATP solution diluted in kinase reaction buffer (50 mM HEPES [pH 7.4], 50 mM MgCl<sub>2</sub>, 0.5 mM MnCl<sub>2</sub>, 0.2 mM Na<sub>3</sub>VO<sub>4</sub>, and 1 mM DTT) was added to each well; 1 μL of various concentrations of indicated compounds diluted in 1% DMSO (v/v) (Sigma, St Louis, MO, USA) were then added to each reaction well. DMSO (1%, v/v) was used as the negative control. The kinase reaction was initiated by the addition of purified tyrosine kinase proteins (FGFR1, FGFR2, FGFR3, FGFR4, VEGFR2, EGFR, ErbB2, PDGFRα, PDGFRβ, c-Met, Flt1, Flt3, RET, c-Src, Bcr-Abl, and EPHA2) diluted in 49 μL of kinase reaction buffer. After incubation for 60 min at 37 °C, the plate was washed for three times with phosphate-buffered saline (PBS) containing 0.1% Tween 20 (T-PBS). Antiphosphotyrosine (PY99) antibody (100 μL; 1:500, diluted in 5 mg/mL BSA T-PBS) was then added. After a 30 min incubation at 37 °C, the plate was washed for three times, and 100 μL of horseradish peroxidase-conjugated goat antimouse IgG (1:1000, diluted in 5 mg/mL BSA T-PBS) was added. The plate was then incubated at 37 °C for 30 min and washed for three times. A 100-μL aliquot of a solution containing 0.03% H<sub>2</sub>O<sub>2</sub> and 2 mg/mL <i>o</i>-phenylenediamine in 0.1 M citrate buffer (pH 5.5) was added. The reaction was terminated by the addition of 50 μL of 2 M H<sub>2</sub>SO<sub>4</sub> as the color changed, and the plate was analyzed using a multiwell spectrophotometer (SpectraMAX190, from Molecular Devices, Palo Alto, CA, USA) at 490 nm. The inhibition rate (%) was calculated using the following equation: [1-(A490/A490 control)] × 100%. The IC<sub>50</sub> values were calculated from the inhibition curves in two independent experiments.</div><div class="NLM_p last">The activity of (<i>R</i>)-<b>21c</b>, at a concentration of 100 nM using an ATP concentration of 10 μM, was screened against a panel of other 43 human protein kinases by Eurofins using the Eurofins Kinase Profiler Selectivity Testing Service.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Cell Culture</h3><div class="NLM_p last">The human lung cancer cell line NCI-H1581, human acute myelogenous leukemia cancer cell line KG-1, and human gastric cancer cell line SNU-16 were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA); human bladder cancer cell line RT112 was purchased from DSMZ-German collection of microorganisms and cell cultures. All the cell lines were routinely maintained in media according to the suppliers’ recommendations.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells were seeded in 96-well cell culture plates. On the day when seeding, the cells were exposed to various concentrations of compounds and further cultured for 72 h at 37 °C. Cell proliferation was then determined using Cell Counts Kit-8 (CCK8) or the thiazolyl blue tetrazolium bromide (MTT, from Sigma-Aldrich, St. Louis, MO, USA) assay. The IC<sub>50</sub> values were calculated by concentration–response curve fitting using the four-parameter method.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Statistical Analysis</h3><div class="NLM_p last">Data from the <i>in vitro</i> assays are presented as the mean ± SD. The statistical difference between multiple treatments and controls was analyzed using Student’s <i>t</i> test. <i>P</i> < 0.05 versus control group was considered statistically significant.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Pharmacokinetic Parameters Obtained in Rats</h3><div class="NLM_p last">Compound (<i>R</i>)-<b>21c</b> or (<i>R</i>)-<b>22</b> was administrated to male Sprague–Dawley (SD) rats (<i>n</i> = 3): either as a 1 mg/kg intravenous in 10% DMSO + 90% (10% HP-β-CD in PBS) or orally by gavage as a suspension in 0.5% CMC-Na at a 5 mg/kg dose. Blood samples were collected at 0.08, 0.25, 0.5, 1, 1.5, 2, 4, 8, and 24 h time points following intravenous dosing and at 0.25, 0.5, 1, 1.5, 2, 4, 6, 8, and 24 h following oral dosing. The blood samples were placed on wet ice, and serum was collected after centrifugation. Serum samples were frozen and stored at −80 °C. The serum samples were analyzed utilizing HPLC-coupled tandem mass spectrometry (LC–MS/MS).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Western Blot Analysis</h3><div class="NLM_p last">KG-1 cell and SNU-16 cell were treated with the indicated dose of (<i>R</i>)-<b>21c</b> for 2 h and then lysed in 1× sodium dodecyl sulfate (SDS) sample buffer. The cell lysates were subsequently resolved by 10% SDS-PAGE and transferred to nitrocellulose membranes. The membranes were probed with the appropriate primary antibodies [phospho-FGFR1, FGFR1, phospho-FGFR2, FGFR2, phospho-ERK, ERK, PLCγ (all from Cell Signaling Technology, Beverly, MA, USA), phospho-PLCγ, GAPDH (KangChen Biotech, Shanghai, China)] and then with horseradish peroxidase-conjugated antirabbit or antimouse IgG. The immunoreactive proteins were detected using an enhanced chemilluminescense detection reagent (Thermo Fisher Scientific, Rockford, IL, USA).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>In Vivo</i> Antitumor Activity Studies</h3><div class="NLM_p">Female nude mice (4–6 weeks) were housed at five or six mice per cage in a specific pathogen free room with a 12 h light/dark schedule at 25 ± 1 °C; the animals were fed an autoclaved chow diet and water ad libitum. All animal experiments were performed according to the institutional ethical guidelines on animal care and approved by the Institute Animal Care and Use Committee at Shanghai Institute of Materia Medica (approval number: 2014-03-DJ-13).</div><div class="NLM_p last">NCI-H1581 cells at a density of 5 × 10<sup>6</sup> were first implanted subcutaneously into the right flank of each mouse and then allowed to grow to 700–800 mm<sup>3</sup>, which was defined as a well-developed tumor. The well-developed tumors were cut into 1.5 mm<sup>3</sup> fragments and transplanted s.c. into the right flank of nude mice using a tracer. When the tumor volume reached 115 mm<sup>3</sup>, the mice were randomly assigned into control and treatment groups. The control groups were given vehicle alone, and the treatment groups received (<i>R</i>)-<b>21c</b> at the indicated doses via oral administration once daily for 21 days. Compound <b>5</b> was a positive drug. The sizes of the tumors were measured twice per week using microcalipers. The tumor volume (TV) was calculated as follows: TV = (length × width<sup>2</sup>)/2. The tumor volume shown was obtained on the indicated days as the median tumor volume ± SEM for indicated groups of mice. The relative tumor volume (RTV) values were measured on the final day of the study for the drug-treated mice compared with the vehicle-treated mice and were calculated as RTV = <i>V</i><sub>t</sub>/<i>V</i><sub>0</sub>, where <i>V</i><sub>0</sub> is the tumor volume at day 0 and <i>V</i><sub>t</sub> is the tumor volume measured each time point. The percentage of tumor growth inhibition (TGI) values were also measured. Significant differences between the treated versus the control groups (<i>P</i> ≤ 0.05) were determined using Student’s <i>t</i> test.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Molecular Modeling</h3><div class="NLM_p last">X-ray protein structure of FGFR1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WJ6">3WJ6</a><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) obtained in Protein Data Bank<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> was prepared with Protein Preparation Wizard panel as implemented in Maestro 9.0.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Both bond orders and hydrogen atoms were assigned, and water molecules were removed. Hydrogen bond assignment and Impref minimization were performed subsequently. The size of box was set to 15 Å × 15 Å × 15 Å centered in native ligand. Molecular docking simulations were conducted using Glide 5.5<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with extra precision (Glide XP) mode.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Both the native ligand and the indicated compounds were built using 2D Sketcher and were prepared with LigPrep<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> with OPLS2005 force field,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> generating possible states at pH 7.0 ± 2.0 using Epik 2.0 module.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> Prior to docking the indicated compound, a redocking run was performed to evaluate the docking performance of Glide XP mode. Glide extra precision mode (Glide XP)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> was successful in reproducing the binding mode of native ligand with a RMSD value of 1.19 Å. <a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a> were generated with PyMOL version 1.7.0.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00056">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00056" class="ext-link">10.1021/acs.jmedchem.6b00056</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of intermediates <b>30</b>–<b>31</b>; analytical data for compounds <b>24</b>–<b>27</b>, <b>32</b>–<b>33</b>, <b>40</b>, (<i>S</i>)-<b>21c</b>, (<i>R</i>)-<b>22</b>, and (<i>S</i>)-<b>22</b>; supplementary kinase inhibition profile of (<i>R</i>)-<b>21c</b>; HPLC analysis of all target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_001.pdf">jm6b00056_si_001.pdf (198.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_002.csv">jm6b00056_si_002.csv (4.49 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00056" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Ai</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-tumor Pharmacology, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#412b20280132282c2c6f20226f222f"><span class="__cf_email__" data-cfemail="c8a2a9a188bba1a5a5e6a9abe6aba6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meiyu Geng</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-tumor Pharmacology, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e78a9e80828980a7948e8a8ac98684c98489"><span class="__cf_email__" data-cfemail="c9a4b0aeaca7ae89baa0a4a4e7a8aae7aaa7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenhu Duan</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, East China University of Science
& Technology, 130
Mei Long Road, Shanghai 200237, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1d6c9c5d4c0cfe1d2c8cccc8fc0c28fc2cf"><span class="__cf_email__" data-cfemail="99eef1fdecf8f7d9eaf0f4f4b7f8fab7faf7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Yan</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, East China University of Science
& Technology, 130
Mei Long Road, Shanghai 200237, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinyi Wang</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-tumor Pharmacology, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Dai</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-tumor Pharmacology, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Zhao</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinying Yang</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-tumor Pharmacology, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Fan</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinglei Gao</span> - <span class="hlFld-Affiliation affiliation">Division
of Anti-tumor Pharmacology, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fanwang Meng</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, College of Sciences, Shanghai
University, 99 Shang
Da Road, Shanghai 200444, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Discovery & Design Center, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuming Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Luo</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery & Design Center, State Key Laboratory of Drug Research,
Shanghai Institute of Materia Medica, Chinese
Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d117e5435-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the National Natural Science Foundation of China (81273365, 81573271, 91229205, 81473243, and 81321092), National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program” (2014ZX09304002-008-001 and 2012ZX09301001-007), the Funding of Shanghai Institute of Materia Medica (CASIMM0120152005 and CASIMM01d20151011), and Chinese Academy of Sciences “Strategic Priority Research Program” (XDA12020303) for their financial support. SA-SIBS Scholarship Program is also gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> ABBREVIATIONS USED</h2><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DDQ</td><td class="NLM_def"><p class="first last">2,3-dichloro-5,6-dicyano-1,4-benzoquinone</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropylamide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Touat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ileana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postel-Vinay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J. C.</span><span> </span><span class="NLM_article-title">Targeting FGFR signaling in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2684</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1078-0432.CCR-14-2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=26078430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVajurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2684-2694&author=M.+Touatauthor=E.+Ileanaauthor=S.+Postel-Vinayauthor=F.+Andreauthor=J.+C.+Soria&title=Targeting+FGFR+signaling+in+cancer&doi=10.1158%2F1078-0432.CCR-14-2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting FGFR Signaling in Cancer</span></div><div class="casAuthors">Touat, Mehdi; Ileana, Ecaterina; Postel-Vinay, Sophie; Andre, Fabrice; Soria, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2684-2694</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fibroblast growth factor signaling pathway (FGFR signaling) is an evolutionary conserved signaling cascade that regulates several basic biol. processes, including tissue development, angiogenesis, and tissue regeneration.  Substantial evidence indicates that aberrant FGFR signaling is involved in the pathogenesis of cancer.  Recent developments of deep sequencing technologies have allowed the discovery of frequent mol. alterations in components of FGFR signaling among several solid tumor types.  Moreover, compelling preclin. models have demonstrated the oncogenic potential of these aberrations in driving tumor growth, promoting angiogenesis, and conferring resistance mechanisms to anticancer therapies.  Recently, the field of FGFR targeting has exponentially progressed thanks to the development of novel agents inhibiting FGFs or FGFRs, which had manageable safety profiles in early-phase trials.  Promising treatment efficacy has been obsd. in different types of malignancies, particularly in tumors harboring aberrant FGFR signaling, thus offering novel therapeutic opportunities in the era of precision medicine.  The most exciting challenges now focus on selecting patients who are most likely to benefit from these agents, increasing the efficacy of therapies with the development of novel potent compds. and combination strategies, and overcoming toxicities assocd. with FGFR inhibitors.  After examn. of the basic and translational research studies that validated the oncogenic potential of aberrant FGFR signaling, this review focuses on recent data from clin. trials evaluating FGFR targeting therapies and discusses the challenges and perspectives for the development of these agents.  Clin Cancer Res; 21(12); 2684-94. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZpKbvUn0hrVg90H21EOLACvtfcHk0lgRbB82--iFJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVajurfP&md5=3dbb11de3f3a7d25d3b4ccb56400fd4d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-2329%26sid%3Dliteratum%253Aachs%26aulast%3DTouat%26aufirst%3DM.%26aulast%3DIleana%26aufirst%3DE.%26aulast%3DPostel-Vinay%26aufirst%3DS.%26aulast%3DAndre%26aufirst%3DF.%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26atitle%3DTargeting%2520FGFR%2520signaling%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D2684%26epage%3D2694%26doi%3D10.1158%2F1078-0432.CCR-14-2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kelleher, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viterbo, A.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptors, developmental corruption and malignant disease</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2198</span><span class="NLM_x">–</span> <span class="NLM_lpage">2205</span><span class="refDoi"> DOI: 10.1093/carcin/bgt254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Fcarcin%2Fbgt254" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2198-2205&author=F.+C.+Kelleherauthor=H.+O%E2%80%99Sullivanauthor=E.+Smythauthor=R.+McDermottauthor=A.+Viterbo&title=Fibroblast+growth+factor+receptors%2C+developmental+corruption+and+malignant+disease&doi=10.1093%2Fcarcin%2Fbgt254"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt254%26sid%3Dliteratum%253Aachs%26aulast%3DKelleher%26aufirst%3DF.%2BC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DH.%26aulast%3DSmyth%26aufirst%3DE.%26aulast%3DMcDermott%26aufirst%3DR.%26aulast%3DViterbo%26aufirst%3DA.%26atitle%3DFibroblast%2520growth%2520factor%2520receptors%252C%2520developmental%2520corruption%2520and%2520malignant%2520disease%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D2198%26epage%3D2205%26doi%3D10.1093%2Fcarcin%2Fbgt254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Weiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltermann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leenders, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabow, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Querings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heukamp, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balke-Want, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baessmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainer, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorimier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustugun, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel-Riedel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timens, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sietsma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heideman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligorio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoelben, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span> </span><span class="NLM_article-title">Frequent and focal FGFR1amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">62ra93</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3001451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1126%2Fscitranslmed.3001451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=21160078" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=62ra93&author=J.+Weissauthor=M.+L.+Sosauthor=D.+Seidelauthor=M.+Peiferauthor=T.+Zanderauthor=J.+M.+Heuckmannauthor=R.+T.+Ullrichauthor=R.+Menonauthor=S.+Maierauthor=A.+Soltermannauthor=H.+Mochauthor=P.+Wagenerauthor=F.+Fischerauthor=S.+Heynckauthor=M.+Kokerauthor=J.+Schottleauthor=F.+Leendersauthor=F.+Gablerauthor=I.+Dabowauthor=S.+Queringsauthor=L.+C.+Heukampauthor=H.+Balke-Wantauthor=S.+Ansenauthor=D.+Rauhauthor=I.+Baessmannauthor=J.+Altmullerauthor=Z.+Wainerauthor=M.+Conronauthor=G.+Wrightauthor=P.+Russellauthor=B.+Solomonauthor=E.+Brambillaauthor=C.+Brambillaauthor=P.+Lorimierauthor=S.+Sollbergauthor=O.+T.+Brustugunauthor=W.+Engel-Riedelauthor=C.+Ludwigauthor=I.+Petersenauthor=J.+Sangerauthor=J.+Clementauthor=H.+Groenauthor=W.+Timensauthor=H.+Sietsmaauthor=E.+Thunnissenauthor=E.+Smitauthor=D.+Heidemanauthor=F.+Cappuzzoauthor=C.+Ligorioauthor=S.+Damianiauthor=M.+Hallekauthor=R.+Beroukhimauthor=W.+Paoauthor=B.+Kleblauthor=M.+Baumannauthor=R.+Buettnerauthor=K.+Ernestusauthor=E.+Stoelbenauthor=J.+Wolfauthor=P.+Nurnbergauthor=S.+Pernerauthor=R.+K.+Thomas&title=Frequent+and+focal+FGFR1amplification+associates+with+therapeutically+tractable+FGFR1+dependency+in+squamous+cell+lung+cancer&doi=10.1126%2Fscitranslmed.3001451"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001451%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DSeidel%26aufirst%3DD.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DZander%26aufirst%3DT.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DUllrich%26aufirst%3DR.%2BT.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DMaier%26aufirst%3DS.%26aulast%3DSoltermann%26aufirst%3DA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DWagener%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DF.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DSchottle%26aufirst%3DJ.%26aulast%3DLeenders%26aufirst%3DF.%26aulast%3DGabler%26aufirst%3DF.%26aulast%3DDabow%26aufirst%3DI.%26aulast%3DQuerings%26aufirst%3DS.%26aulast%3DHeukamp%26aufirst%3DL.%2BC.%26aulast%3DBalke-Want%26aufirst%3DH.%26aulast%3DAnsen%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DBaessmann%26aufirst%3DI.%26aulast%3DAltmuller%26aufirst%3DJ.%26aulast%3DWainer%26aufirst%3DZ.%26aulast%3DConron%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DRussell%26aufirst%3DP.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DBrambilla%26aufirst%3DE.%26aulast%3DBrambilla%26aufirst%3DC.%26aulast%3DLorimier%26aufirst%3DP.%26aulast%3DSollberg%26aufirst%3DS.%26aulast%3DBrustugun%26aufirst%3DO.%2BT.%26aulast%3DEngel-Riedel%26aufirst%3DW.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DI.%26aulast%3DSanger%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DJ.%26aulast%3DGroen%26aufirst%3DH.%26aulast%3DTimens%26aufirst%3DW.%26aulast%3DSietsma%26aufirst%3DH.%26aulast%3DThunnissen%26aufirst%3DE.%26aulast%3DSmit%26aufirst%3DE.%26aulast%3DHeideman%26aufirst%3DD.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DLigorio%26aufirst%3DC.%26aulast%3DDamiani%26aufirst%3DS.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DM.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DErnestus%26aufirst%3DK.%26aulast%3DStoelben%26aufirst%3DE.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DNurnberg%26aufirst%3DP.%26aulast%3DPerner%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26atitle%3DFrequent%2520and%2520focal%2520FGFR1amplification%2520associates%2520with%2520therapeutically%2520tractable%2520FGFR1%2520dependency%2520in%2520squamous%2520cell%2520lung%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D62ra93%26doi%3D10.1126%2Fscitranslmed.3001451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tomiguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto-Ibusuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto-Yamaguchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sueta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span> </span><span class="NLM_article-title">FGFR1 protein expression is associated with prognosis in ER-positive/HER2-negative primary breast cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="refDoi"> DOI: 10.1111/cas.12897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1111%2Fcas.12897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=26801869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVymtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=491&author=M.+Tomiguchiauthor=Y.+Yamamotoauthor=M.+Yamamoto-Ibusukiauthor=L.+Goto-Yamaguchiauthor=Y.+Fujikiauthor=S.+Fujiwaraauthor=A.+Suetaauthor=M.+Hayashiauthor=T.+Takeshitaauthor=T.+Inaoauthor=H.+Iwase&title=FGFR1+protein+expression+is+associated+with+prognosis+in+ER-positive%2FHER2-negative+primary+breast+cancer&doi=10.1111%2Fcas.12897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer</span></div><div class="casAuthors">Tomiguchi, Mai; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Goto-Yamaguchi, Lisa; Fujiki, Yoshitaka; Fujiwara, Saori; Sueta, Aiko; Hayashi, Mitsuhiro; Takeshita, Takashi; Inao, Touko; Iwase, Hirotaka</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-498</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Recently, research into the development of new targeted therapies has focused on specific genetic alterations to create advanced, more personalized treatment.  One of the target genes, fibroblast growth factor receptor-1 (FGFR1), has been reported to be amplified in estrogen receptor (ER)-pos. subtype breast cancer, and is considered one possible mechanism of endocrine resistance through cross-talk between ER and growth factor receptor signaling.  We performed a comprehensive anal. of FGFR1 at the levels of gene copy no., transcript and protein expression, and examd. the relationships between FGFR1 status and clinicopathol. parameters, including prognosis in 307 ER-pos./HER2-neg. primary breast cancer patients treated with std. care at our institute.  Most notably, a high level of FGFR1 protein expression was obsd. in 85 patients (27.7%), and was pos. assocd. with invasive tumor size (P = 0.039).  Furthermore, univariate anal. revealed that high FGFR1 protein expression was significantly correlated with poor relapse-free survival rate (P = 0.0019, HR: 2.63, 95% confidence interval: 1.17-5.98), and showed a tendency towards an increase in recurrent events if the observation period extended beyond the 5 years of the std. endocrine treatment term.  FGFR1 gain/amplification was found in 43 (14.0%) patients, which was only assocd. with higher nuclear grade (P = 0.010).  No correlation was found between FGFR1 mRNA expression levels and any clinicopathol. factors.  Overall, the level of FGFR1 protein expression may be a biomarker of ER-pos./HER2-neg. primary breast cancer with possible resistance to std. treatment, and may be a useful tool to identify more specific patients who would benefit from FGFR-1 targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89jP4QEld57Vg90H21EOLACvtfcHk0ljyz7K5eEgeDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVymtbk%253D&md5=977a39539ae0124dd43b7a102f271107</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fcas.12897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12897%26sid%3Dliteratum%253Aachs%26aulast%3DTomiguchi%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamamoto-Ibusuki%26aufirst%3DM.%26aulast%3DGoto-Yamaguchi%26aufirst%3DL.%26aulast%3DFujiki%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DSueta%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DTakeshita%26aufirst%3DT.%26aulast%3DInao%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DH.%26atitle%3DFGFR1%2520protein%2520expression%2520is%2520associated%2520with%2520prognosis%2520in%2520ER-positive%252FHER2-negative%2520primary%2520breast%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2016%26volume%3D107%26spage%3D491%26doi%3D10.1111%2Fcas.12897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Shoji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span> </span><span class="NLM_article-title">Amplification of FGFR2 gene in patients with advanced gastric cancer receiving chemotherapy: prevalence and prognostic significance</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">5055</span><span class="NLM_x">–</span> <span class="NLM_lpage">5061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=26254407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2itL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=5055-5061&author=H.+Shojiauthor=Y.+Yamadaauthor=N.+Okitaauthor=A.+Takashimaauthor=Y.+Honmaauthor=S.+Iwasaauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimada&title=Amplification+of+FGFR2+gene+in+patients+with+advanced+gastric+cancer+receiving+chemotherapy%3A+prevalence+and+prognostic+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of FGFR2 gene in patients with advanced gastric cancer receiving chemotheraphy: prevalence and prognostic significance</span></div><div class="casAuthors">Shoji, Hirokazu; Yamada, Yasuhide; Okita, Natsuko; Takashima, Atsuo; Honma, Yoshitaka; Iwasa, Satoru; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5055-5062</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: fibroblast growth factors and their receptors regulate key cellular functions, such as proliferation, differentiation and survival. herein, we studied the prevalence and prognostic role of fibroblast growth factor receptor 2 (fgfr2) amplification in patients with advanced gastric cancer (agc) who received systemic chemotherapy. patients and methods: the gene copy no. of fgfr2 was investigated in 80 patients with agc who received systemic chemotherapy. fgfr2 gene status was assessed by dual-color fluorescence in-situ hybridization. results: among 80 patients, fgfr2 amplification was obsd. in seven cases (11.5%). patients with fgfr2 amplification had significantly shorter overall survival (os) than did those without fgfr2 amplification (9.1 vs. 16.5 mo; p = 0.037). in multivariate anal., disease status and no. of metastatic sites were assocd. with worse os (p = 0.015 and p = 0.009, resp.). fgfr2 amplification tended to be correlated with a poorer outcome (p = 0.080). conclusion: fgfr2 amplification tended to result in a shorter survival period compared to cases without amplification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHgo8pWCE5JrVg90H21EOLACvtfcHk0ljyz7K5eEgeDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2itL%252FI&md5=17d42d68f8177843e0154453e163986d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoji%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DOkita%26aufirst%3DN.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DHonma%26aufirst%3DY.%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26atitle%3DAmplification%2520of%2520FGFR2%2520gene%2520in%2520patients%2520with%2520advanced%2520gastric%2520cancer%2520receiving%2520chemotherapy%253A%2520prevalence%2520and%2520prognostic%2520significance%26jtitle%3DAnticancer%2520Res.%26date%3D2015%26volume%3D35%26spage%3D5055%26epage%3D5061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Neuzillet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rhijn, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigoda, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bapat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostrom, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleshner, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallie, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotta, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kwast, T. H.</span><span> </span><span class="NLM_article-title">FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer</span> <span class="citation_source-journal">Virchows Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1007/s00428-014-1596-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs00428-014-1596-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=24880661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVCrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2014&pages=207-213&author=Y.+Neuzilletauthor=B.+W.+van+Rhijnauthor=N.+L.+Prigodaauthor=B.+Bapatauthor=L.+Liuauthor=P.+J.+Bostromauthor=N.+E.+Fleshnerauthor=B.+L.+Gallieauthor=A.+R.+Zlottaauthor=M.+A.+Jewettauthor=T.+H.+van+der+Kwast&title=FGFR3+mutations%2C+but+not+FGFR3+expression+and+FGFR3+copy-number+variations%2C+are+associated+with+favourable+non-muscle+invasive+bladder+cancer&doi=10.1007%2Fs00428-014-1596-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer</span></div><div class="casAuthors">Neuzillet, Yann; van Rhijn, Bas W. G.; Prigoda, Nadia L.; Bapat, Bharati; Liu, Liyang; Bostrom, Peter J.; Fleshner, Neil E.; Gallie, Brenda L.; Zlotta, Alexandre R.; Jewett, Michael A. S.; van der Kwast, Theo H.</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-213</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The fibroblast growth factor receptor 3 (FGFR3) is a tyrosine kinase receptor frequently activated by point mutations in bladder cancer (BC).  These mutations are assocd. with genetically stable, Ta and low-grade BC, representing the favorable BC pathway.  Conversely, FGFR3 over-expression was recently found in 40 % of muscle invasive BC.  We examd. FGFR3 mutation status and protein expression in patients originally diagnosed as T1.  We also investigated copy-no. variations in FGFR3 as a possible alternative mechanism to activate FGFR3.  We included 84 patients with T1 BC as their initial diagnosis.  A uropathologist reviewed the slides for grade and (sub)stage.  The FGFR3 mutation status was examd. by PCR-SNaPshot and FGFR3 protein expression by std. immuno-histochem. (FGFR3-B9).  Copy-no. status was detd. in 69/84 cases with nine probes covering nine exons of the FGFR3 gene (MLPA).  Of 27 BC with FGFR3 mutations, 26 (96 %) showed FGFR3 over-expression.  Of the 57 wild-type BC, 27 (47 %) BC showed over-expression.  Pathol. parameters significantly differed (p < 0.01) between mutant and wild-type tumors with the FGFR3 mutation pointing to more favorable BC.  However, if the BC exhibited wild-type FGFR3, FGFR3 protein status had no influence on grade and (sub)stage.  We found six tumors with more than or equal to three copies of FGFR3.  Only 1 of 22 wild-type tumors with over-expression of FGFR3 had more than or equal to three gene copies.  In initially diagnosed T1 BC, only the FGFR3 mutation was significantly assocd. with favorable BC disease characteristics.  In addn. to almost all FGFR3 mutant BC, 47 % of wild-type BC displayed FGFR3 over-expression, suggesting an alternative mechanism to activate FGFR3.  Increased FGFR3 copy no. was a rare event and did not account for this mechanism.  Nevertheless, FGFR3 wild-type tumors with over-expression of the protein may still represent a subset that might potentially benefit from FGFR3-targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph-K2r8F1OEbVg90H21EOLACvtfcHk0ljyz7K5eEgeDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVCrsbg%253D&md5=924327a1f6540fabb5095d18fb62c39b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00428-014-1596-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00428-014-1596-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeuzillet%26aufirst%3DY.%26aulast%3Dvan%2BRhijn%26aufirst%3DB.%2BW.%26aulast%3DPrigoda%26aufirst%3DN.%2BL.%26aulast%3DBapat%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBostrom%26aufirst%3DP.%2BJ.%26aulast%3DFleshner%26aufirst%3DN.%2BE.%26aulast%3DGallie%26aufirst%3DB.%2BL.%26aulast%3DZlotta%26aufirst%3DA.%2BR.%26aulast%3DJewett%26aufirst%3DM.%2BA.%26aulast%3Dvan%2Bder%2BKwast%26aufirst%3DT.%2BH.%26atitle%3DFGFR3%2520mutations%252C%2520but%2520not%2520FGFR3%2520expression%2520and%2520FGFR3%2520copy-number%2520variations%252C%2520are%2520associated%2520with%2520favourable%2520non-muscle%2520invasive%2520bladder%2520cancer%26jtitle%3DVirchows%2520Arch.%26date%3D2014%26volume%3D465%26spage%3D207%26epage%3D213%26doi%3D10.1007%2Fs00428-014-1596-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Taylor, J. G.,  VI</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheuk, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youngblood, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catchpoole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qualman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J.</span><span> </span><span class="NLM_article-title">Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3395</span><span class="NLM_x">–</span> <span class="NLM_lpage">3407</span><span class="refDoi"> DOI: 10.1172/JCI39703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1172%2FJCI39703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3395-3407&author=J.+G.+Taylorauthor=A.+T.+Cheukauthor=P.+S.+Tsangauthor=J.+Y.+Chungauthor=Y.+K.+Songauthor=K.+Desaiauthor=Y.+Yuauthor=Q.+R.+Chenauthor=K.+Shahauthor=V.+Youngbloodauthor=J.+Fangauthor=S.+Y.+Kimauthor=C.+Yeungauthor=L.+J.+Helmanauthor=A.+Mendozaauthor=V.+Ngoauthor=L.+M.+Staudtauthor=J.+S.+Weiauthor=C.+Khannaauthor=D.+Catchpooleauthor=S.+J.+Qualmanauthor=S.+M.+Hewittauthor=G.+Merlinoauthor=S.+J.+Chanockauthor=J.+Khan&title=Identification+of+FGFR4-activating+mutations+in+human+rhabdomyosarcomas+that+promote+metastasis+in+xenotransplanted+models&doi=10.1172%2FJCI39703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI39703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI39703%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DCheuk%26aufirst%3DA.%2BT.%26aulast%3DTsang%26aufirst%3DP.%2BS.%26aulast%3DChung%26aufirst%3DJ.%2BY.%26aulast%3DSong%26aufirst%3DY.%2BK.%26aulast%3DDesai%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%2BR.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DV.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DYeung%26aufirst%3DC.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DWei%26aufirst%3DJ.%2BS.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DCatchpoole%26aufirst%3DD.%26aulast%3DQualman%26aufirst%3DS.%2BJ.%26aulast%3DHewitt%26aufirst%3DS.%2BM.%26aulast%3DMerlino%26aufirst%3DG.%26aulast%3DChanock%26aufirst%3DS.%2BJ.%26aulast%3DKhan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520FGFR4-activating%2520mutations%2520in%2520human%2520rhabdomyosarcomas%2520that%2520promote%2520metastasis%2520in%2520xenotransplanted%2520models%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3395%26epage%3D3407%26doi%3D10.1172%2FJCI39703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gauglhofer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrottmaier, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wingelhofer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naegelen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinzle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte-Hermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krupitza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasl-Kraupp, B.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2338</span><span class="refDoi"> DOI: 10.1093/carcin/bgu151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Fcarcin%2Fbgu151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=25031272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2ltLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=2331-2338&author=C.+Gauglhoferauthor=J.+Paurauthor=W.+C.+Schrottmaierauthor=B.+Wingelhoferauthor=D.+Huberauthor=I.+Naegelenauthor=C.+Pirkerauthor=T.+Mohrauthor=C.+Heinzleauthor=K.+Holzmannauthor=B.+Marianauthor=R.+Schulte-Hermannauthor=W.+Bergerauthor=G.+Krupitzaauthor=M.+Gruschauthor=B.+Grasl-Kraupp&title=Fibroblast+growth+factor+receptor+4%3A+a+putative+key+driver+for+the+aggressive+phenotype+of+hepatocellular+carcinoma&doi=10.1093%2Fcarcin%2Fbgu151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma</span></div><div class="casAuthors">Gauglhofer, Christine; Paur, Jakob; Schrottmaier, Waltraud C.; Wingelhofer, Bettina; Huber, Daniela; Naegelen, Isabelle; Pirker, Christine; Mohr, Thomas; Heinzle, Christine; Holzmann, Klaus; Marian, Brigitte; Schulte-Hermann, Rolf; Berger, Walter; Krupitza, Georg; Grusch, Michael; Grasl-Kraupp, Bettina</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2331-2338</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Recently, we found upregulation of fibroblast growth factor receptor 4 (FGFR4) in a subset of hepatocellular carcinoma (HCC).  Here, we provide mechanistic insight into the role of FGFR4-mediated signalling for the aggressive behavior of HCC cells.  To overexpress FGFR4, hepatoma/hepatocarcinoma cells were transfected with a construct coding for FGFR4.  For downmodulation of endogenous FGFR4, we used small interfering RNA or adenoviral infection with dominant-neg. FGFR4 constructs being either kinase dead (kdFGFR4) or coding for the autoinhibitory sol. domain (solFGFR4).  FGFR4 overexpression in non-tumorigenic hepatocarcinoma cells significantly reduced cell-matrix adhesion, enabled cells to grow anchorage-independently in soft agar, to disintegrate the lymph-/blood-endothelial barrier for intra-/extravasation of tumor cells and to form tumors in SCID mice.  Transcriptome anal. revealed altered expression of genes involved in cell-matrix interactions.  Conversely, in highly tumorigenic cell lines, kdFGFR4 or solFGFR4 lowered the proportion of cells in S phase of the cell cycle, enhanced the G0/G1 and G2/M-phase proportions, reduced anchorage-independent growth in vitro and attenuated disintegration of the lymph-/blood-endothelium and tumor formation in vivo.  These findings were confirmed by altered expression profiles of genes being important for late stages of cell division.  Deregulated FGFR4 expression appears to be one of the key drivers of the malignant phenotype of HCC cells.  Accordingly, blockade of FGFR4-mediated signalling by sol. dominant-neg. constructs, like solFGFR4, may be a feasible and promising therapeutic approach to antagonize aggressive behavior of hepatoma/hepatocarcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM2s006KqFlrVg90H21EOLACvtfcHk0lgKDsZt3epxHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2ltLfF&md5=4703b05e6584d855dbf2eace3ab07a47</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgu151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgu151%26sid%3Dliteratum%253Aachs%26aulast%3DGauglhofer%26aufirst%3DC.%26aulast%3DPaur%26aufirst%3DJ.%26aulast%3DSchrottmaier%26aufirst%3DW.%2BC.%26aulast%3DWingelhofer%26aufirst%3DB.%26aulast%3DHuber%26aufirst%3DD.%26aulast%3DNaegelen%26aufirst%3DI.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DMohr%26aufirst%3DT.%26aulast%3DHeinzle%26aufirst%3DC.%26aulast%3DHolzmann%26aufirst%3DK.%26aulast%3DMarian%26aufirst%3DB.%26aulast%3DSchulte-Hermann%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKrupitza%26aufirst%3DG.%26aulast%3DGrusch%26aufirst%3DM.%26aulast%3DGrasl-Kraupp%26aufirst%3DB.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25204%253A%2520a%2520putative%2520key%2520driver%2520for%2520the%2520aggressive%2520phenotype%2520of%2520hepatocellular%2520carcinoma%26jtitle%3DCarcinogenesis%26date%3D2014%26volume%3D35%26spage%3D2331%26epage%3D2338%26doi%3D10.1093%2Fcarcin%2Fbgu151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span><span class="refDoi"> DOI: 10.1038/onc.2014.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1038%2Fonc.2014.51" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1083-1093&author=B.+Kimauthor=S.+Wangauthor=J.+M.+Leeauthor=Y.+Jeongauthor=T.+Ahnauthor=D.+S.+Sonauthor=H.+W.+Parkauthor=H.+S.+Yooauthor=Y.+J.+Songauthor=E.+Leeauthor=Y.+M.+Ohauthor=S.+B.+Leeauthor=J.+Choiauthor=J.+C.+Murrayauthor=Y.+Zhouauthor=P.+H.+Songauthor=K.+A.+Kimauthor=L.+M.+Weiner&title=Synthetic+lethal+screening+reveals+FGFR+as+one+of+the+combinatorial+targets+to+overcome+resistance+to+Met-targeted+therapy&doi=10.1038%2Fonc.2014.51"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.51%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DT.%26aulast%3DSon%26aufirst%3DD.%2BS.%26aulast%3DPark%26aufirst%3DH.%2BW.%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DSong%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DOh%26aufirst%3DY.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DP.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BA.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DSynthetic%2520lethal%2520screening%2520reveals%2520FGFR%2520as%2520one%2520of%2520the%2520combinatorial%2520targets%2520to%2520overcome%2520resistance%2520to%2520Met-targeted%2520therapy%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D1083%26epage%3D1093%26doi%3D10.1038%2Fonc.2014.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Saito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefor, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span> </span><span class="NLM_article-title">The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="refDoi"> DOI: 10.1186/s12885-015-1065-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1186%2Fs12885-015-1065-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=82&author=S.+Saitoauthor=K.+Morishimaauthor=T.+Uiauthor=H.+Hoshinoauthor=D.+Matsubaraauthor=S.+Ishikawaauthor=H.+Aburataniauthor=M.+Fukayamaauthor=Y.+Hosoyaauthor=N.+Sataauthor=A.+K.+Leforauthor=Y.+Yasudaauthor=T.+Niki&title=The+role+of+HGF%2FMET+and+FGF%2FFGFR+in+fibroblast-derived+growth+stimulation+and+lapatinib-resistance+of+esophageal+squamous+cell+carcinoma&doi=10.1186%2Fs12885-015-1065-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1065-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1065-8%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DK.%26aulast%3DUi%26aufirst%3DT.%26aulast%3DHoshino%26aufirst%3DH.%26aulast%3DMatsubara%26aufirst%3DD.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DFukayama%26aufirst%3DM.%26aulast%3DHosoya%26aufirst%3DY.%26aulast%3DSata%26aufirst%3DN.%26aulast%3DLefor%26aufirst%3DA.%2BK.%26aulast%3DYasuda%26aufirst%3DY.%26aulast%3DNiki%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520HGF%252FMET%2520and%2520FGF%252FFGFR%2520in%2520fibroblast-derived%2520growth%2520stimulation%2520and%2520lapatinib-resistance%2520of%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D82%26doi%3D10.1186%2Fs12885-015-1065-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Turner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Garcia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natrajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iorns, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2094</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F0008-5472.CAN-09-3746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=20179196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=2085-2094&author=N.+Turnerauthor=A.+Pearsonauthor=R.+Sharpeauthor=M.+Lambrosauthor=F.+Geyerauthor=M.+A.+Lopez-Garciaauthor=R.+Natrajanauthor=C.+Marchioauthor=E.+Iornsauthor=A.+Mackayauthor=C.+Gillettauthor=A.+Grigoriadisauthor=A.+Tuttauthor=J.+S.+Reis-Filhoauthor=A.+Ashworth&title=FGFR1+amplification+drives+endocrine+therapy+resistance+and+is+a+therapeutic+target+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-09-3746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer</span></div><div class="casAuthors">Turner, Nicholas; Pearson, Alex; Sharpe, Rachel; Lambros, Maryou; Geyer, Felipe; Lopez-Garcia, Maria A.; Natrajan, Rachael; Marchio, Caterina; Iorns, Elizabeth; Mackay, Alan; Gillett, Cheryl; Grigoriadis, Anita; Tutt, Andrew; Reis-Filho, Jorge S.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2085-2094</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Amplification of fibroblast growth factor receptor 1 (FGFR1) occurs in ∼10% of breast cancers and is assocd. with poor prognosis.  However, it is uncertain whether overexpression of FGFR1 is causally linked to the poor prognosis of amplified cancers.  Here, we show that FGFR1 overexpression is robustly assocd. with FGFR1 amplification in two independent series of breast cancers.  Breast cancer cell lines with FGFR1 overexpression and amplification show enhanced ligand-dependent signaling, with increased activation of the mitogen-activated protein kinase and phosphoinositide 3-kinase-AKT signaling pathways in response to FGF2, but also show basal ligand-independent signaling, and are dependent on FGFR signaling for anchorage-independent growth.  FGFR1-amplified cell lines show resistance to 4-hydroxytamoxifen, which is reversed by small interfering RNA silencing of FGFR1, suggesting that FGFR1 overexpression also promotes endocrine therapy resistance.  FGFR1 signaling suppresses progesterone receptor (PR) expression in vitro, and likewise, amplified cancers are frequently PR neg., identifying a potential biomarker for FGFR1 activity.  Furthermore, we show that amplified cancers have a high proliferative rate assessed by Ki67 staining and that FGFR1 amplification is found in 16% to 27% of luminal B-type breast cancers.  Our data suggest that amplification and overexpression of FGFR1 may be a major contributor to poor prognosis in luminal-type breast cancers, driving anchorage-independent proliferation and endocrine therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbsQ_wPmoftLVg90H21EOLACvtfcHk0lgKDsZt3epxHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWis7s%253D&md5=d14ce3b47614b090c4f7bfa7e4ce8a38</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3746%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DN.%26aulast%3DPearson%26aufirst%3DA.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DLambros%26aufirst%3DM.%26aulast%3DGeyer%26aufirst%3DF.%26aulast%3DLopez-Garcia%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DMarchio%26aufirst%3DC.%26aulast%3DIorns%26aufirst%3DE.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DGillett%26aufirst%3DC.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFGFR1%2520amplification%2520drives%2520endocrine%2520therapy%2520resistance%2520and%2520is%2520a%2520therapeutic%2520target%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D2085%26epage%3D2094%26doi%3D10.1158%2F0008-5472.CAN-09-3746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machajewski, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonios-McCrea, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menezes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aardalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernette-Hammond, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">Design, structure-activity relationships and <i>in vivo</i> characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1021/jm800790t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800790t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=278-292&author=P.+A.+Renhoweauthor=S.+Pecchiauthor=C.+M.+Shaferauthor=T.+D.+Machajewskiauthor=E.+M.+Jazanauthor=C.+Taylorauthor=W.+Antonios-McCreaauthor=C.+M.+McBrideauthor=K.+Frazierauthor=M.+Wiesmannauthor=G.+R.+Lapointeauthor=P.+H.+Feuchtauthor=R.+L.+Warneauthor=C.+C.+Heiseauthor=D.+Menezesauthor=K.+Aardalenauthor=H.+Yeauthor=M.+Heauthor=V.+Leauthor=J.+Voraauthor=J.+M.+Jansenauthor=M.+E.+Wernette-Hammondauthor=A.+L.+Harris&title=Design%2C+structure-activity+relationships+and+in+vivo+characterization+of+4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones%3A+a+novel+class+of+receptor+tyrosine+kinase+inhibitors&doi=10.1021%2Fjm800790t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Structure-Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Renhowe, Paul A.; Pecchi, Sabina; Shafer, Cynthia M.; Machajewski, Timothy D.; Jazan, Elisa M.; Taylor, Clarke; Antonios-McCrea, William; McBride, Christopher M.; Frazier, Kelly; Wiesmann, Marion; Lapointe, Gena R.; Feucht, Paul H.; Warne, Robert L.; Heise, Carla C.; Menezes, Daniel; Aardalen, Kimberly; Ye, Helen; He, Molly; Le, Vincent; Vora, Jayesh; Jansen, Johanna M.; Wernette-Hammond, Mary Ellen; Harris, Alex L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in oncol. research over the last several years.  Many potent small mol. inhibitors of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases have been evaluated.  More recently, compds. that act through the complex inhibition of multiple kinase targets have been reported and may exhibit improved clin. efficacy.  We report herein a series of potent, orally efficacious 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one analogs as inhibitors of VEGF, PDGF, and fibroblast growth factor (FGF) receptor tyrosine kinases.  Compds. in this class, such as TKI258 (I), are reversible ATP-competitive inhibitors of VEGFR-2, FGFR-1, and PDGFRβ with IC50 values <0.1 μM.  On the basis of its favorable in vitro and in vivo properties, compd. I was selected for clin. evaluation and is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUf3qVBfCr87Vg90H21EOLACvtfcHk0lhMyTQWoTkoqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sl&md5=f20f564bb7dacb5a450a29dae9e04b50</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800790t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800790t%26sid%3Dliteratum%253Aachs%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DMachajewski%26aufirst%3DT.%2BD.%26aulast%3DJazan%26aufirst%3DE.%2BM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DAntonios-McCrea%26aufirst%3DW.%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DFrazier%26aufirst%3DK.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DLapointe%26aufirst%3DG.%2BR.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DWarne%26aufirst%3DR.%2BL.%26aulast%3DHeise%26aufirst%3DC.%2BC.%26aulast%3DMenezes%26aufirst%3DD.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DWernette-Hammond%26aufirst%3DM.%2BE.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DDesign%252C%2520structure-activity%2520relationships%2520and%2520in%2520vivo%2520characterization%2520of%25204-amino-3-benzimidazol-2-ylhydroquinolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D278%26epage%3D292%26doi%3D10.1021%2Fjm800790t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colbatzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handschuh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann-Lintz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4466</span><span class="NLM_x">–</span> <span class="NLM_lpage">4480</span><span class="refDoi"> DOI: 10.1021/jm900431g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900431g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFygsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4466-4480&author=G.+J.+Rothauthor=A.+Heckelauthor=F.+Colbatzkyauthor=S.+Handschuhauthor=J.+Kleyauthor=T.+Lehmann-Lintzauthor=R.+Lotzauthor=U.+Tontsch-Gruntauthor=R.+Walterauthor=F.+Hilberg&title=Design%2C+synthesis%2C+and+evaluation+of+indolinones+as+triple+angiokinase+inhibitors+and+the+discovery+of+a+highly+specific+6-methoxycarbonyl-substituted+indolinone+%28BIBF+1120%29&doi=10.1021%2Fjm900431g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)</span></div><div class="casAuthors">Roth, Gerald J.; Heckel, Armin; Colbatzky, Florian; Handschuh, Sandra; Kley, Jorg; Lehmann-Lintz, Thorsten; Lotz, Ralf; Tontsch-Grunt, Ulrike; Walter, Rainer; Hilberg, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4466-4480</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncol.  Preclin. findings suggest that blockade of addnl. pro-angiogenic kinases, such as fibroblast and platelet-derived growth factor receptors (FGFR and PDGFR), may improve the efficacy of pharmacol. cancer treatment.  Indolinones substituted in position 6 were identified as selective inhibitors of VEGF-, PDGF-, and FGF-receptor kinases.  In particular, 6-methoxycarbonyl-substituted indolinones showed a highly favorable selectivity profile.  Optimization identified potent inhibitors of VEGF-related endothelial cell proliferation with addnl. efficacy on pericyctes and smooth muscle cells.  In contrast, no direct inhibition of tumor cell proliferation was obsd.  Compds. 2 (BIBF 1000) and 3 (BIBF 1120) are orally available and display encouraging efficacy in in vivo tumor models while being well tolerated.  The triple angiokinase inhibitor 3 (I) is currently in phase III clin. trials for the treatment of nonsmall cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvcX-_HYCS7Vg90H21EOLACvtfcHk0lhMyTQWoTkoqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFygsL4%253D&md5=1b8af461631ae3117520fc4811130bb3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900431g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900431g%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3DColbatzky%26aufirst%3DF.%26aulast%3DHandschuh%26aufirst%3DS.%26aulast%3DKley%26aufirst%3DJ.%26aulast%3DLehmann-Lintz%26aufirst%3DT.%26aulast%3DLotz%26aufirst%3DR.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DHilberg%26aufirst%3DF.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520indolinones%2520as%2520triple%2520angiokinase%2520inhibitors%2520and%2520the%2520discovery%2520of%2520a%2520highly%2520specific%25206-methoxycarbonyl-substituted%2520indolinone%2520%2528BIBF%25201120%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4466%26epage%3D4480%26doi%3D10.1021%2Fjm900431g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brave, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilburn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgensmeier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span> </span><span class="NLM_article-title">AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4389-4400&author=S.+R.+Wedgeauthor=J.+Kendrewauthor=L.+F.+Hennequinauthor=P.+J.+Valentineauthor=S.+T.+Barryauthor=S.+R.+Braveauthor=N.+R.+Smithauthor=N.+H.+Jamesauthor=M.+Dukesauthor=J.+O.+Curwenauthor=R.+Chesterauthor=J.+A.+Jacksonauthor=S.+J.+Boffeyauthor=L.+L.+Kilburnauthor=S.+Barnettauthor=G.+H.+Richmondauthor=P.+F.+Wadsworthauthor=M.+Walkerauthor=A.+L.+Bigleyauthor=S.+T.+Taylorauthor=L.+Cooperauthor=S.+Beckauthor=J.+M.+Jurgensmeierauthor=D.+J.+Ogilvie&title=AZD2171%3A+a+highly+potent%2C+orally+bioavailable%2C+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DValentine%26aufirst%3DP.%2BJ.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DBrave%26aufirst%3DS.%2BR.%26aulast%3DSmith%26aufirst%3DN.%2BR.%26aulast%3DJames%26aufirst%3DN.%2BH.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DChester%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DJ.%2BA.%26aulast%3DBoffey%26aufirst%3DS.%2BJ.%26aulast%3DKilburn%26aufirst%3DL.%2BL.%26aulast%3DBarnett%26aufirst%3DS.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%26aulast%3DWadsworth%26aufirst%3DP.%2BF.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DBigley%26aufirst%3DA.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%2BT.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DJurgensmeier%26aufirst%3DJ.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DAZD2171%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4389%26epage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Izzedine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhaescu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rixe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deray, G.</span><span> </span><span class="NLM_article-title">Sunitinib malate</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1007/s00280-006-0376-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs00280-006-0376-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=17136543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=357-364&author=H.+Izzedineauthor=I.+Buhaescuauthor=O.+Rixeauthor=G.+Deray&title=Sunitinib+malate&doi=10.1007%2Fs00280-006-0376-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sunitinib malate</span></div><div class="casAuthors">Izzedine, Hassane; Buhaescu, Irina; Rixe, Olivier; Deray, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-364</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Recently, there has been a growing interest in understanding the role of receptor tyrosine kinases (RTK), such as vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), stem cell factor receptor (KIT), and fms-like tyrosine kinase 3 (FLT3), in promoting tumor angiogenesis, tumor growth and metastasis.  Sunitinib (sunitinib malate; SU11248; SUTENT; Pfizer Inc, New York, NY, USA) is a novel, orally bio-available, oxindole, multi-targeted tyrosine kinase inhibitor with high binding affinity for VEGFR and PDGFR which has shown anti-tumor and anti-angiogenic activities.  This drug recently received approval from the US Food and Administration (FDA) in two indications simultaneously: advanced renal cell carcinoma (adRCC) and gastrointestinal stromal tumors (GIST), in patients who are resistant or intolerant to the treatment with imatinib.  The present article reviews the recent pharmacol. and clin. data related to the use of this new promising drug in the field of oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaJ5uxPevVALVg90H21EOLACvtfcHk0lg4tkNMGnuffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVKqu7c%253D&md5=251c65b0f915633c9f735c8b33b46988</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00280-006-0376-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-006-0376-5%26sid%3Dliteratum%253Aachs%26aulast%3DIzzedine%26aufirst%3DH.%26aulast%3DBuhaescu%26aufirst%3DI.%26aulast%3DRixe%26aufirst%3DO.%26aulast%3DDeray%26aufirst%3DG.%26atitle%3DSunitinib%2520malate%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D60%26spage%3D357%26epage%3D364%26doi%3D10.1007%2Fs00280-006-0376-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ahmad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span> </span><span class="NLM_article-title">Kinase inhibition with BAY 43–9006 in renal cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">6388S</span><span class="NLM_x">–</span> <span class="NLM_lpage">6392S</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-040028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1078-0432.CCR-040028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=6388S-6392S&author=T.+Ahmadauthor=T.+Eisen&title=Kinase+inhibition+with+BAY+43%E2%80%939006+in+renal+cell+carcinoma&doi=10.1158%2F1078-0432.CCR-040028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-040028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-040028%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DT.%26atitle%3DKinase%2520inhibition%2520with%2520BAY%252043%25E2%2580%25939006%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D6388S%26epage%3D6392S%26doi%3D10.1158%2F1078-0432.CCR-040028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harris, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boloor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Ward, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperly, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkle, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R. N.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knick, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudeman, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczyk, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span> </span><span class="NLM_article-title">Discovery of 5-[[4-[(2,3-dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4632</span><span class="NLM_x">–</span> <span class="NLM_lpage">4640</span><span class="refDoi"> DOI: 10.1021/jm800566m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800566m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4632-4640&author=P.+A.+Harrisauthor=A.+Boloorauthor=M.+Cheungauthor=R.+Kumarauthor=R.+M.+Crosbyauthor=R.+G.+Davis-Wardauthor=A.+H.+Epperlyauthor=K.+W.+Hinkleauthor=R.+N.+Hunterauthor=J.+H.+Johnsonauthor=V.+B.+Knickauthor=C.+P.+Laudemanauthor=D.+K.+Luttrellauthor=R.+A.+Mookauthor=R.+T.+Nolteauthor=S.+K.+Rudolphauthor=J.+R.+Szewczykauthor=A.+T.+Truesdaleauthor=J.+M.+Vealauthor=L.+Wangauthor=J.+A.+Stafford&title=Discovery+of+5-%5B%5B4-%5B%282%2C3-dimethyl-2H-indazol-6-yl%29methylamino%5D-2-pyrimidinyl%5Damino%5D-2-methyl-benzenesulfonamide+%28Pazopanib%29%2C+a+novel+and+potent+vascular+endothelial+growth+factor+receptor+inhibitor&doi=10.1021%2Fjm800566m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor</span></div><div class="casAuthors">Harris, Philip A.; Boloor, Amogh; Cheung, Mui; Kumar, Rakesh; Crosby, Renae M.; Davis-Ward, Ronda G.; Epperly, Andrea H.; Hinkle, Kevin W.; Hunter, Robert N., III; Johnson, Jennifer H.; Knick, Victoria B.; Laudeman, Christopher P.; Luttrell, Deirdre K.; Mook, Robert A.; Nolte, Robert T.; Rudolph, Sharon K.; Szewczyk, Jerzy R.; Truesdale, Anne T.; Veal, James M.; Wang, Liping; Stafford, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4632-4640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway has emerged as one of the most promising new approaches for cancer therapy.  We describe herein the key steps starting from an initial screening hit leading to the discovery of pazopanib, N4-(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl-N2-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine, a potent pan-VEGF receptor (VEGFR) inhibitor under clin. development for renal-cell cancer and other solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIb4UT-IbEi7Vg90H21EOLACvtfcHk0lg4tkNMGnuffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D&md5=a8737a6e003a3f6002575b4b96712fc9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm800566m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800566m%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DDavis-Ward%26aufirst%3DR.%2BG.%26aulast%3DEpperly%26aufirst%3DA.%2BH.%26aulast%3DHinkle%26aufirst%3DK.%2BW.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DLaudeman%26aufirst%3DC.%2BP.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DRudolph%26aufirst%3DS.%2BK.%26aulast%3DSzewczyk%26aufirst%3DJ.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25205-%255B%255B4-%255B%25282%252C3-dimethyl-2H-indazol-6-yl%2529methylamino%255D-2-pyrimidinyl%255Damino%255D-2-methyl-benzenesulfonamide%2520%2528Pazopanib%2529%252C%2520a%2520novel%2520and%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4632%26epage%3D4640%26doi%3D10.1021%2Fjm800566m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musgrove, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, E. S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span> </span><span class="NLM_article-title">ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4645</span><span class="NLM_x">–</span> <span class="NLM_lpage">4655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4645-4655&author=S.+R.+Wedgeauthor=D.+J.+Ogilvieauthor=M.+Dukesauthor=J.+Kendrewauthor=R.+Chesterauthor=J.+A.+Jacksonauthor=S.+J.+Boffeyauthor=P.+J.+Valentineauthor=J.+O.+Curwenauthor=H.+L.+Musgroveauthor=G.+A.+Grahamauthor=G.+D.+Hughesauthor=A.+P.+Thomasauthor=E.+S.+E.+Stokesauthor=B.+Curryauthor=G.+H.+P.+Richmondauthor=P.+F.+Wadsworthauthor=A.+L.+Bigleyauthor=L.+F.+Hennequin&title=ZD6474+inhibits+vascular+endothelial+growth+factor+signaling%2C+angiogenesis%2C+and+tumor+growth+following+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DChester%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DJ.%2BA.%26aulast%3DBoffey%26aufirst%3DS.%2BJ.%26aulast%3DValentine%26aufirst%3DP.%2BJ.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DMusgrove%26aufirst%3DH.%2BL.%26aulast%3DGraham%26aufirst%3DG.%2BA.%26aulast%3DHughes%26aufirst%3DG.%2BD.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DStokes%26aufirst%3DE.%2BS.%2BE.%26aulast%3DCurry%26aufirst%3DB.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%2BP.%26aulast%3DWadsworth%26aufirst%3DP.%2BF.%26aulast%3DBigley%26aufirst%3DA.%2BL.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DZD6474%2520inhibits%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%252C%2520angiogenesis%252C%2520and%2520tumor%2520growth%2520following%2520oral%2520administration%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4645%26epage%3D4655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Cohen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudard, S.</span><span> </span><span class="NLM_article-title">Antiangiogenic therapy for advanced renal cell carcinoma: management of treatment-related toxicities</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2066</span><span class="NLM_x">–</span> <span class="NLM_lpage">2079</span><span class="refDoi"> DOI: 10.1007/s10637-012-9796-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs10637-012-9796-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=2066-2079&author=R.+B.+Cohenauthor=S.+Oudard&title=Antiangiogenic+therapy+for+advanced+renal+cell+carcinoma%3A+management+of+treatment-related+toxicities&doi=10.1007%2Fs10637-012-9796-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs10637-012-9796-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-012-9796-8%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%2BB.%26aulast%3DOudard%26aufirst%3DS.%26atitle%3DAntiangiogenic%2520therapy%2520for%2520advanced%2520renal%2520cell%2520carcinoma%253A%2520management%2520of%2520treatment-related%2520toxicities%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D2066%26epage%3D2079%26doi%3D10.1007%2Fs10637-012-9796-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Herbst, R. S.</span><span> </span><span class="NLM_article-title">Toxicities of antiangiogenic therapy in non-small-cell lung cancer</span> <span class="citation_source-journal">Clin. Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">S23</span><span class="NLM_x">–</span> <span class="NLM_lpage">S30</span><span class="refDoi"> DOI: 10.3816/CLC.2006.s.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.3816%2FCLC.2006.s.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=S23-S30&author=R.+S.+Herbst&title=Toxicities+of+antiangiogenic+therapy+in+non-small-cell+lung+cancer&doi=10.3816%2FCLC.2006.s.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3816%2FCLC.2006.s.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLC.2006.s.010%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26atitle%3DToxicities%2520of%2520antiangiogenic%2520therapy%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DClin.%2520Lung%2520Cancer%26date%3D2006%26volume%3D8%26spage%3DS23%26epage%3DS30%26doi%3D10.3816%2FCLC.2006.s.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tuder, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chacon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taraseviciene-Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cool, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacoub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polak, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelkel, N. F.</span><span> </span><span class="NLM_article-title">Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1002/path.953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1002%2Fpath.953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=11673836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2001&pages=367-374&author=R.+M.+Tuderauthor=M.+Chaconauthor=L.+Algerauthor=J.+Wangauthor=L.+Taraseviciene-Stewartauthor=Y.+Kasaharaauthor=C.+D.+Coolauthor=A.+E.+Bishopauthor=M.+Geraciauthor=G.+L.+Semenzaauthor=M.+Yacoubauthor=J.+M.+Polakauthor=N.+F.+Voelkel&title=Expression+of+angiogenesis-related+molecules+in+plexiform+lesions+in+severe+pulmonary+hypertension%3A+evidence+for+a+process+of+disordered+angiogenesis&doi=10.1002%2Fpath.953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis</span></div><div class="casAuthors">Tuder, Rubin M.; Chacon, Mati; Alger, Lori; Wang, Jun; Taraseviciene-Stewart, Laimute; Kasahara, Yasunori; Cool, Carlyne D.; Bishop, Anne E.; Geraci, Mark; Semenza, Gregg L.; Yacoub, Magdi; Polak, Julia M.; Voelkel, Norbert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Pulmonary arteries of patients with severe pulmonary hypertension (SPH) presenting in an idiopathic form (primary PH-PPH) or assocd. with congenital heart malformations or collagen vascular diseases show plexiform lesions.  It is postulated that in lungs with SPH, endothelial cells in plexiform lesions express genes encoding for proteins involved in angiogenesis, in particular, vascular endothelial growth factor (VEGF) and those involved in VEGF receptor-2 (VEGFR-2) signaling.  On immunohistochem. and in situ hybridization, endothelial cells in the plexiform lesions expressed VEGF mRNA and protein and overexpressed the mRNA and protein of VEGFR-2, and the transcription factor subunits HIF-1α and HIF-1β of hypoxia inducible factor, which are responsible for the hypoxia-dependent induction of VEGF.  When compared with normal lungs, SPH lungs showed decreased expression of the kinases PI3 kinase and src, which, together with Akt, relay the signal transduction downstream of VEGFR-2.  Because markers of angiogenesis are expressed in plexiform lesions in SPH, it is proposed that these lesions may form by a process of disordered angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWFxm-dZMILVg90H21EOLACvtfcHk0lglSA_H91ua3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlGqu7s%253D&md5=57c426e30ba09a9d99c556432c0eb2d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fpath.953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.953%26sid%3Dliteratum%253Aachs%26aulast%3DTuder%26aufirst%3DR.%2BM.%26aulast%3DChacon%26aufirst%3DM.%26aulast%3DAlger%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTaraseviciene-Stewart%26aufirst%3DL.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DCool%26aufirst%3DC.%2BD.%26aulast%3DBishop%26aufirst%3DA.%2BE.%26aulast%3DGeraci%26aufirst%3DM.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DYacoub%26aufirst%3DM.%26aulast%3DPolak%26aufirst%3DJ.%2BM.%26aulast%3DVoelkel%26aufirst%3DN.%2BF.%26atitle%3DExpression%2520of%2520angiogenesis-related%2520molecules%2520in%2520plexiform%2520lesions%2520in%2520severe%2520pulmonary%2520hypertension%253A%2520evidence%2520for%2520a%2520process%2520of%2520disordered%2520angiogenesis%26jtitle%3DJ.%2520Pathol.%26date%3D2001%26volume%3D195%26spage%3D367%26epage%3D374%26doi%3D10.1002%2Fpath.953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Douget, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graus Porta, D.</span><span> </span><span class="NLM_article-title">Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7066</span><span class="NLM_x">–</span> <span class="NLM_lpage">7083</span><span class="refDoi"> DOI: 10.1021/jm2006222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2006222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7066-7083&author=V.+Guagnanoauthor=P.+Furetauthor=C.+Spankaauthor=V.+Bordasauthor=M.+Le+Dougetauthor=C.+Stammauthor=J.+Brueggenauthor=M.+R.+Jensenauthor=C.+Schnellauthor=H.+Schmidauthor=M.+Wartmannauthor=J.+Berghausenauthor=P.+Drueckesauthor=A.+Zimmerlinauthor=D.+Bussiereauthor=J.+Murrayauthor=D.+Graus+Porta&title=Discovery+of+3-%282%2C6-dichloro-3%2C5-dimethoxy-phenyl%29-1-%7B6-%5B4-%284-ethyl-piperazin-1-yl%29-phenylamino%5D-pyrimidin-4-yl%7D-1-methyl-urea+%28NVP-BGJ398%29%2C+a+potent+and+selective+inhibitor+of+the+fibroblast+growth+factor+receptor+family+of+receptor+tyrosine+kinase&doi=10.1021%2Fjm2006222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase</span></div><div class="casAuthors">Guagnano, Vito; Furet, Pascal; Spanka, Carsten; Bordas, Vincent; Le Douget, Mickael; Stamm, Christelle; Brueggen, Josef; Jensen, Michael R.; Schnell, Christian; Schmid, Herbert; Wartmann, Markus; Berghausen, Joerg; Drueckes, Peter; Zimmerlin, Alfred; Bussiere, Dirksen; Murray, Jeremy; Graus Porta, Diana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7066-7083</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of N-aryl-N'-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring.  On the basis of its in vitro profile, compd. 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3.  These results support the potential therapeutic use of 1h as a new anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSC1v0A_6I_bVg90H21EOLACvtfcHk0ljaeLkT0wvNNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK&md5=f9a2d742294cd3814e872bdd8add1ffa</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2006222%26sid%3Dliteratum%253Aachs%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSpanka%26aufirst%3DC.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DLe%2BDouget%26aufirst%3DM.%26aulast%3DStamm%26aufirst%3DC.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DH.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DZimmerlin%26aufirst%3DA.%26aulast%3DBussiere%26aufirst%3DD.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DGraus%2BPorta%26aufirst%3DD.%26atitle%3DDiscovery%2520of%25203-%25282%252C6-dichloro-3%252C5-dimethoxy-phenyl%2529-1-%257B6-%255B4-%25284-ethyl-piperazin-1-yl%2529-phenylamino%255D-pyrimidin-4-yl%257D-1-methyl-urea%2520%2528NVP-BGJ398%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor%2520family%2520of%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7066%26epage%3D7083%26doi%3D10.1021%2Fjm2006222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gavine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgour, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Kadhimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinowska, T.</span><span> </span><span class="NLM_article-title">AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2045</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F0008-5472.CAN-11-3034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=22369928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1Wgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2045-2056&author=P.+R.+Gavineauthor=L.+Mooneyauthor=E.+Kilgourauthor=A.+P.+Thomasauthor=K.+Al-Kadhimiauthor=S.+Beckauthor=C.+Rooneyauthor=T.+Colemanauthor=D.+Bakerauthor=M.+J.+Mellorauthor=A.+N.+Brooksauthor=T.+Klinowska&title=AZD4547%3A+an+orally+bioavailable%2C+potent%2C+and+selective+inhibitor+of+the+fibroblast+growth+factor+receptor+tyrosine+kinase+family&doi=10.1158%2F0008-5472.CAN-11-3034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family</span></div><div class="casAuthors">Gavine, Paul R.; Mooney, Lorraine; Kilgour, Elaine; Thomas, Andrew P.; Al-Kadhimi, Katherine; Beck, Sarah; Rooney, Claire; Coleman, Tanya; Baker, Dawn; Mellor, Martine J.; Brooks, A. Nigel; Klinowska, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2045-2056</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fibroblast growth factor (FGF) signaling axis is increasingly implicated in tumorigenesis and chemoresistance.  Several small-mol. FGF receptor (FGFR) kinase inhibitors are currently in clin. development; however, the predominant activity of the most advanced of these agents is against the kinase insert domain receptor (KDR), which compromises the FGFR selectivity.  Here, we report the pharmacol. profile of AZD4547, a novel and selective inhibitor of the FGFR1, 2, and 3 tyrosine kinases.  AZD4547 inhibited recombinant FGFR kinase activity in vitro and suppressed FGFR signaling and growth in tumor cell lines with deregulated FGFR expression.  In a representative FGFR-driven human tumor xenograft model, oral administration of AZD4547 was well tolerated and resulted in potent dose-dependent antitumor activity, consistent with plasma exposure and pharmacodynamic modulation of tumor FGFR.  Importantly, at efficacious doses, no evidence of anti-KDR-related effects were obsd., confirming the in vivo FGFR selectivity of AZD4547.  Taken together, our findings show that AZD4547 is a novel selective small-mol. inhibitor of FGFR with potent antitumor activity against FGFR-deregulated tumors in preclin. models.  AZD4547 is under clin. investigation for the treatment of FGFR-dependent tumors.  Cancer Res; 72(8); 2045-56.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnpExryJc9xbVg90H21EOLACvtfcHk0ljaeLkT0wvNNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1Wgsrs%253D&md5=cba90ad8f9b9e51cd10288868bbcc85e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3034%26sid%3Dliteratum%253Aachs%26aulast%3DGavine%26aufirst%3DP.%2BR.%26aulast%3DMooney%26aufirst%3DL.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DAl-Kadhimi%26aufirst%3DK.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DRooney%26aufirst%3DC.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DBrooks%26aufirst%3DA.%2BN.%26aulast%3DKlinowska%26aufirst%3DT.%26atitle%3DAZD4547%253A%2520an%2520orally%2520bioavailable%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520family%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2045%26epage%3D2056%26doi%3D10.1158%2F0008-5472.CAN-11-3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isobe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebiike, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span> </span><span class="NLM_article-title">The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2547</span><span class="NLM_x">–</span> <span class="NLM_lpage">2558</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1535-7163.MCT-14-0248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=25169980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGju73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2547-2558&author=Y.+Nakanishiauthor=N.+Akiyamaauthor=T.+Tsukaguchiauthor=T.+Fujiiauthor=K.+Sakataauthor=H.+Saseauthor=T.+Isobeauthor=K.+Morikamiauthor=H.+Shindohauthor=T.+Mioauthor=H.+Ebiikeauthor=N.+Takaauthor=Y.+Aokiauthor=N.+Ishii&title=The+fibroblast+growth+factor+receptor+genetic+status+as+a+potential+predictor+of+the+sensitivity+to+CH5183284%2FDebio+1347%2C+a+novel+selective+FGFR+inhibitor&doi=10.1158%2F1535-7163.MCT-14-0248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor</span></div><div class="casAuthors">Nakanishi, Yoshito; Akiyama, Nukinori; Tsukaguchi, Toshiyuki; Fujii, Toshihiko; Sakata, Kiyoaki; Sase, Hitoshi; Isobe, Takehito; Morikami, Kenji; Shindoh, Hidetoshi; Mio, Toshiyuki; Ebiike, Hirosato; Taka, Naoki; Aoki, Yuko; Ishii, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2547-2558</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The FGF receptors (FGFR) are tyrosine kinases that are constitutively activated in a subset of tumors by genetic alterations such as gene amplifications, point mutations, or chromosomal translocations/rearrangements.  Recently, small-mol. inhibitors that can inhibit the FGFR family as well as the VEGF receptor (VEGFR) or platelet-derived growth factor receptor (PDGFR) family displayed clin. benefits in cohorts of patients with FGFR genetic alterations.  However, to achieve more potent and prolonged activity in such populations, a selective FGFR inhibitor is still needed.  Here, we report the identification of CH5183284/Debio 1347, a selective and orally available FGFR1, FGFR2, and FGFR3 inhibitor that has a unique chem. scaffold.  By interacting with unique residues in the ATP-binding site of FGFR1, FGFR2, or FGFR3, CH5183284/Debio 1347 selectively inhibits FGFR1, FGFR2, and FGFR3 but does not inhibit kinase insert domain receptor (KDR) or other kinases.  Consistent with its high selectivity for FGFR enzymes, CH5183284/Debio 1347 displayed preferential antitumor activity against cancer cells with various FGFR genetic alterations in a panel of 327 cancer cell lines and in xenograft models.  Because of its unique binding mode, CH5183284/Debio 1347 can inhibit FGFR2 harboring one type of the gatekeeper mutation that causes resistance to other FGFR inhibitors and block FGFR2 V564F-driven tumor growth.  CH5183284/Debio 1347 is under clin. investigation for the treatment of patients harboring FGFR genetic alterations.  Mol Cancer Ther; 13(11); 2547-58. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGIBEnK21337Vg90H21EOLACvtfcHk0ljaeLkT0wvNNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGju73F&md5=35629d891a421582022b0f6ae0496479</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0248%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DN.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DSase%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DShindoh%26aufirst%3DH.%26aulast%3DMio%26aufirst%3DT.%26aulast%3DEbiike%26aufirst%3DH.%26aulast%3DTaka%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26atitle%3DThe%2520fibroblast%2520growth%2520factor%2520receptor%2520genetic%2520status%2520as%2520a%2520potential%2520predictor%2520of%2520the%2520sensitivity%2520to%2520CH5183284%252FDebio%25201347%252C%2520a%2520novel%2520selective%2520FGFR%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D2547%26epage%3D2558%26doi%3D10.1158%2F1535-7163.MCT-14-0248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zia-Ebrahimi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloem, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, D. J.</span><span> </span><span class="NLM_article-title">A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2200</span><span class="NLM_x">–</span> <span class="NLM_lpage">2210</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1535-7163.MCT-11-0306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=21900693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVeltb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2200-2210&author=G.+Zhaoauthor=W.+Y.+Liauthor=D.+Chenauthor=J.+R.+Henryauthor=H.+Y.+Liauthor=Z.+Chenauthor=M.+Zia-Ebrahimiauthor=L.+Bloemauthor=Y.+Zhaiauthor=K.+Hussauthor=S.+B.+Pengauthor=D.+J.+McCann&title=A+novel%2C+selective+inhibitor+of+fibroblast+growth+factor+receptors+that+shows+a+potent+broad+spectrum+of+antitumor+activity+in+several+tumor+xenograft+models&doi=10.1158%2F1535-7163.MCT-11-0306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models</span></div><div class="casAuthors">Zhao, Genshi; Li, Wei-ying; Chen, Daohong; Henry, James R.; Li, Hong-Yu; Chen, Zhaogen; Zia-Ebrahimi, Mohammad; Bloem, Laura; Zhai, Yan; Huss, Karen; Peng, Sheng-bin; McCann, Denis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2200-2210</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fibroblast growth factor receptors (FGFR) are tyrosine kinases that are present in many types of endothelial and tumor cells and play an important role in tumor cell growth, survival, and migration as well as in maintaining tumor angiogenesis.  Overexpression of FGFRs or aberrant regulation of their activities has been implicated in many forms of human malignancies.  Therefore, targeting FGFRs represents an attractive strategy for development of cancer treatment options by simultaneously inhibiting tumor cell growth, survival, and migration as well as tumor angiogenesis.  Here, we describe a potent, selective, small-mol. FGFR inhibitor, (R)-(E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1H-indazol-3yl)vinyl)-1H-pyrazol-1-yl)ethanol, designated as LY2874455.  This mol. is active against all 4 FGFRs, with a similar potency in biochem. assays.  It exhibits a potent activity against FGF/FGFR-mediated signaling in several cancer cell lines and shows an excellent broad spectrum of antitumor activity in several tumor xenograft models representing the major FGF/FGFR relevant tumor histologies including lung, gastric, and bladder cancers and multiple myeloma, and with a well-defined pharmacokinetic/pharmacodynamic relationship.  LY2874455 also exhibits a 6- to 9-fold in vitro and in vivo selectivity on inhibition of FGF- over VEGF-mediated target signaling in mice.  Furthermore, LY2874455 did not show VEGF receptor 2-mediated toxicities such as hypertension at efficacious doses.  Currently, this mol. is being evaluated for its potential use in the clinic.  Mol Cancer Ther; 10(11); 2200-10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLrzAyZQK_grVg90H21EOLACvtfcHk0lgigYz3h7zIRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVeltb7N&md5=eaf08fd213a836f48da2055e01bd9c29</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0306%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZia-Ebrahimi%26aufirst%3DM.%26aulast%3DBloem%26aufirst%3DL.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DHuss%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26atitle%3DA%2520novel%252C%2520selective%2520inhibitor%2520of%2520fibroblast%2520growth%2520factor%2520receptors%2520that%2520shows%2520a%2520potent%2520broad%2520spectrum%2520of%2520antitumor%2520activity%2520in%2520several%2520tumor%2520xenograft%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2200%26epage%3D2210%26doi%3D10.1158%2F1535-7163.MCT-11-0306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoon, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4653</span><span class="refDoi"> DOI: 10.1021/jm0500931</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0500931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4628-4653&author=A.+M.+Thompsonauthor=A.+M.+Delaneyauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=T.+A.+Spoonauthor=S.+M.+Creanauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+relationships+of+soluble+7-substituted+3-%283%2C5-dimethoxyphenyl%29-1%2C6-naphthyridin-2-amines+and+related+ureas+as+dual+inhibitors+of+the+fibroblast+growth+factor+receptor-1+and+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinases&doi=10.1021%2Fjm0500931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0500931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500931%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DSpoon%26aufirst%3DT.%2BA.%26aulast%3DCrean%26aufirst%3DS.%2BM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520soluble%25207-substituted%25203-%25283%252C5-dimethoxyphenyl%2529-1%252C6-naphthyridin-2-amines%2520and%2520related%2520ureas%2520as%2520dual%2520inhibitors%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor-1%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4628%26epage%3D4653%26doi%3D10.1021%2Fjm0500931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseenkova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5896</span><span class="NLM_x">–</span> <span class="NLM_lpage">5904</span><span class="refDoi"> DOI: 10.1093/emboj/17.20.5896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Femboj%2F17.20.5896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=9774334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=5896-5904&author=M.+Mohammadiauthor=S.+Froumauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=R.+L.+Panekauthor=G.+H.+Luauthor=A.+V.+Eliseenkovaauthor=D.+Greenauthor=J.+Schlessingerauthor=S.+R.+Hubbard&title=Crystal+structure+of+an+angiogenesis+inhibitor+bound+to+the+FGF+receptor+tyrosine+kinase+domain&doi=10.1093%2Femboj%2F17.20.5896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span></div><div class="casAuthors">Mohammadi, Moosa; Froum, Scott; Hamby, James M.; Schroeder, Mel C.; Panek, Robert L.; Lu, Gina H.; Eliseenkova, Anna V.; Green, David; Schlessinger, Joseph; Hubbard, Stevan R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5896-5904</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is an essential physiol. process in development, yet also plays a major role in the progression of human diseases such as diabetic retinopathy, atherosclerosis and cancer.  The effects of the most potent angiogenic factors, vascular endothelial growth factor (VEGF), angiopoietin and fibroblast growth factor (FGF) are mediated through cell surface receptors that possess intrinsic protein tyrosine kinase activity.  In this report, the authors describe a synthetic compd. of the pyrido[2,3-d]pyrimidine class, designated PD 173074, that selectively inhibits the tyrosine kinase activities of the FGF and VEGF receptors.  The authors show that systemic administration of PD 173074 in mice can effectively block angiogenesis induced by either FGF or VEGF with no apparent toxicity.  To elucidate the determinants of selectivity, the authors have detd. the crystal structure of PD 173074 in complex with the tyrosine kinase domain of FGF receptor 1 at 2.5 Å resoln.  A high degree of surface complementarity between PD 173074 and the hydrophobic, ATP-binding pocket of FGF receptor 1 underlies the potency and selectivity of this inhibitor.  PD 173074 is thus a promising candidate for a therapeutic angiogenesis inhibitor to be used in the treatment of cancer and other diseases whose progression is dependent upon new blood vessel formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zdEklzyMx7Vg90H21EOLACvtfcHk0lgigYz3h7zIRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D&md5=a76b085ddc9d352878a2c6bc9d1cd6ff</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.20.5896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.20.5896%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DFroum%26aufirst%3DS.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DEliseenkova%26aufirst%3DA.%2BV.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DCrystal%2520structure%2520of%2520an%2520angiogenesis%2520inhibitor%2520bound%2520to%2520the%2520FGF%2520receptor%2520tyrosine%2520kinase%2520domain%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D5896%26epage%3D5904%26doi%3D10.1093%2Femboj%2F17.20.5896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Grygielewicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunerka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamparska-Przybysz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieczorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzwonek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdzalik, D.</span><span> </span><span class="NLM_article-title">Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells</span> <span class="citation_source-journal">Gastric Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1007/s10120-014-0444-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs10120-014-0444-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=53-62&author=P.+Grygielewiczauthor=B.+Dymekauthor=A.+Bujakauthor=P.+Gunerkaauthor=A.+Stanczakauthor=M.+Lamparska-Przybyszauthor=M.+Wieczorekauthor=K.+Dzwonekauthor=D.+Zdzalik&title=Epithelial-mesenchymal+transition+confers+resistance+to+selective+FGFR+inhibitors+in+SNU-16+gastric+cancer+cells&doi=10.1007%2Fs10120-014-0444-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10120-014-0444-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10120-014-0444-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrygielewicz%26aufirst%3DP.%26aulast%3DDymek%26aufirst%3DB.%26aulast%3DBujak%26aufirst%3DA.%26aulast%3DGunerka%26aufirst%3DP.%26aulast%3DStanczak%26aufirst%3DA.%26aulast%3DLamparska-Przybysz%26aufirst%3DM.%26aulast%3DWieczorek%26aufirst%3DM.%26aulast%3DDzwonek%26aufirst%3DK.%26aulast%3DZdzalik%26aufirst%3DD.%26atitle%3DEpithelial-mesenchymal%2520transition%2520confers%2520resistance%2520to%2520selective%2520FGFR%2520inhibitors%2520in%2520SNU-16%2520gastric%2520cancer%2520cells%26jtitle%3DGastric%2520Cancer%26date%3D2016%26volume%3D19%26spage%3D53%26epage%3D62%26doi%3D10.1007%2Fs10120-014-0444-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Javidi-Sharifi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlap, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span> </span><span class="NLM_article-title">Crosstalk between KIT and FGFR3 promotes gastrointestinal stromal tumor cell growth and drug resistance</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F0008-5472.CAN-14-0573" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=880-891&author=N.+Javidi-Sharifiauthor=E.+Traerauthor=J.+Martinezauthor=A.+Guptaauthor=T.+Taguchiauthor=J.+Dunlapauthor=M.+C.+Heinrichauthor=C.+L.+Corlessauthor=B.+P.+Rubinauthor=B.+J.+Drukerauthor=J.+W.+Tyner&title=Crosstalk+between+KIT+and+FGFR3+promotes+gastrointestinal+stromal+tumor+cell+growth+and+drug+resistance&doi=10.1158%2F0008-5472.CAN-14-0573"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0573%26sid%3Dliteratum%253Aachs%26aulast%3DJavidi-Sharifi%26aufirst%3DN.%26aulast%3DTraer%26aufirst%3DE.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DTaguchi%26aufirst%3DT.%26aulast%3DDunlap%26aufirst%3DJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DCorless%26aufirst%3DC.%2BL.%26aulast%3DRubin%26aufirst%3DB.%2BP.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26atitle%3DCrosstalk%2520between%2520KIT%2520and%2520FGFR3%2520promotes%2520gastrointestinal%2520stromal%2520tumor%2520cell%2520growth%2520and%2520drug%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D880%26epage%3D891%26doi%3D10.1158%2F0008-5472.CAN-14-0573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Byron, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartside, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehkhoda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, P. M.</span><span> </span><span class="NLM_article-title">The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1593/neo.121106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1593%2Fneo.121106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=975-988&author=S.+A.+Byronauthor=H.+Chenauthor=A.+Wortmannauthor=D.+Lochauthor=M.+G.+Gartsideauthor=F.+Dehkhodaauthor=S.+P.+Blaisauthor=T.+A.+Neubertauthor=M.+Mohammadiauthor=P.+M.+Pollock&title=The+N550K%2FH+mutations+in+FGFR2+confer+differential+resistance+to+PD173074%2C+dovitinib%2C+and+ponatinib+ATP-competitive+inhibitors&doi=10.1593%2Fneo.121106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1593%2Fneo.121106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.121106%26sid%3Dliteratum%253Aachs%26aulast%3DByron%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWortmann%26aufirst%3DA.%26aulast%3DLoch%26aufirst%3DD.%26aulast%3DGartside%26aufirst%3DM.%2BG.%26aulast%3DDehkhoda%26aufirst%3DF.%26aulast%3DBlais%26aufirst%3DS.%2BP.%26aulast%3DNeubert%26aufirst%3DT.%2BA.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DPollock%26aufirst%3DP.%2BM.%26atitle%3DThe%2520N550K%252FH%2520mutations%2520in%2520FGFR2%2520confer%2520differential%2520resistance%2520to%2520PD173074%252C%2520dovitinib%252C%2520and%2520ponatinib%2520ATP-competitive%2520inhibitors%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D975%26epage%3D988%26doi%3D10.1593%2Fneo.121106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span> </span><span class="NLM_article-title">Design and structure-activity relationship of 3-benzimidazol-2-yl-1<i>H</i>-indazoles as inhibitors of receptor tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3595</span><span class="NLM_x">–</span> <span class="NLM_lpage">3599</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.03.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2Fj.bmcl.2006.03.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3595-3599&author=C.+M.+McBrideauthor=P.+A.+Renhoweauthor=C.+Heiseauthor=J.+M.+Jansenauthor=G.+Lapointeauthor=S.+Maauthor=R.+Pinedaauthor=J.+Voraauthor=M.+Wiesmannauthor=C.+M.+Shafer&title=Design+and+structure-activity+relationship+of+3-benzimidazol-2-yl-1H-indazoles+as+inhibitors+of+receptor+tyrosine+kinases&doi=10.1016%2Fj.bmcl.2006.03.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.03.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.03.069%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DLapointe%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DPineda%26aufirst%3DR.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDesign%2520and%2520structure-activity%2520relationship%2520of%25203-benzimidazol-2-yl-1H-indazoles%2520as%2520inhibitors%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3595%26epage%3D3599%26doi%3D10.1016%2Fj.bmcl.2006.03.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span><span class="refDoi"> DOI: 10.1021/jm2007613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.+P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29&doi=10.1021%2Fjm2007613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0li0Q7Js9O2LdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6342%26epage%3D6363%26doi%3D10.1021%2Fjm2007613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ho, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhe, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aung, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1016/j.jhep.2008.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2Fj.jhep.2008.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=19008009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A280%3ADC%252BD1cjotVOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=118-127&author=H.+K.+Hoauthor=S.+Pokauthor=S.+Streitauthor=J.+E.+Ruheauthor=S.+Hartauthor=K.+S.+Limauthor=H.+L.+Looauthor=M.+O.+Aungauthor=S.+G.+Limauthor=A.+Ullrich&title=Fibroblast+growth+factor+receptor+4+regulates+proliferation%2C+anti-apoptosis+and+alpha-fetoprotein+secretion+during+hepatocellular+carcinoma+progression+and+represents+a+potential+target+for+therapeutic+intervention&doi=10.1016%2Fj.jhep.2008.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention</span></div><div class="casAuthors">Ho Han Kiat; Pok Sharon; Streit Sylvia; Ruhe Jens E; Hart Stefan; Lim Kah Suan; Loo Hooi Linn; Aung Myat Oo; Lim Seng Gee; Ullrich Axel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-27</span>
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  FGFR4, a member of the fibroblast growth factor receptor family, has been recently associated with progression of melanoma, breast and head and neck carcinoma.  Given its uniquely high expression in the liver, we investigated its contributory role to hepatocellular carcinoma (HCC).  METHODS:  We performed a comprehensive sequencing of full-length FGFR4 transcript in 57 tumor/normal HCC tissue pairs, and quantified their mRNA expressions.  Notable mutations and expression patterns were correlated with patient data.  Clinically significant trends were examined in in vitro models.  RESULTS:  We found eight genetic alterations including two highly frequent polymorphisms (V10I and G338R).  Secretion of alpha-fetoprotein (AFP), a HCC biomarker, was increased among patients bearing homozygous Arg388 alleles.  One-third of these patients exhibited increased FGFR4 mRNA expression in the matched tumor/normal tissue.  Subsequent in vitro perturbation of FGFR4 signaling through both FGF19-stimulation and FGFR4 silencing confirmed a mechanistic link between FGFR4 activities and tumor aggressiveness.  More importantly, inhibition of FGFR activity with PD173074 exquisitely blocked HuH7 (high FGFR4 expression) proliferation as compared to control cell lines.  CONCLUSIONS:  FGFR4 contributes significantly to HCC progression by modulating AFP secretion, proliferation and anti-apoptosis.  Its frequent overexpression in patients renders its inhibition a novel and much needed pharmacological approach against HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgZzOqmNA8JynGiHuhFGv8fW6udTcc2eZgZkDKqoLF8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjotVOksg%253D%253D&md5=3196fd73fe899f09292e6ef773dcfd16</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DPok%26aufirst%3DS.%26aulast%3DStreit%26aufirst%3DS.%26aulast%3DRuhe%26aufirst%3DJ.%2BE.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DK.%2BS.%26aulast%3DLoo%26aufirst%3DH.%2BL.%26aulast%3DAung%26aufirst%3DM.%2BO.%26aulast%3DLim%26aufirst%3DS.%2BG.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25204%2520regulates%2520proliferation%252C%2520anti-apoptosis%2520and%2520alpha-fetoprotein%2520secretion%2520during%2520hepatocellular%2520carcinoma%2520progression%2520and%2520represents%2520a%2520potential%2520target%2520for%2520therapeutic%2520intervention%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3D118%26epage%3D127%26doi%3D10.1016%2Fj.jhep.2008.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Buchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, S. R.</span><span> </span><span class="NLM_article-title">Direct acting, highly mutagenic, α-hydroxy <i>N</i>-nitrosamines from 4-chloroindoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">4115</span><span class="NLM_x">–</span> <span class="NLM_lpage">4119</span><span class="refDoi"> DOI: 10.1021/ja00274a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00274a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=1986&pages=4115-4119&author=G.+Buchiauthor=G.+C.+Leeauthor=D.+Yangauthor=S.+R.+Tannenbaum&title=Direct+acting%2C+highly+mutagenic%2C+%CE%B1-hydroxy+N-nitrosamines+from+4-chloroindoles&doi=10.1021%2Fja00274a043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja00274a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00274a043%26sid%3Dliteratum%253Aachs%26aulast%3DBuchi%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DG.%2BC.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DTannenbaum%26aufirst%3DS.%2BR.%26atitle%3DDirect%2520acting%252C%2520highly%2520mutagenic%252C%2520%25CE%25B1-hydroxy%2520N-nitrosamines%2520from%25204-chloroindoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1986%26volume%3D108%26spage%3D4115%26epage%3D4119%26doi%3D10.1021%2Fja00274a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Mizuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekine, M.</span><span> </span><span class="NLM_article-title">Fluorescent pyrimidopyrimidoindole nucleosides: control of photophysical characterizations by substituent effects</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">5046</span><span class="NLM_x">–</span> <span class="NLM_lpage">5055</span><span class="refDoi"> DOI: 10.1021/jo070206j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo070206j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt12htb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=5046-5055&author=M.+Mizutaauthor=K.+Seioauthor=K.+Miyataauthor=M.+Sekine&title=Fluorescent+pyrimidopyrimidoindole+nucleosides%3A+control+of+photophysical+characterizations+by+substituent+effects&doi=10.1021%2Fjo070206j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent Pyrimidopyrimidoindole Nucleosides: Control of Photophysical Characterizations by Substituent Effects</span></div><div class="casAuthors">Mizuta, Masahiro; Seio, Kohji; Miyata, Kenichi; Sekine, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5046-5055</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">10-(2-Deoxy-β-D-ribofuranosyl)pyrimido[4',5':4,5]pyrimido[1,6-a]indole-6,9(7H)-dione (I) and its derivs. were synthesized via the Suzuki-Miyaura coupling reaction of 5-iododeoxycytidine with 5-substituted N-Boc-indole-2-borates and characterized by UV-vis and fluorescence spectroscopy.  The new fluorescent nucleosides showed rather large Stokes shifts (116-139 nm) in an aq. buffer.  The fluorescent intensities were dependent on the nature of the substituents on the indole rings.  The electron-withdrawing groups increased the fluorescent intensity while the electron-donating groups having lone pairs decreased it.  Among the substituted I derivs. tested, the trimethylammonium deriv. of I was found to emit the brightest fluorescent light.  The solvatochromism of I and its derivs. was also studied.  Some of the I derivs. showed interesting solvent-dependent fluorescence enhancement and could be useful as new fluorescent structural probes for nucleic acids.  The Lippert-Mataga analyses of the Stokes shift were also carried out to obtain estd. values of the dipole moment of the excited states of some of the derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2SRQLbXqDI7Vg90H21EOLACvtfcHk0lhX3bL561Qtig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt12htb4%253D&md5=cf5084a569a994f96ed717f4032a8a6b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo070206j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo070206j%26sid%3Dliteratum%253Aachs%26aulast%3DMizuta%26aufirst%3DM.%26aulast%3DSeio%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DK.%26aulast%3DSekine%26aufirst%3DM.%26atitle%3DFluorescent%2520pyrimidopyrimidoindole%2520nucleosides%253A%2520control%2520of%2520photophysical%2520characterizations%2520by%2520substituent%2520effects%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D5046%26epage%3D5055%26doi%3D10.1021%2Fjo070206j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chen, D. H.; Li, H. Y.; Zhao, G. S.</span><span> </span><span class="NLM_article-title">Vinyl indazolyl compounds</span>. Patent WO2010129509,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+H.+Chen&author=H.+Y.+Li&author=G.+S.+Zhao&title=Vinyl+indazolyl+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%2BH.%26atitle%3DVinyl%2520indazolyl%2520compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ramachandran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameed, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanbhag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morayya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautela, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panduga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saralaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanduri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raichurkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menasinakai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn-Flynn, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosagrahara, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span> </span><span class="NLM_article-title"><i>N</i>-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6642</span><span class="NLM_x">–</span> <span class="NLM_lpage">6652</span><span class="refDoi"> DOI: 10.1021/jm500715u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500715u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6642-6652&author=S.+Ramachandranauthor=P.+S.+Hameedauthor=A.+Srivastavaauthor=G.+Shanbhagauthor=S.+Morayyaauthor=N.+Rautelaauthor=D.+Awasthyauthor=S.+Kavanaghauthor=S.+Bharathauthor=J.+Reddyauthor=V.+Pandugaauthor=K.+R.+Prabhakarauthor=R.+Saralayaauthor=R.+Nanduriauthor=A.+Raichurkarauthor=S.+Menasinakaiauthor=V.+Acharauthor=M.+B.+Jimenez-Diazauthor=M.+S.+Martinezauthor=I.+Angulo-Barturenauthor=S.+Ferrerauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=S.+Duffyauthor=V.+M.+Averyauthor=D.+Watersonauthor=M.+C.+S.+Leeauthor=O.+Coburn-Flynnauthor=D.+A.+Fidockauthor=P.+S.+Iyerauthor=S.+Narayananauthor=V.+Hosagraharaauthor=V.+K.+Sambandamurthy&title=N-aryl-2-aminobenzimidazoles%3A+novel%2C+efficacious%2C+antimalarial+lead+compounds&doi=10.1021%2Fjm500715u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds</span></div><div class="casAuthors">Ramachandran, Sreekanth; Hameed P., Shahul; Srivastava, Abhishek; Shanbhag, Gajanan; Morayya, Sapna; Rautela, Nikhil; Awasthy, Disha; Kavanagh, Stefan; Bharath, Sowmya; Reddy, Jitendar; Panduga, Vijender; Prabhakar, K. R.; Saralaya, Ramanatha; Nanduri, Robert; Raichurkar, Anandkumar; Menasinakai, Sreenivasaiah; Achar, Vijayashree; Jimenez-Diaz, Maria Belen; Martinez, Maria Santos; Angulo-Barturen, Inigo; Ferrer, Santiago; Sanz, Laura Maria; Gamo, Francisco Javier; Duffy, Sandra; Avery, Vicky M.; Waterson, David; Lee, Marcus C. S.; Coburn-Flynn, Olivia; Fidock, David A.; Iyer, Pravin S.; Narayanan, Shridhar; Hosagrahara, Vinayak; Sambandamurthy, Vasan K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6642-6652</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From the phenotypic screening of the AstraZeneca corporate compd. collection, N-aryl-2-aminobenzimidazoles have emerged as novel hits against the asexual blood stage of Plasmodium falciparum (Pf).  Medicinal chem. optimization of the potency against Pf and ADME properties resulted in the identification of 12 as a lead mol.  Compd. 12 was efficacious in the P. berghei (Pb) model of malaria.  This compd. displayed an excellent pharmacokinetic profile with a long half-life (19 h) in rat blood.  This profile led to an extended survival of animals for over 30 days following a dose of 50 mg/kg in the Pb malaria model.  Compd. 12 retains its potency against a panel of Pf isolates with known mechanisms of resistance.  The fast killing obsd. in the in vitro parasite redn. ratio (PRR) assay coupled with the extended survival highlights the promise of this novel chem. class for the treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkMoylS1KmbbVg90H21EOLACvtfcHk0lhX3bL561Qtig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr3I&md5=73b596070bb83ea1b7c557deb24bb3bd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm500715u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500715u%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DHameed%26aufirst%3DP.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DShanbhag%26aufirst%3DG.%26aulast%3DMorayya%26aufirst%3DS.%26aulast%3DRautela%26aufirst%3DN.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DNanduri%26aufirst%3DR.%26aulast%3DRaichurkar%26aufirst%3DA.%26aulast%3DMenasinakai%26aufirst%3DS.%26aulast%3DAchar%26aufirst%3DV.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26atitle%3DN-aryl-2-aminobenzimidazoles%253A%2520novel%252C%2520efficacious%252C%2520antimalarial%2520lead%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6642%26epage%3D6652%26doi%3D10.1021%2Fjm500715u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Young, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yudkovitz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mount, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, M. T.</span><span> </span><span class="NLM_article-title">2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00026-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2FS0960-894X%2802%2900026-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=11859012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlKqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=827-832&author=J.+R.+Youngauthor=S.+X.+Huangauthor=T.+F.+Walshauthor=M.+J.+Wyvrattauthor=Y.+T.+Yangauthor=J.+B.+Yudkovitzauthor=J.+Cuiauthor=G.+R.+Mountauthor=R.+N.+Renauthor=T.+J.+Wuauthor=X.+Shenauthor=K.+A.+Lyonsauthor=A.+H.+Maoauthor=J.+R.+Carlinauthor=B.+V.+Karanamauthor=S.+H.+Vincentauthor=K.+Chengauthor=M.+T.+Goulet&title=2-Arylindoles+as+gonadotropin+releasing+hormone+%28GnRH%29+antagonists%3A+optimization+of+the+tryptamine+side+chain&doi=10.1016%2FS0960-894X%2802%2900026-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain</span></div><div class="casAuthors">Young, Jonathan R.; Huang, Song X.; Walsh, Thomas F.; Wyvratt, Matthew J.; Yang, Yi Tien; Yudkovitz, Joel B.; Cui, Jisong; Mount, George R.; Ren, Rena Ning; Wu, Tsuei-Ju; Shen, Xiaolan; Lyons, Kathryn A.; Mao, An-Hua; Carlin, Josephine R.; Karanam, Bindhu V.; Vincent, Stella H.; Cheng, Kang; Goulet, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-832</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 2-arylindoles contg. novel heteroarom. substituents on the tryptamine tether, based on compd. I, was prepd. and evaluated for their ability to act as gonadotropin releasing hormone antagonists.  Successful modifications of I included chain length variation (redn.) and replacement of the pyridine with heteroarom. groups.  These alterations culminated in the discovery of a compd. which had excellent in vitro potency and oral efficacy in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIqPJ3Xnah2rVg90H21EOLACvtfcHk0lgEcOugkLUroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlKqsLY%253D&md5=6416a665673dc33876ff3f1e5277cb64</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900026-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900026-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26aulast%3DHuang%26aufirst%3DS.%2BX.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DY.%2BT.%26aulast%3DYudkovitz%26aufirst%3DJ.%2BB.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DMount%26aufirst%3DG.%2BR.%26aulast%3DRen%26aufirst%3DR.%2BN.%26aulast%3DWu%26aufirst%3DT.%2BJ.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%2BH.%26aulast%3DCarlin%26aufirst%3DJ.%2BR.%26aulast%3DKaranam%26aufirst%3DB.%2BV.%26aulast%3DVincent%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DM.%2BT.%26atitle%3D2-Arylindoles%2520as%2520gonadotropin%2520releasing%2520hormone%2520%2528GnRH%2529%2520antagonists%253A%2520optimization%2520of%2520the%2520tryptamine%2520side%2520chain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D827%26epage%3D832%26doi%3D10.1016%2FS0960-894X%2802%2900026-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chinchilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heumann, A.</span><span> </span><span class="NLM_article-title">Kinetic resolution of racemic alcohols with chiral carboxylic acids and dicyclohexylcarbodiimide</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1016/S0957-4166(00)82271-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2FS0957-4166%2800%2982271-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1990&pages=851-854&author=R.+Chinchillaauthor=C.+N%C3%A1jeraauthor=M.+Yusauthor=A.+Heumann&title=Kinetic+resolution+of+racemic+alcohols+with+chiral+carboxylic+acids+and+dicyclohexylcarbodiimide&doi=10.1016%2FS0957-4166%2800%2982271-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2800%2982271-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252800%252982271-5%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DN%25C3%25A1jera%26aufirst%3DC.%26aulast%3DYus%26aufirst%3DM.%26aulast%3DHeumann%26aufirst%3DA.%26atitle%3DKinetic%2520resolution%2520of%2520racemic%2520alcohols%2520with%2520chiral%2520carboxylic%2520acids%2520and%2520dicyclohexylcarbodiimide%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1990%26volume%3D1%26spage%3D851%26epage%3D854%26doi%3D10.1016%2FS0957-4166%2800%2982271-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span> </span><span class="NLM_article-title">Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">–</span> <span class="NLM_lpage">1804</span><span class="refDoi"> DOI: 10.1016/j.bmc.2005.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2Fj.bmc.2005.10.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1792-1804&author=N.+Foloppeauthor=L.+M.+Fisherauthor=G.+Francisauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potter&title=Identification+of+a+buried+pocket+for+potent+and+selective+inhibition+of+Chk1%3A+prediction+and+verification&doi=10.1016%2Fj.bmc.2005.10.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520buried%2520pocket%2520for%2520potent%2520and%2520selective%2520inhibition%2520of%2520Chk1%253A%2520prediction%2520and%2520verification%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1792%26epage%3D1804%26doi%3D10.1016%2Fj.bmc.2005.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Chang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S. F.</span><span> </span><span class="NLM_article-title">Synthesis of 2-arylbenzoxazoles via DDQ promoted oxidative cyclization of phenolic Schiff bases—a solution-phase strategy for library synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)02302-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2FS0040-4039%2801%2902302-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=951-954&author=J.+B.+Changauthor=K.+Zhaoauthor=S.+F.+Pan&title=Synthesis+of+2-arylbenzoxazoles+via+DDQ+promoted+oxidative+cyclization+of+phenolic+Schiff+bases%E2%80%94a+solution-phase+strategy+for+library+synthesis&doi=10.1016%2FS0040-4039%2801%2902302-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-arylbenzoxazoles via DDQ promoted oxidative cyclization of phenolic Schiff bases-a solution-phase strategy for library synthesis</span></div><div class="casAuthors">Chang, Junbiao; Zhao, Kang; Pan, Shifeng</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">951-954</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The Schiff base derived from the condensation of o-aminophenol with benzaldehydes was induced to undergo oxidative cyclization in the presence of DDQ.  The resulting 2-arylbenzoxazoles were sepd. from the reduced DDQ byproduct (4,5-dichloro-3,6-dihydroxy-1,2-benzenedicarbonitrile ) by treatment of reaction mixt. with a strongly basic ion-exchange resin (e.g. Amberlite IRA-900).  The applicability of this chem. to spatially sep. library synthesis is demonstrated by the prepn. of a 352-member library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe80bdAUGZi7Vg90H21EOLACvtfcHk0lgEcOugkLUroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslKjtA%253D%253D&md5=7ac23ca1805f6afcc3df1916d4ea7a33</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902302-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902302-4%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BB.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DPan%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520of%25202-arylbenzoxazoles%2520via%2520DDQ%2520promoted%2520oxidative%2520cyclization%2520of%2520phenolic%2520Schiff%2520bases%25E2%2580%2594a%2520solution-phase%2520strategy%2520for%2520library%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D951%26epage%3D954%26doi%3D10.1016%2FS0040-4039%2801%2902302-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Moir, D. T.; Aiello, D.; Peet, N. P.; Williamms, J. D.</span><span> </span><span class="NLM_article-title">Inhibitors of bacterial type III secretion system</span>. Patent WO2010118046,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+T.+Moir&author=D.+Aiello&author=N.+P.+Peet&author=J.+D.+Williamms&title=Inhibitors+of+bacterial+type+III+secretion+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoir%26aufirst%3DD.%2BT.%26atitle%3DInhibitors%2520of%2520bacterial%2520type%2520III%2520secretion%2520system%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0liJevZAjXpN-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span> <span class="citation_source-book">Maestro</span>, version 9.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span> <span class="citation_source-book">Glide</span>, version 5.5; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span><span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein%E2%80%93ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0liJevZAjXpN-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span> <span class="citation_source-book">LigPrep</span>, version 2.3; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span> </span><span class="NLM_article-title">Integrated modeling program, applied chemical theory (IMPACT)</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1780</span><span class="refDoi"> DOI: 10.1002/jcc.20292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1002%2Fjcc.20292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=16211539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1752-1780&author=J.+L.+Banksauthor=H.+S.+Beardauthor=Y.+Caoauthor=A.+E.+Choauthor=W.+Dammauthor=R.+Faridauthor=A.+K.+Feltsauthor=T.+A.+Halgrenauthor=D.+T.+Mainzauthor=J.+R.+Mapleauthor=R.+Murphyauthor=D.+M.+Philippauthor=M.+P.+Repaskyauthor=L.+Y.+Zhangauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=E.+Gallicchioauthor=R.+M.+Levy&title=Integrated+modeling+program%2C+applied+chemical+theory+%28IMPACT%29&doi=10.1002%2Fjcc.20292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated modeling program, applied chemical theory (IMPACT)</span></div><div class="casAuthors">Banks, Jay L.; Beard, Hege S.; Cao, Yixiang; Cho, Art E.; Damm, Wolfgang; Farid, Ramy; Felts, Anthony K.; Halgren, Thomas A.; Mainz, Daniel T.; Maple, Jon R.; Murphy, Robert; Philipp, Dean M.; Repasky, Matthew P.; Zhang, Linda Y.; Berne, Bruce J.; Friesner, Richard A.; Gallicchio, Emilio; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1752-1780</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  We provide an overview of the IMPACT mol. mechanics program with an emphasis on recent developments and a description of its current functionality.  With respect to core mol. mechanics technologies we include a status report for the fixed charge and polarizable force fields that can be used with the program and illustrate how the force fields, when used together with new atom typing and parameter assignment modules, have greatly expanded the coverage of org. compds. and medicinally relevant ligands.  As we discuss in this review, explicit solvent simulations have been used to guide our design of implicit solvent models based on the generalized Born framework and a novel nonpolar estimator that have recently been incorporated into the program.  With IMPACT it is possible to use several different advanced conformational sampling algorithms based on combining features of mol. dynamics and Monte Carlo simulations.  The program includes two specialized mol. mechanics modules: Glide, a high-throughput docking program, and QSite, a mixed quantum mechanics/mol. mechanics module.  These modules employ the IMPACT infrastructure as a starting point for the construction of the protein model and assignment of mol. mechanics parameters, but have then been developed to meet specialized objectives with respect to sampling and the energy function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZX2FzcGWGM7Vg90H21EOLACvtfcHk0li05OMRFluVMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI&md5=0094f15727c7fb77a0fae16ccf8292f0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20292%26sid%3Dliteratum%253Aachs%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BK.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DIntegrated%2520modeling%2520program%252C%2520applied%2520chemical%2520theory%2520%2528IMPACT%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1752%26epage%3D1780%26doi%3D10.1002%2Fjcc.20292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span> <span class="citation_source-book">Epik</span>, version 2.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DEpik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Shelley, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholleti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timlin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchimaya, M.</span><span> </span><span class="NLM_article-title">Epik: a software program for pK<sub>a</sub> prediction and protonation state generation for drug-like molecules</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1007/s10822-007-9133-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs10822-007-9133-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=17899391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKrtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=681-691&author=J.+C.+Shelleyauthor=A.+Cholletiauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=M.+R.+Timlinauthor=M.+Uchimaya&title=Epik%3A+a+software+program+for+pKa+prediction+and+protonation+state+generation+for+drug-like+molecules&doi=10.1007%2Fs10822-007-9133-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Epik: a software program for pKa prediction and protonation state generation for drug-like molecules</span></div><div class="casAuthors">Shelley, John C.; Cholleti, Anuradha; Frye, Leah L.; Greenwood, Jeremy R.; Timlin, Mathew R.; Uchimaya, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">681-691</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Epik is a computer program for predicting pKa values for drug-like mols.  Epik can use this capability in combination with technol. for tautomerization to adjust the protonation state of small drug-like mols. to automatically generate one or more of the most probable forms for use in further mol. modeling studies.  Many medicinal chems. can exchange protons with their environment, resulting in various ionization and tautomeric states, collectively known as protonation states.  The protonation state of a drug can affect its soly. and membrane permeability.  In modeling, the protonation state of a ligand will also affect which conformations are predicted for the mol., as well as predictions for binding modes and ligand affinities based upon protein-ligand interactions.  Despite the importance of the protonation state, many databases of candidate mols. used in drug development do not store reliable information on the most probable protonation states.  Epik is sufficiently rapid and accurate to process large databases of drug-like mols. to provide this information.  Several new technologies are employed.  Extensions to the well-established Hammett and Taft approaches are used for pKa prediction, namely, mesomer standardization, charge cancellation, and charge spreading to make the predicted results reflect the nature of the mol. itself rather just for the particular Lewis structure used on input.  In addn., a new iterative technol. for generating, ranking and culling the generated protonation states is employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6PRLT1xT8LVg90H21EOLACvtfcHk0li05OMRFluVMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKrtbzP&md5=f4f429ea3894e1ad2519cdf3333a5645</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs10822-007-9133-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-007-9133-z%26sid%3Dliteratum%253Aachs%26aulast%3DShelley%26aufirst%3DJ.%2BC.%26aulast%3DCholleti%26aufirst%3DA.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DTimlin%26aufirst%3DM.%2BR.%26aulast%3DUchimaya%26aufirst%3DM.%26atitle%3DEpik%253A%2520a%2520software%2520program%2520for%2520pKa%2520prediction%2520and%2520protonation%2520state%2520generation%2520for%2520drug-like%2520molecules%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2007%26volume%3D21%26spage%3D681%26epage%3D691%26doi%3D10.1007%2Fs10822-007-9133-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span> <span class="citation_source-book">The PyMOL molecular graphics system</span>, version 1.7.0; <span class="NLM_publisher-name">Schrodinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+molecular+graphics+system%2C+version+1.7.0%3B+Schrodinger%2C+LLC%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DThe%2520PyMOL%2520molecular%2520graphics%2520system%26pub%3DSchrodinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hefeng Zhang, Xia Peng, Yang Dai, Jingwei Shao, Yinchun Ji, Yiming Sun, Bo Liu, Xu Cheng, Jing Ai, <span class="NLM_string-name hlFld-ContribAuthor">Wenhu Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Pyrimidinedione Derivative as a Potent and Orally Bioavailable Axl Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3956-3975. <a href="https://doi.org/10.1021/acs.jmedchem.0c02093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPyrimidinedione%252BDerivative%252Bas%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BAxl%252BInhibitor%26aulast%3DZhang%26aufirst%3DHefeng%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03122020%26date%3D18032021%26volume%3D64%26issue%3D7%26spage%3D3956%26epage%3D3975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Jia, Qiang Tang, Meiming Luo, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoming Zeng</span>. </span><span class="cited-content_cbyCitation_article-title">Direct ortho-Selective Amination of 2-Naphthol and Its Analogues with Hydrazines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (9)
                                     , 5082-5091. <a href="https://doi.org/10.1021/acs.joc.8b00421" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00421%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252Bortho-Selective%252BAmination%252Bof%252B2-Naphthol%252Band%252BIts%252BAnalogues%252Bwith%252BHydrazines%26aulast%3DJia%26aufirst%3DLei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13022018%26date%3D16042018%26date%3D12042018%26volume%3D83%26issue%3D9%26spage%3D5082%26epage%3D5091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruifeng  Mao</span>, <span class="hlFld-ContribAuthor ">Jingwei  Shao</span>, <span class="hlFld-ContribAuthor ">Kongkai  Zhu</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Ding</span>, <span class="hlFld-ContribAuthor ">Chenhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhe  Shi</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Dequn  Sun</span>, <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>, and <span class="hlFld-ContribAuthor ">Cheng  Luo</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6289-6304. <a href="https://doi.org/10.1021/acs.jmedchem.7b00587" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00587%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252Band%252BCell%252BActive%252BProtein%252BArginine%252BMethyltransferase%252B5%252B%252528PRMT5%252529%252BInhibitor%252BDeveloped%252Bby%252BStructure-Based%252BVirtual%252BScreening%252Band%252BHit%252BOptimization%26aulast%3DMao%26aufirst%3DRuifeng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18042017%26date%3D12072017%26date%3D27072017%26date%3D26062017%26volume%3D60%26issue%3D14%26spage%3D6289%26epage%3D6304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Kalpana  Tilekar</span>, <span class="hlFld-ContribAuthor ">Sabreena  Safuan</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kumar</span>, <span class="hlFld-ContribAuthor ">Jimmy  Stalin</span>, <span class="hlFld-ContribAuthor ">Curzio  Ruegg</span>, <span class="hlFld-ContribAuthor ">Ramaa C S</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Anti‐angiogenic Drug Discovery Efforts To Combat Cancer. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (23)
                                     , 5689-5700. <a href="https://doi.org/10.1002/slct.202101792" title="DOI URL">https://doi.org/10.1002/slct.202101792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101792%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DRecent%252BAnti%2525E2%252580%252590angiogenic%252BDrug%252BDiscovery%252BEfforts%252BTo%252BCombat%252BCancer%26aulast%3DUpadhyay%26aufirst%3DNeha%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D23%26spage%3D5689%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingping  Su</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Xiuli  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Hanyun  Que</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Yiwen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 1
              H
              -pyrrolo[2,3-
              b
              ]pyridine derivatives as potent fibroblast growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (34)
                                     , 20651-20661. <a href="https://doi.org/10.1039/D1RA02660G" title="DOI URL">https://doi.org/10.1039/D1RA02660G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA02660G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA02660G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1%252BH%252B-pyrrolo%25255B2%25252C3-%252Bb%252B%25255Dpyridine%252Bderivatives%252Bas%252Bpotent%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DSu%26aufirst%3DXingping%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D34%26spage%3D20651%26epage%3D20661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zong-jun  Xia</span>, <span class="hlFld-ContribAuthor ">Yin-chun  Ji</span>, <span class="hlFld-ContribAuthor ">De-qiao  Sun</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Ying-lei  Gao</span>, <span class="hlFld-ContribAuthor ">Yan-fen  Fang</span>, <span class="hlFld-ContribAuthor ">Xing-dong  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei-bo  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Mei-yu  Geng</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>. </span><span class="cited-content_cbyCitation_article-title">SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>42 </em>
                                    (6)
                                     , 998-1004. <a href="https://doi.org/10.1038/s41401-020-00513-3" title="DOI URL">https://doi.org/10.1038/s41401-020-00513-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-00513-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-00513-3%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DSAF-189s%25252C%252Ba%252Bpotent%252Bnew-generation%252BROS1%252Binhibitor%25252C%252Bis%252Bactive%252Bagainst%252Bcrizotinib-resistant%252BROS1%252Bmutant-driven%252Btumors%26aulast%3DXia%26aufirst%3DZong-jun%26date%3D2021%26date%3D2020%26volume%3D42%26issue%3D6%26spage%3D998%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Lingtian  Zhang</span>, <span class="hlFld-ContribAuthor ">Fengping  Lv</span>, <span class="hlFld-ContribAuthor ">Marialuisa  Moccia</span>, <span class="hlFld-ContribAuthor ">Francesca  Carlomagno</span>, <span class="hlFld-ContribAuthor ">Christophe  Landry</span>, <span class="hlFld-ContribAuthor ">Massimo  Santoro</span>, <span class="hlFld-ContribAuthor ">Fabien  Gosselet</span>, <span class="hlFld-ContribAuthor ">Brendan  Frett</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113265. <a href="https://doi.org/10.1016/j.ejmech.2021.113265" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113265%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpyrazolo-thieno%25255B3%25252C2-d%25255Dpyrimidinylamino-phenyl%252Bacetamides%252Bas%252Btype-II%252Bpan-tropomyosin%252Breceptor%252Bkinase%252B%252528TRK%252529%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DYan%26aufirst%3DWei%26date%3D2021%26volume%3D216%26spage%3D113265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Huang</span>, <span class="hlFld-ContribAuthor ">Xulong  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Fu</span>, <span class="hlFld-ContribAuthor ">Haoxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Biao  Tang</span>, <span class="hlFld-ContribAuthor ">Yirong  Xiao</span>, <span class="hlFld-ContribAuthor ">Caixia  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhiqiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Yujun  Wan</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Zizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Huipeng  Yao</span>, <span class="hlFld-ContribAuthor ">Zhi  Shan</span>, <span class="hlFld-ContribAuthor ">Tongliang  Bu</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand based 3D-QSAR model, pharmacophore, molecular docking and ADME to identify potential fibroblast growth factor receptor 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>10 </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2021.1899049" title="DOI URL">https://doi.org/10.1080/07391102.2021.1899049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1899049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1899049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DLigand%252Bbased%252B3D-QSAR%252Bmodel%25252C%252Bpharmacophore%25252C%252Bmolecular%252Bdocking%252Band%252BADME%252Bto%252Bidentify%252Bpotential%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B1%252Binhibitors%26aulast%3DHuang%26aufirst%3DLu%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Liang</span>, <span class="hlFld-ContribAuthor ">Juelan  Wang</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Yonghe  Hu</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of dual FGFR inhibitors as a novel therapy for cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113205. <a href="https://doi.org/10.1016/j.ejmech.2021.113205" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113205%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bdual%252BFGFR%252Binhibitors%252Bas%252Ba%252Bnovel%252Btherapy%252Bfor%252Bcancer%26aulast%3DLiang%26aufirst%3DQi%26date%3D2021%26volume%3D214%26spage%3D113205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolu  Chen</span>, <span class="hlFld-ContribAuthor ">Yanan  Liu</span>, <span class="hlFld-ContribAuthor ">Liting  Zhang</span>, <span class="hlFld-ContribAuthor ">Daoxing  Chen</span>, <span class="hlFld-ContribAuthor ">Zhaojun  Dong</span>, <span class="hlFld-ContribAuthor ">Chengguang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Qinqin  Xia</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Yongheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zheng</span>, <span class="hlFld-ContribAuthor ">Yuepiao  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113219. <a href="https://doi.org/10.1016/j.ejmech.2021.113219" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113219%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bindazole%252Bderivatives%252Bas%252Bselective%252Band%252Bpotent%252BFGFR4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BFGF19-driven%252Bhepatocellular%252Bcancer%26aulast%3DChen%26aufirst%3DXiaolu%26date%3D2021%26volume%3D214%26spage%3D113219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Refaat</span>. </span><span class="cited-content_cbyCitation_article-title">Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s43094-020-00048-8" title="DOI URL">https://doi.org/10.1186/s43094-020-00048-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s43094-020-00048-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs43094-020-00048-8%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DVersatile%252Bmechanisms%252Bof%252B2-substituted%252Bbenzimidazoles%252Bin%252Btargeted%252Bcancer%252Btherapy%26aulast%3DIbrahim%26aufirst%3DHeba%2BA.%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohammad Shahar  Yar</span>, <span class="hlFld-ContribAuthor ">Vinod Kumar  Sharma</span>, <span class="hlFld-ContribAuthor ">Ahsan Ahmed  Khan</span>, <span class="hlFld-ContribAuthor ">Zulphikar  Ali</span>, <span class="hlFld-ContribAuthor ">MD. Rafi  Haider</span>, <span class="hlFld-ContribAuthor ">Ankita  Pathak</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress of Benzimidazole Hybrids for Anticancer Potential. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (35)
                                     , 5970-6014. <a href="https://doi.org/10.2174/0929867326666190808122929" title="DOI URL">https://doi.org/10.2174/0929867326666190808122929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190808122929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190808122929%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bof%252BBenzimidazole%252BHybrids%252Bfor%252BAnticancer%252BPotential%26aulast%3DAkhtar%26aufirst%3DMd.%2BJawaid%26date%3D2020%26volume%3D27%26issue%3D35%26spage%3D5970%26epage%3D6014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Wu-Chen  Xie</span>, <span class="hlFld-ContribAuthor ">Si-Ping  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in the development of novel, selective and potent FGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111884. <a href="https://doi.org/10.1016/j.ejmech.2019.111884" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111884%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Bthe%252Bdevelopment%252Bof%252Bnovel%25252C%252Bselective%252Band%252Bpotent%252BFGFR%252Binhibitors%26aulast%3DLiu%26aufirst%3DFeng-Tao%26date%3D2020%26volume%3D186%26spage%3D111884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Marseglia</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Riccardo  Castelli</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast growth factor receptor inhibitors: patent review (2015–2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 965-977. <a href="https://doi.org/10.1080/13543776.2019.1688300" title="DOI URL">https://doi.org/10.1080/13543776.2019.1688300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1688300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1688300%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%25253A%252Bpatent%252Breview%252B%2525282015%2525E2%252580%2525932019%252529%26aulast%3DMarseglia%26aufirst%3DGiuseppe%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D965%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Pengcong  Hou</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Yanyan  Shen</span>, <span class="hlFld-ContribAuthor ">Yi  Su</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Yueliang  Wang</span>, <span class="hlFld-ContribAuthor ">Deqiao  Sun</span>, <span class="hlFld-ContribAuthor ">Yuchen  Jiang</span>, <span class="hlFld-ContribAuthor ">Chuantao  Zha</span>, <span class="hlFld-ContribAuthor ">Zuoquan  Xie</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1357-y" title="DOI URL">https://doi.org/10.1186/s13046-019-1357-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1357-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1357-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DPreclinical%252Bevaluation%252Bof%252B3D185%25252C%252Ba%252Bnovel%252Bpotent%252Binhibitor%252Bof%252BFGFR1%25252F2%25252F3%252Band%252BCSF-1R%25252C%252Bin%252BFGFR-dependent%252Band%252Bmacrophage-dominant%252Bcancer%252Bmodels%26aulast%3DPeng%26aufirst%3DXia%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galyna  Volynets</span>, <span class="hlFld-ContribAuthor ">Sergiy  Lukashov</span>, <span class="hlFld-ContribAuthor ">Iryna  Borysenko</span>, <span class="hlFld-ContribAuthor ">Andrii  Gryshchenko</span>, <span class="hlFld-ContribAuthor ">Sergiy  Starosyla</span>, <span class="hlFld-ContribAuthor ">Volodymyr  Bdzhola</span>, <span class="hlFld-ContribAuthor ">Tetiana  Ruban</span>, <span class="hlFld-ContribAuthor ">Anna  Iatsyshyna</span>, <span class="hlFld-ContribAuthor ">Lyubov  Lukash</span>, <span class="hlFld-ContribAuthor ">Yaroslav  Bilokin</span>, <span class="hlFld-ContribAuthor ">Sergiy  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of protein kinase fibroblast growth factor receptor 1 (FGFR1) inhibitors among the derivatives of 5-(5,6-dimethoxybenzimidazol-1-yl)-3-hydroxythiophene-2-carboxylic acid. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2019,</strong> <em>150 </em>
                                    (10)
                                     , 1801-1808. <a href="https://doi.org/10.1007/s00706-019-02493-5" title="DOI URL">https://doi.org/10.1007/s00706-019-02493-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-019-02493-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-019-02493-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DIdentification%252Bof%252Bprotein%252Bkinase%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B1%252B%252528FGFR1%252529%252Binhibitors%252Bamong%252Bthe%252Bderivatives%252Bof%252B5-%2525285%25252C6-dimethoxybenzimidazol-1-yl%252529-3-hydroxythiophene-2-carboxylic%252Bacid%26aulast%3DVolynets%26aufirst%3DGalyna%26date%3D2019%26date%3D2019%26volume%3D150%26issue%3D10%26spage%3D1801%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaling  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiaoli  Hou</span>, <span class="hlFld-ContribAuthor ">Xiabing  Li</span>, <span class="hlFld-ContribAuthor ">Jiuling  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Baolin  Li</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhao</span>, <span class="hlFld-ContribAuthor ">Haibin  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 417-432. <a href="https://doi.org/10.1016/j.ejmech.2019.06.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnrichment%252Bof%252Bnovel%252Bquinazoline%252Bderivatives%252Bwith%252Bhigh%252Bantitumor%252Bactivity%252Bin%252Bmitochondria%252Btracked%252Bby%252Bits%252Bself-fluorescence%26aulast%3DZhang%26aufirst%3DYaling%26date%3D2019%26volume%3D178%26spage%3D417%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>, <span class="hlFld-ContribAuthor ">Fanie R.  Van Heerden</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the distinct mechanistic binding and activity of 5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-3-(5-(4-methylpiperazin-1-yl)-1
              H
              -benzo[
              d
              ]imidazol-2-yl)-1
              H
              -indazole enantiomers against FGFR1. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2019,</strong> <em>21 </em>
                                    (27)
                                     , 15120-15132. <a href="https://doi.org/10.1039/C9CP02112D" title="DOI URL">https://doi.org/10.1039/C9CP02112D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP02112D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP02112D%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DRevealing%252Bthe%252Bdistinct%252Bmechanistic%252Bbinding%252Band%252Bactivity%252Bof%252B5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-3-%2525285-%2525284-methylpiperazin-1-yl%252529-1%252BH%252B-benzo%25255B%252Bd%252B%25255Dimidazol-2-yl%252529-1%252BH%252B-indazole%252Benantiomers%252Bagainst%252BFGFR1%26aulast%3DFarrokhzadeh%26aufirst%3DAbdolkarim%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D27%26spage%3D15120%26epage%3D15132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatiana N.  Pashirova</span>, <span class="hlFld-ContribAuthor ">Nataliya A.  Zhukova</span>, <span class="hlFld-ContribAuthor ">Svetlana S.  Lukashenko</span>, <span class="hlFld-ContribAuthor ">Farida G.  Valeeva</span>, <span class="hlFld-ContribAuthor ">Evgenia A.  Burilova</span>, <span class="hlFld-ContribAuthor ">Anastasia S.  Sapunova</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Voloshina</span>, <span class="hlFld-ContribAuthor ">Alla B.  Mirgorodskaya</span>, <span class="hlFld-ContribAuthor ">Lucia Y.  Zakharova</span>, <span class="hlFld-ContribAuthor ">Oleg G.  Sinyashin</span>, <span class="hlFld-ContribAuthor ">Vakhid A.  Mamedov</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-targeted approach by 2-benzimidazolylquinoxalines-loaded cationic arginine liposomes against сervical cancer cells in vitro. </span><span class="cited-content_cbyCitation_journal-name">Colloids and Surfaces B: Biointerfaces</span><span> <strong>2019,</strong> <em>178 </em>, 317-328. <a href="https://doi.org/10.1016/j.colsurfb.2019.03.021" title="DOI URL">https://doi.org/10.1016/j.colsurfb.2019.03.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.colsurfb.2019.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.colsurfb.2019.03.021%26sid%3Dliteratum%253Aachs%26jtitle%3DColloids%2520and%2520Surfaces%2520B%253A%2520Biointerfaces%26atitle%3DMulti-targeted%252Bapproach%252Bby%252B2-benzimidazolylquinoxalines-loaded%252Bcationic%252Barginine%252Bliposomes%252Bagainst%252B%2525D1%252581ervical%252Bcancer%252Bcells%252Bin%252Bvitro%26aulast%3DPashirova%26aufirst%3DTatiana%2BN.%26date%3D2019%26volume%3D178%26spage%3D317%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang'an  Sun</span>, <span class="hlFld-ContribAuthor ">Lei  Fang</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng  Gao</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 7-formyl-naphthyridyl-ureas derivatives as potential selective FGFR4 inhibitors: Design, synthesis, and biological activity studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (10)
                                     , 1932-1941. <a href="https://doi.org/10.1016/j.bmc.2019.04.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.04.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.04.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B7-formyl-naphthyridyl-ureas%252Bderivatives%252Bas%252Bpotential%252Bselective%252BFGFR4%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bactivity%252Bstudies%26aulast%3DSun%26aufirst%3DChang%2527an%26date%3D2019%26volume%3D27%26issue%3D10%26spage%3D1932%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaling  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Xiabing  Li</span>, <span class="hlFld-ContribAuthor ">Li  Gao</span>, <span class="hlFld-ContribAuthor ">Yunxia  Hao</span>, <span class="hlFld-ContribAuthor ">Baolin  Li</span>, <span class="hlFld-ContribAuthor ">Yaping  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 4-arylaminoquinazolines bearing
              N
              ,
              N
              -diethyl(aminoethyl)amino moiety with antitumour activity as EGFR
              wt
              -TK inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 1668-1677. <a href="https://doi.org/10.1080/14756366.2019.1667341" title="DOI URL">https://doi.org/10.1080/14756366.2019.1667341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1667341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1667341%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B4-arylaminoquinazolines%252Bbearing%252BN%252B%25252C%252BN%252B-diethyl%252528aminoethyl%252529amino%252Bmoiety%252Bwith%252Bantitumour%252Bactivity%252Bas%252BEGFR%252Bwt%252B-TK%252Binhibitor%26aulast%3DZhang%26aufirst%3DYaling%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1668%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Anfeng  Cui</span>, <span class="hlFld-ContribAuthor ">De-Yong  Ye</span>, <span class="hlFld-ContribAuthor ">Meng  Xiang</span>, <span class="hlFld-ContribAuthor ">Yong  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (20)
                                     , 5479-5493. <a href="https://doi.org/10.1016/j.bmc.2018.09.027" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Banti-inflammatory%252Bevaluation%252Bof%252Bbenzothiazepinones%252B%252528BTZs%252529%252Bas%252Bnovel%252Bnon-ATP%252Bcompetitive%252Binhibitors%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252B%252528GSK-3%2525CE%2525B2%252529%26aulast%3DGao%26aufirst%3DYang%26date%3D2018%26volume%3D26%26issue%3D20%26spage%3D5479%26epage%3D5493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyun  Dong</span>, <span class="hlFld-ContribAuthor ">Qijing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Guang  Huang</span>, <span class="hlFld-ContribAuthor ">Shaoshun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Indazole-based Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1490-1507. <a href="https://doi.org/10.1002/cmdc.201800253" title="DOI URL">https://doi.org/10.1002/cmdc.201800253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BIndazole-based%252BAnticancer%252BAgents%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1490%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnaud  Chevalier</span>, <span class="hlFld-ContribAuthor ">Abdelaaziz  Ouahrouch</span>, <span class="hlFld-ContribAuthor ">Alexandre  Arnaud</span>, <span class="hlFld-ContribAuthor ">Thibault  Gallavardin</span>, <span class="hlFld-ContribAuthor ">Xavier  Franck</span>. </span><span class="cited-content_cbyCitation_article-title">An optimized procedure for direct access to 1
              H
              -indazole-3-carboxaldehyde derivatives by nitrosation of indoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (24)
                                     , 13121-13128. <a href="https://doi.org/10.1039/C8RA01546E" title="DOI URL">https://doi.org/10.1039/C8RA01546E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01546E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01546E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAn%252Boptimized%252Bprocedure%252Bfor%252Bdirect%252Baccess%252Bto%252B1%252BH%252B-indazole-3-carboxaldehyde%252Bderivatives%252Bby%252Bnitrosation%252Bof%252Bindoles%26aulast%3DChevalier%26aufirst%3DArnaud%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D24%26spage%3D13121%26epage%3D13128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-Ting  Miao</span>, <span class="hlFld-ContribAuthor ">Xu-Bing  Tao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Yi  Geng</span>, <span class="hlFld-ContribAuthor ">Shi-Fa  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (31)
                                     , 17511-17526. <a href="https://doi.org/10.1039/C8RA02078G" title="DOI URL">https://doi.org/10.1039/C8RA02078G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA02078G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA02078G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-aryl-benzimidazole%252Bderivatives%252Bof%252Bdehydroabietic%252Bacid%252Bas%252Bnovel%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DMiao%26aufirst%3DTing-Ting%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D31%26spage%3D17511%26epage%3D17526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Yaling  Zhang</span>, <span class="hlFld-ContribAuthor ">Juan  Liu</span>, <span class="hlFld-ContribAuthor ">Weijia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiabing  Li</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Baolin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 4-arylaminoquinazoline derivatives with ( E )-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 689-697. <a href="https://doi.org/10.1016/j.ejmech.2017.06.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B4-arylaminoquinazoline%252Bderivatives%252Bwith%252B%252528%252BE%252B%252529-propen-1-yl%252Bmoiety%252Bas%252Bpotent%252BEGFR%252Binhibitors%252Bwith%252Benhanced%252Bantiproliferative%252Bactivities%252Bagainst%252Btumor%252Bcells%26aulast%3DChen%26aufirst%3DLi%26date%3D2017%26volume%3D138%26spage%3D689%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">De-Yong  Ye</span>, <span class="hlFld-ContribAuthor ">Wei-Cheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Yong  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 370-381. <a href="https://doi.org/10.1016/j.ejmech.2017.04.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bnovel%252Bbenzothiazinones%252Bas%252Bhighly%252Bselective%252Bnon-ATP%252Bcompetitive%252Bglycogen%252Bsynthase%252Bkinase%252B3%2525CE%2525B2%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bovarian%252Bcancer%26aulast%3DGao%26aufirst%3DYang%26date%3D2017%26volume%3D135%26spage%3D370%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Yanyan  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Xu</span>, <span class="hlFld-ContribAuthor ">Mengpeng  Li</span>, <span class="hlFld-ContribAuthor ">Murugavel  Ponnusamy</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Xun  Wang</span>, <span class="hlFld-ContribAuthor ">Pei-Feng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A FGFR1 inhibitor patent review: progress since 2010. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 439-454. <a href="https://doi.org/10.1080/13543776.2017.1272574" title="DOI URL">https://doi.org/10.1080/13543776.2017.1272574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1272574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1272574%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252BFGFR1%252Binhibitor%252Bpatent%252Breview%25253A%252Bprogress%252Bsince%252B2010%26aulast%3DYu%26aufirst%3DTao%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D439%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Tongchao  Liu</span>, <span class="hlFld-ContribAuthor ">Chaoyun  Wang</span>, <span class="hlFld-ContribAuthor ">Yuchi  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (4)
                                     , 583. <a href="https://doi.org/10.3390/molecules22040583" title="DOI URL">https://doi.org/10.3390/molecules22040583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22040583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22040583%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BSeries%252Bof%252BPyrrolo%25255B2%25252C3-b%25255Dpyrazines%252Bas%252BNovel%252BFGFR%252BInhibitors%26aulast%3DZhang%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D4%26spage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shenggui  Liu</span>, <span class="hlFld-ContribAuthor ">Rongkai  Pan</span>, <span class="hlFld-ContribAuthor ">Wenyi  Su</span>, <span class="hlFld-ContribAuthor ">Guobi  Li</span>, <span class="hlFld-ContribAuthor ">Chunlin  Ni</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Ruthenium Complex Based on 2,6-Bis[1-(Pyridin-2-yl)-1H-Benzo[d]Imidazol-2-yl]Pyridine and Catalytic Oxidation of (1H-Benzo[d]-Imidazol-2-yl)Methanol to 1H-Benzo[d]Imidazole-2-Carbaldehyde with H
              2
              O
              2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2017,</strong> <em>41 </em>
                                    (2)
                                     , 88-92. <a href="https://doi.org/10.3184/174751917X14858862342106" title="DOI URL">https://doi.org/10.3184/174751917X14858862342106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751917X14858862342106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751917X14858862342106%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DSynthesis%252Bof%252Ba%252BRuthenium%252BComplex%252BBased%252Bon%252B2%25252C6-Bis%25255B1-%252528Pyridin-2-yl%252529-1H-Benzo%25255Bd%25255DImidazol-2-yl%25255DPyridine%252Band%252BCatalytic%252BOxidation%252Bof%252B%2525281H-Benzo%25255Bd%25255D-Imidazol-2-yl%252529Methanol%252Bto%252B1H-Benzo%25255Bd%25255DImidazole-2-Carbaldehyde%252Bwith%252BH%252B2%252BO%252B2%26aulast%3DLiu%26aufirst%3DShenggui%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D2%26spage%3D88%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">M.A.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Syed Hassan  Mehdi</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 705-753. <a href="https://doi.org/10.1016/j.ejmech.2016.12.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bevolution%252Bof%252Bbenzimidazole%252Bderivatives%252Bin%252Bthe%252Blast%252Bquinquennial%252Bperiod%26aulast%3DAkhtar%26aufirst%3DWasim%26date%3D2017%26volume%3D126%26spage%3D705%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ze-lin  Li</span>, <span class="hlFld-ContribAuthor ">Li-kun  Jin</span>, <span class="hlFld-ContribAuthor ">Chun  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of 2-substituted azoles: radical C–H alkylation of azoles with dicumyl peroxide, methylarenes and cycloalkanes under metal-free condition. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (10)
                                     , 2039-2043. <a href="https://doi.org/10.1039/C7QO00396J" title="DOI URL">https://doi.org/10.1039/C7QO00396J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00396J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00396J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DEfficient%252Bsynthesis%252Bof%252B2-substituted%252Bazoles%25253A%252Bradical%252BC%2525E2%252580%252593H%252Balkylation%252Bof%252Bazoles%252Bwith%252Bdicumyl%252Bperoxide%25252C%252Bmethylarenes%252Band%252Bcycloalkanes%252Bunder%252Bmetal-free%252Bcondition%26aulast%3DLi%26aufirst%3DZe-lin%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D10%26spage%3D2039%26epage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative FGFR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative approved VEGFR2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0011.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding mode of compound <b>9</b> to FGFR1 kinase domain. The atoms of compound <b>9</b> are colored as follows: carbon orange, oxygen red, nitrogen blue, fluorine light blue, and hydrogen white. The docked protein structure of FGFR1 is shown in the cartoon and key residues are colored as follows: carbon green, oxygen red, nitrogen blue, and hydrogen white. The hydrogen bonds are colored in black.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of our compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed binding mode of compound <b>14a</b> to FGFR1 kinase domain. The atoms of compound <b>14a</b> are colored as follows: carbon orange, oxygen red, nitrogen blue, and hydrogen white. The docked protein structure of FGFR1 is shown in the cartoon and key residues are colored as follows: carbon green, oxygen red, nitrogen blue, and hydrogen white. The hydrogen bonds are colored in black.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0014.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures and activities of the enantiomers of <b>21c</b> and <b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0015.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound (<i>R</i>)-<b>21c</b> effectively inhibits the phosphorylation of FGFR and the downstream effectors PLCγ and Erk in KG-1 and SNU-16 cells. KG1 (A) or SNU-16 (B) cells treated with (<i>R</i>)-<b>21c</b> for 2 h at the indicated concentrations were lysed and subjected to Western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0016.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Inhibitory effect of (<i>R</i>)-<b>21c</b> on tumor growth in NCI-H1581 xenograft model. Compound (<i>R</i>)-<b>21c</b> was administered orally once daily for 21 days. (A) The percentage of tumor growth inhibition values (TGI) was measured on the final day of the study for the drug-treated mice compared with the vehicle control mice: (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001, versus vehicle group, using Student’s <i>t</i> test. Results are expressed as the mean ± SEM (<i>n</i> = 6 for inhibitor-treated group, <i>n</i> = 12 for vehicle control group). (B) Body weight measurements during the treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0017.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Proposed binding mode of (<i>R</i>)-<b>21c</b> with FGFR1. (A) The atoms of (<i>R</i>)-<b>21c</b> are colored as follows: carbon orange, oxygen red, nitrogen blue, chlorine green, and hydrogen white. The docked protein structure of FGFR1 is shown in the cartoon and key residues are colored as follows: carbon green, oxygen red, nitrogen blue, and hydrogen white. The hydrogen bonds are colored in black. (B) The docked protein structure of FGFR1 is shown in surface. The surfaces of Gly485 and Glu486 are omitted for clarity. (C) The <i>R</i>-methyl fit in a pocket surrounded by three residues (Asp641, Val492, and Glu485).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0018.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 5-hydroxyindole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (b) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O/dioxane, 0 °C to rt; (c) Et<sub>3</sub>N, piperidine, NMP, 120 °C; (d) H<sub>2</sub>, 10% Pd/C, MeOH, rt; (e) S<sub>8</sub>, DMF, 90 °C.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0019.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for <b>30a</b> and <b>30c</b>, LDA, acetaldehyde, THF, −78 °C; for <b>30b</b>, LDA, propionaldehyde, THF, −78 °C; (b) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (c) 5-hydroxyindole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (d) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O/dioxane, 0 °C to rt; (e) <b>28</b>, S<sub>8</sub>, DMF, 90 °C.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0020.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for <b>16a</b> and <b>16c</b>, S<sub>8</sub>, DMF, 90 °C; for <b>16b</b>, (i) DMF, 90 °C; (ii) DDQ, CHCl<sub>3</sub>, reflux; (b) (i) Cs<sub>2</sub>CO<sub>3</sub>, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, dioxane, 90 °C; (ii) 4 N HCl in MeOH.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0021.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) H<sub>2</sub>, 10% Pd/C, MeOH, rt; (ii) <b>33a</b>, S<sub>8</sub>, DMF, 90 °C; (b) for <b>26d</b>, methylammonium chloride, DIPEA, NMP, 140 °C; for <b>40</b>, DIPEA, NMP, 120 °C; (c) (i) 2-bromoacetyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt; (ii) dimethylamine, THF, rt.</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0022.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DCC, 4-DMAP, toluene, 0 °C; (ii) NaOH, H<sub>2</sub>O, EtOH, rt; (b) (i) HOAc, DIAD, PPh<sub>3</sub>, THF, 0 °C to rt; (ii) NaOH, H<sub>2</sub>O, EtOH, rt.</p></p></figure><figure data-id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/medium/jm-2016-000565_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0023.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00056/20160722/images/large/jm-2016-000565_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00056&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (b) 5-hydroxyindole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; (c) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O/dioxane, 0 °C to rt; (d) (i) <b>40c</b>, H<sub>2</sub>, 10% Pd/C, MeOH, rt; (ii) S<sub>8</sub>, DMF, 90 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Touat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ileana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postel-Vinay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J. C.</span><span> </span><span class="NLM_article-title">Targeting FGFR signaling in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2684</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1078-0432.CCR-14-2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=26078430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVajurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2684-2694&author=M.+Touatauthor=E.+Ileanaauthor=S.+Postel-Vinayauthor=F.+Andreauthor=J.+C.+Soria&title=Targeting+FGFR+signaling+in+cancer&doi=10.1158%2F1078-0432.CCR-14-2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting FGFR Signaling in Cancer</span></div><div class="casAuthors">Touat, Mehdi; Ileana, Ecaterina; Postel-Vinay, Sophie; Andre, Fabrice; Soria, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2684-2694</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fibroblast growth factor signaling pathway (FGFR signaling) is an evolutionary conserved signaling cascade that regulates several basic biol. processes, including tissue development, angiogenesis, and tissue regeneration.  Substantial evidence indicates that aberrant FGFR signaling is involved in the pathogenesis of cancer.  Recent developments of deep sequencing technologies have allowed the discovery of frequent mol. alterations in components of FGFR signaling among several solid tumor types.  Moreover, compelling preclin. models have demonstrated the oncogenic potential of these aberrations in driving tumor growth, promoting angiogenesis, and conferring resistance mechanisms to anticancer therapies.  Recently, the field of FGFR targeting has exponentially progressed thanks to the development of novel agents inhibiting FGFs or FGFRs, which had manageable safety profiles in early-phase trials.  Promising treatment efficacy has been obsd. in different types of malignancies, particularly in tumors harboring aberrant FGFR signaling, thus offering novel therapeutic opportunities in the era of precision medicine.  The most exciting challenges now focus on selecting patients who are most likely to benefit from these agents, increasing the efficacy of therapies with the development of novel potent compds. and combination strategies, and overcoming toxicities assocd. with FGFR inhibitors.  After examn. of the basic and translational research studies that validated the oncogenic potential of aberrant FGFR signaling, this review focuses on recent data from clin. trials evaluating FGFR targeting therapies and discusses the challenges and perspectives for the development of these agents.  Clin Cancer Res; 21(12); 2684-94. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZpKbvUn0hrVg90H21EOLACvtfcHk0lhYSXvUsxQ5qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVajurfP&md5=3dbb11de3f3a7d25d3b4ccb56400fd4d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-2329%26sid%3Dliteratum%253Aachs%26aulast%3DTouat%26aufirst%3DM.%26aulast%3DIleana%26aufirst%3DE.%26aulast%3DPostel-Vinay%26aufirst%3DS.%26aulast%3DAndre%26aufirst%3DF.%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26atitle%3DTargeting%2520FGFR%2520signaling%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D2684%26epage%3D2694%26doi%3D10.1158%2F1078-0432.CCR-14-2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kelleher, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viterbo, A.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptors, developmental corruption and malignant disease</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2198</span><span class="NLM_x">–</span> <span class="NLM_lpage">2205</span><span class="refDoi"> DOI: 10.1093/carcin/bgt254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Fcarcin%2Fbgt254" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2198-2205&author=F.+C.+Kelleherauthor=H.+O%E2%80%99Sullivanauthor=E.+Smythauthor=R.+McDermottauthor=A.+Viterbo&title=Fibroblast+growth+factor+receptors%2C+developmental+corruption+and+malignant+disease&doi=10.1093%2Fcarcin%2Fbgt254"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt254%26sid%3Dliteratum%253Aachs%26aulast%3DKelleher%26aufirst%3DF.%2BC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DH.%26aulast%3DSmyth%26aufirst%3DE.%26aulast%3DMcDermott%26aufirst%3DR.%26aulast%3DViterbo%26aufirst%3DA.%26atitle%3DFibroblast%2520growth%2520factor%2520receptors%252C%2520developmental%2520corruption%2520and%2520malignant%2520disease%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D2198%26epage%3D2205%26doi%3D10.1093%2Fcarcin%2Fbgt254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Weiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltermann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leenders, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabow, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Querings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heukamp, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balke-Want, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baessmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainer, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorimier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustugun, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel-Riedel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timens, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sietsma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heideman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligorio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoelben, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span> </span><span class="NLM_article-title">Frequent and focal FGFR1amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">62ra93</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3001451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1126%2Fscitranslmed.3001451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=21160078" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=62ra93&author=J.+Weissauthor=M.+L.+Sosauthor=D.+Seidelauthor=M.+Peiferauthor=T.+Zanderauthor=J.+M.+Heuckmannauthor=R.+T.+Ullrichauthor=R.+Menonauthor=S.+Maierauthor=A.+Soltermannauthor=H.+Mochauthor=P.+Wagenerauthor=F.+Fischerauthor=S.+Heynckauthor=M.+Kokerauthor=J.+Schottleauthor=F.+Leendersauthor=F.+Gablerauthor=I.+Dabowauthor=S.+Queringsauthor=L.+C.+Heukampauthor=H.+Balke-Wantauthor=S.+Ansenauthor=D.+Rauhauthor=I.+Baessmannauthor=J.+Altmullerauthor=Z.+Wainerauthor=M.+Conronauthor=G.+Wrightauthor=P.+Russellauthor=B.+Solomonauthor=E.+Brambillaauthor=C.+Brambillaauthor=P.+Lorimierauthor=S.+Sollbergauthor=O.+T.+Brustugunauthor=W.+Engel-Riedelauthor=C.+Ludwigauthor=I.+Petersenauthor=J.+Sangerauthor=J.+Clementauthor=H.+Groenauthor=W.+Timensauthor=H.+Sietsmaauthor=E.+Thunnissenauthor=E.+Smitauthor=D.+Heidemanauthor=F.+Cappuzzoauthor=C.+Ligorioauthor=S.+Damianiauthor=M.+Hallekauthor=R.+Beroukhimauthor=W.+Paoauthor=B.+Kleblauthor=M.+Baumannauthor=R.+Buettnerauthor=K.+Ernestusauthor=E.+Stoelbenauthor=J.+Wolfauthor=P.+Nurnbergauthor=S.+Pernerauthor=R.+K.+Thomas&title=Frequent+and+focal+FGFR1amplification+associates+with+therapeutically+tractable+FGFR1+dependency+in+squamous+cell+lung+cancer&doi=10.1126%2Fscitranslmed.3001451"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001451%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DSeidel%26aufirst%3DD.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DZander%26aufirst%3DT.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DUllrich%26aufirst%3DR.%2BT.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DMaier%26aufirst%3DS.%26aulast%3DSoltermann%26aufirst%3DA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DWagener%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DF.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DSchottle%26aufirst%3DJ.%26aulast%3DLeenders%26aufirst%3DF.%26aulast%3DGabler%26aufirst%3DF.%26aulast%3DDabow%26aufirst%3DI.%26aulast%3DQuerings%26aufirst%3DS.%26aulast%3DHeukamp%26aufirst%3DL.%2BC.%26aulast%3DBalke-Want%26aufirst%3DH.%26aulast%3DAnsen%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DBaessmann%26aufirst%3DI.%26aulast%3DAltmuller%26aufirst%3DJ.%26aulast%3DWainer%26aufirst%3DZ.%26aulast%3DConron%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DRussell%26aufirst%3DP.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DBrambilla%26aufirst%3DE.%26aulast%3DBrambilla%26aufirst%3DC.%26aulast%3DLorimier%26aufirst%3DP.%26aulast%3DSollberg%26aufirst%3DS.%26aulast%3DBrustugun%26aufirst%3DO.%2BT.%26aulast%3DEngel-Riedel%26aufirst%3DW.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DI.%26aulast%3DSanger%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DJ.%26aulast%3DGroen%26aufirst%3DH.%26aulast%3DTimens%26aufirst%3DW.%26aulast%3DSietsma%26aufirst%3DH.%26aulast%3DThunnissen%26aufirst%3DE.%26aulast%3DSmit%26aufirst%3DE.%26aulast%3DHeideman%26aufirst%3DD.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DLigorio%26aufirst%3DC.%26aulast%3DDamiani%26aufirst%3DS.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DM.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DErnestus%26aufirst%3DK.%26aulast%3DStoelben%26aufirst%3DE.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DNurnberg%26aufirst%3DP.%26aulast%3DPerner%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26atitle%3DFrequent%2520and%2520focal%2520FGFR1amplification%2520associates%2520with%2520therapeutically%2520tractable%2520FGFR1%2520dependency%2520in%2520squamous%2520cell%2520lung%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D62ra93%26doi%3D10.1126%2Fscitranslmed.3001451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tomiguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto-Ibusuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto-Yamaguchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sueta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span> </span><span class="NLM_article-title">FGFR1 protein expression is associated with prognosis in ER-positive/HER2-negative primary breast cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="refDoi"> DOI: 10.1111/cas.12897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1111%2Fcas.12897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=26801869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVymtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=491&author=M.+Tomiguchiauthor=Y.+Yamamotoauthor=M.+Yamamoto-Ibusukiauthor=L.+Goto-Yamaguchiauthor=Y.+Fujikiauthor=S.+Fujiwaraauthor=A.+Suetaauthor=M.+Hayashiauthor=T.+Takeshitaauthor=T.+Inaoauthor=H.+Iwase&title=FGFR1+protein+expression+is+associated+with+prognosis+in+ER-positive%2FHER2-negative+primary+breast+cancer&doi=10.1111%2Fcas.12897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer</span></div><div class="casAuthors">Tomiguchi, Mai; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Goto-Yamaguchi, Lisa; Fujiki, Yoshitaka; Fujiwara, Saori; Sueta, Aiko; Hayashi, Mitsuhiro; Takeshita, Takashi; Inao, Touko; Iwase, Hirotaka</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-498</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Recently, research into the development of new targeted therapies has focused on specific genetic alterations to create advanced, more personalized treatment.  One of the target genes, fibroblast growth factor receptor-1 (FGFR1), has been reported to be amplified in estrogen receptor (ER)-pos. subtype breast cancer, and is considered one possible mechanism of endocrine resistance through cross-talk between ER and growth factor receptor signaling.  We performed a comprehensive anal. of FGFR1 at the levels of gene copy no., transcript and protein expression, and examd. the relationships between FGFR1 status and clinicopathol. parameters, including prognosis in 307 ER-pos./HER2-neg. primary breast cancer patients treated with std. care at our institute.  Most notably, a high level of FGFR1 protein expression was obsd. in 85 patients (27.7%), and was pos. assocd. with invasive tumor size (P = 0.039).  Furthermore, univariate anal. revealed that high FGFR1 protein expression was significantly correlated with poor relapse-free survival rate (P = 0.0019, HR: 2.63, 95% confidence interval: 1.17-5.98), and showed a tendency towards an increase in recurrent events if the observation period extended beyond the 5 years of the std. endocrine treatment term.  FGFR1 gain/amplification was found in 43 (14.0%) patients, which was only assocd. with higher nuclear grade (P = 0.010).  No correlation was found between FGFR1 mRNA expression levels and any clinicopathol. factors.  Overall, the level of FGFR1 protein expression may be a biomarker of ER-pos./HER2-neg. primary breast cancer with possible resistance to std. treatment, and may be a useful tool to identify more specific patients who would benefit from FGFR-1 targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89jP4QEld57Vg90H21EOLACvtfcHk0ljlp07vVvdrGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVymtbk%253D&md5=977a39539ae0124dd43b7a102f271107</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fcas.12897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12897%26sid%3Dliteratum%253Aachs%26aulast%3DTomiguchi%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamamoto-Ibusuki%26aufirst%3DM.%26aulast%3DGoto-Yamaguchi%26aufirst%3DL.%26aulast%3DFujiki%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DSueta%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DTakeshita%26aufirst%3DT.%26aulast%3DInao%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DH.%26atitle%3DFGFR1%2520protein%2520expression%2520is%2520associated%2520with%2520prognosis%2520in%2520ER-positive%252FHER2-negative%2520primary%2520breast%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2016%26volume%3D107%26spage%3D491%26doi%3D10.1111%2Fcas.12897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Shoji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span> </span><span class="NLM_article-title">Amplification of FGFR2 gene in patients with advanced gastric cancer receiving chemotherapy: prevalence and prognostic significance</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">5055</span><span class="NLM_x">–</span> <span class="NLM_lpage">5061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=26254407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2itL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=5055-5061&author=H.+Shojiauthor=Y.+Yamadaauthor=N.+Okitaauthor=A.+Takashimaauthor=Y.+Honmaauthor=S.+Iwasaauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimada&title=Amplification+of+FGFR2+gene+in+patients+with+advanced+gastric+cancer+receiving+chemotherapy%3A+prevalence+and+prognostic+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of FGFR2 gene in patients with advanced gastric cancer receiving chemotheraphy: prevalence and prognostic significance</span></div><div class="casAuthors">Shoji, Hirokazu; Yamada, Yasuhide; Okita, Natsuko; Takashima, Atsuo; Honma, Yoshitaka; Iwasa, Satoru; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5055-5062</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: fibroblast growth factors and their receptors regulate key cellular functions, such as proliferation, differentiation and survival. herein, we studied the prevalence and prognostic role of fibroblast growth factor receptor 2 (fgfr2) amplification in patients with advanced gastric cancer (agc) who received systemic chemotherapy. patients and methods: the gene copy no. of fgfr2 was investigated in 80 patients with agc who received systemic chemotherapy. fgfr2 gene status was assessed by dual-color fluorescence in-situ hybridization. results: among 80 patients, fgfr2 amplification was obsd. in seven cases (11.5%). patients with fgfr2 amplification had significantly shorter overall survival (os) than did those without fgfr2 amplification (9.1 vs. 16.5 mo; p = 0.037). in multivariate anal., disease status and no. of metastatic sites were assocd. with worse os (p = 0.015 and p = 0.009, resp.). fgfr2 amplification tended to be correlated with a poorer outcome (p = 0.080). conclusion: fgfr2 amplification tended to result in a shorter survival period compared to cases without amplification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHgo8pWCE5JrVg90H21EOLACvtfcHk0ljBZzin8CJLyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2itL%252FI&md5=17d42d68f8177843e0154453e163986d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoji%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DOkita%26aufirst%3DN.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DHonma%26aufirst%3DY.%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26atitle%3DAmplification%2520of%2520FGFR2%2520gene%2520in%2520patients%2520with%2520advanced%2520gastric%2520cancer%2520receiving%2520chemotherapy%253A%2520prevalence%2520and%2520prognostic%2520significance%26jtitle%3DAnticancer%2520Res.%26date%3D2015%26volume%3D35%26spage%3D5055%26epage%3D5061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Neuzillet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rhijn, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigoda, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bapat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostrom, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleshner, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallie, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotta, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kwast, T. H.</span><span> </span><span class="NLM_article-title">FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer</span> <span class="citation_source-journal">Virchows Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1007/s00428-014-1596-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs00428-014-1596-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=24880661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVCrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2014&pages=207-213&author=Y.+Neuzilletauthor=B.+W.+van+Rhijnauthor=N.+L.+Prigodaauthor=B.+Bapatauthor=L.+Liuauthor=P.+J.+Bostromauthor=N.+E.+Fleshnerauthor=B.+L.+Gallieauthor=A.+R.+Zlottaauthor=M.+A.+Jewettauthor=T.+H.+van+der+Kwast&title=FGFR3+mutations%2C+but+not+FGFR3+expression+and+FGFR3+copy-number+variations%2C+are+associated+with+favourable+non-muscle+invasive+bladder+cancer&doi=10.1007%2Fs00428-014-1596-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer</span></div><div class="casAuthors">Neuzillet, Yann; van Rhijn, Bas W. G.; Prigoda, Nadia L.; Bapat, Bharati; Liu, Liyang; Bostrom, Peter J.; Fleshner, Neil E.; Gallie, Brenda L.; Zlotta, Alexandre R.; Jewett, Michael A. S.; van der Kwast, Theo H.</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-213</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The fibroblast growth factor receptor 3 (FGFR3) is a tyrosine kinase receptor frequently activated by point mutations in bladder cancer (BC).  These mutations are assocd. with genetically stable, Ta and low-grade BC, representing the favorable BC pathway.  Conversely, FGFR3 over-expression was recently found in 40 % of muscle invasive BC.  We examd. FGFR3 mutation status and protein expression in patients originally diagnosed as T1.  We also investigated copy-no. variations in FGFR3 as a possible alternative mechanism to activate FGFR3.  We included 84 patients with T1 BC as their initial diagnosis.  A uropathologist reviewed the slides for grade and (sub)stage.  The FGFR3 mutation status was examd. by PCR-SNaPshot and FGFR3 protein expression by std. immuno-histochem. (FGFR3-B9).  Copy-no. status was detd. in 69/84 cases with nine probes covering nine exons of the FGFR3 gene (MLPA).  Of 27 BC with FGFR3 mutations, 26 (96 %) showed FGFR3 over-expression.  Of the 57 wild-type BC, 27 (47 %) BC showed over-expression.  Pathol. parameters significantly differed (p < 0.01) between mutant and wild-type tumors with the FGFR3 mutation pointing to more favorable BC.  However, if the BC exhibited wild-type FGFR3, FGFR3 protein status had no influence on grade and (sub)stage.  We found six tumors with more than or equal to three copies of FGFR3.  Only 1 of 22 wild-type tumors with over-expression of FGFR3 had more than or equal to three gene copies.  In initially diagnosed T1 BC, only the FGFR3 mutation was significantly assocd. with favorable BC disease characteristics.  In addn. to almost all FGFR3 mutant BC, 47 % of wild-type BC displayed FGFR3 over-expression, suggesting an alternative mechanism to activate FGFR3.  Increased FGFR3 copy no. was a rare event and did not account for this mechanism.  Nevertheless, FGFR3 wild-type tumors with over-expression of the protein may still represent a subset that might potentially benefit from FGFR3-targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph-K2r8F1OEbVg90H21EOLACvtfcHk0ljBZzin8CJLyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVCrsbg%253D&md5=924327a1f6540fabb5095d18fb62c39b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00428-014-1596-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00428-014-1596-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeuzillet%26aufirst%3DY.%26aulast%3Dvan%2BRhijn%26aufirst%3DB.%2BW.%26aulast%3DPrigoda%26aufirst%3DN.%2BL.%26aulast%3DBapat%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBostrom%26aufirst%3DP.%2BJ.%26aulast%3DFleshner%26aufirst%3DN.%2BE.%26aulast%3DGallie%26aufirst%3DB.%2BL.%26aulast%3DZlotta%26aufirst%3DA.%2BR.%26aulast%3DJewett%26aufirst%3DM.%2BA.%26aulast%3Dvan%2Bder%2BKwast%26aufirst%3DT.%2BH.%26atitle%3DFGFR3%2520mutations%252C%2520but%2520not%2520FGFR3%2520expression%2520and%2520FGFR3%2520copy-number%2520variations%252C%2520are%2520associated%2520with%2520favourable%2520non-muscle%2520invasive%2520bladder%2520cancer%26jtitle%3DVirchows%2520Arch.%26date%3D2014%26volume%3D465%26spage%3D207%26epage%3D213%26doi%3D10.1007%2Fs00428-014-1596-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Taylor, J. G.,  VI</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheuk, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youngblood, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catchpoole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qualman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J.</span><span> </span><span class="NLM_article-title">Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3395</span><span class="NLM_x">–</span> <span class="NLM_lpage">3407</span><span class="refDoi"> DOI: 10.1172/JCI39703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1172%2FJCI39703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3395-3407&author=J.+G.+Taylorauthor=A.+T.+Cheukauthor=P.+S.+Tsangauthor=J.+Y.+Chungauthor=Y.+K.+Songauthor=K.+Desaiauthor=Y.+Yuauthor=Q.+R.+Chenauthor=K.+Shahauthor=V.+Youngbloodauthor=J.+Fangauthor=S.+Y.+Kimauthor=C.+Yeungauthor=L.+J.+Helmanauthor=A.+Mendozaauthor=V.+Ngoauthor=L.+M.+Staudtauthor=J.+S.+Weiauthor=C.+Khannaauthor=D.+Catchpooleauthor=S.+J.+Qualmanauthor=S.+M.+Hewittauthor=G.+Merlinoauthor=S.+J.+Chanockauthor=J.+Khan&title=Identification+of+FGFR4-activating+mutations+in+human+rhabdomyosarcomas+that+promote+metastasis+in+xenotransplanted+models&doi=10.1172%2FJCI39703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI39703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI39703%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DCheuk%26aufirst%3DA.%2BT.%26aulast%3DTsang%26aufirst%3DP.%2BS.%26aulast%3DChung%26aufirst%3DJ.%2BY.%26aulast%3DSong%26aufirst%3DY.%2BK.%26aulast%3DDesai%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%2BR.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DV.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DYeung%26aufirst%3DC.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DWei%26aufirst%3DJ.%2BS.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DCatchpoole%26aufirst%3DD.%26aulast%3DQualman%26aufirst%3DS.%2BJ.%26aulast%3DHewitt%26aufirst%3DS.%2BM.%26aulast%3DMerlino%26aufirst%3DG.%26aulast%3DChanock%26aufirst%3DS.%2BJ.%26aulast%3DKhan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520FGFR4-activating%2520mutations%2520in%2520human%2520rhabdomyosarcomas%2520that%2520promote%2520metastasis%2520in%2520xenotransplanted%2520models%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3395%26epage%3D3407%26doi%3D10.1172%2FJCI39703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gauglhofer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrottmaier, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wingelhofer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naegelen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinzle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte-Hermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krupitza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasl-Kraupp, B.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2338</span><span class="refDoi"> DOI: 10.1093/carcin/bgu151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Fcarcin%2Fbgu151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=25031272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2ltLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=2331-2338&author=C.+Gauglhoferauthor=J.+Paurauthor=W.+C.+Schrottmaierauthor=B.+Wingelhoferauthor=D.+Huberauthor=I.+Naegelenauthor=C.+Pirkerauthor=T.+Mohrauthor=C.+Heinzleauthor=K.+Holzmannauthor=B.+Marianauthor=R.+Schulte-Hermannauthor=W.+Bergerauthor=G.+Krupitzaauthor=M.+Gruschauthor=B.+Grasl-Kraupp&title=Fibroblast+growth+factor+receptor+4%3A+a+putative+key+driver+for+the+aggressive+phenotype+of+hepatocellular+carcinoma&doi=10.1093%2Fcarcin%2Fbgu151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma</span></div><div class="casAuthors">Gauglhofer, Christine; Paur, Jakob; Schrottmaier, Waltraud C.; Wingelhofer, Bettina; Huber, Daniela; Naegelen, Isabelle; Pirker, Christine; Mohr, Thomas; Heinzle, Christine; Holzmann, Klaus; Marian, Brigitte; Schulte-Hermann, Rolf; Berger, Walter; Krupitza, Georg; Grusch, Michael; Grasl-Kraupp, Bettina</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2331-2338</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Recently, we found upregulation of fibroblast growth factor receptor 4 (FGFR4) in a subset of hepatocellular carcinoma (HCC).  Here, we provide mechanistic insight into the role of FGFR4-mediated signalling for the aggressive behavior of HCC cells.  To overexpress FGFR4, hepatoma/hepatocarcinoma cells were transfected with a construct coding for FGFR4.  For downmodulation of endogenous FGFR4, we used small interfering RNA or adenoviral infection with dominant-neg. FGFR4 constructs being either kinase dead (kdFGFR4) or coding for the autoinhibitory sol. domain (solFGFR4).  FGFR4 overexpression in non-tumorigenic hepatocarcinoma cells significantly reduced cell-matrix adhesion, enabled cells to grow anchorage-independently in soft agar, to disintegrate the lymph-/blood-endothelial barrier for intra-/extravasation of tumor cells and to form tumors in SCID mice.  Transcriptome anal. revealed altered expression of genes involved in cell-matrix interactions.  Conversely, in highly tumorigenic cell lines, kdFGFR4 or solFGFR4 lowered the proportion of cells in S phase of the cell cycle, enhanced the G0/G1 and G2/M-phase proportions, reduced anchorage-independent growth in vitro and attenuated disintegration of the lymph-/blood-endothelium and tumor formation in vivo.  These findings were confirmed by altered expression profiles of genes being important for late stages of cell division.  Deregulated FGFR4 expression appears to be one of the key drivers of the malignant phenotype of HCC cells.  Accordingly, blockade of FGFR4-mediated signalling by sol. dominant-neg. constructs, like solFGFR4, may be a feasible and promising therapeutic approach to antagonize aggressive behavior of hepatoma/hepatocarcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM2s006KqFlrVg90H21EOLACvtfcHk0lhdUMHNnjcPHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2ltLfF&md5=4703b05e6584d855dbf2eace3ab07a47</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgu151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgu151%26sid%3Dliteratum%253Aachs%26aulast%3DGauglhofer%26aufirst%3DC.%26aulast%3DPaur%26aufirst%3DJ.%26aulast%3DSchrottmaier%26aufirst%3DW.%2BC.%26aulast%3DWingelhofer%26aufirst%3DB.%26aulast%3DHuber%26aufirst%3DD.%26aulast%3DNaegelen%26aufirst%3DI.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DMohr%26aufirst%3DT.%26aulast%3DHeinzle%26aufirst%3DC.%26aulast%3DHolzmann%26aufirst%3DK.%26aulast%3DMarian%26aufirst%3DB.%26aulast%3DSchulte-Hermann%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKrupitza%26aufirst%3DG.%26aulast%3DGrusch%26aufirst%3DM.%26aulast%3DGrasl-Kraupp%26aufirst%3DB.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25204%253A%2520a%2520putative%2520key%2520driver%2520for%2520the%2520aggressive%2520phenotype%2520of%2520hepatocellular%2520carcinoma%26jtitle%3DCarcinogenesis%26date%3D2014%26volume%3D35%26spage%3D2331%26epage%3D2338%26doi%3D10.1093%2Fcarcin%2Fbgu151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span><span class="refDoi"> DOI: 10.1038/onc.2014.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1038%2Fonc.2014.51" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1083-1093&author=B.+Kimauthor=S.+Wangauthor=J.+M.+Leeauthor=Y.+Jeongauthor=T.+Ahnauthor=D.+S.+Sonauthor=H.+W.+Parkauthor=H.+S.+Yooauthor=Y.+J.+Songauthor=E.+Leeauthor=Y.+M.+Ohauthor=S.+B.+Leeauthor=J.+Choiauthor=J.+C.+Murrayauthor=Y.+Zhouauthor=P.+H.+Songauthor=K.+A.+Kimauthor=L.+M.+Weiner&title=Synthetic+lethal+screening+reveals+FGFR+as+one+of+the+combinatorial+targets+to+overcome+resistance+to+Met-targeted+therapy&doi=10.1038%2Fonc.2014.51"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.51%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DT.%26aulast%3DSon%26aufirst%3DD.%2BS.%26aulast%3DPark%26aufirst%3DH.%2BW.%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DSong%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DOh%26aufirst%3DY.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DP.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BA.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DSynthetic%2520lethal%2520screening%2520reveals%2520FGFR%2520as%2520one%2520of%2520the%2520combinatorial%2520targets%2520to%2520overcome%2520resistance%2520to%2520Met-targeted%2520therapy%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D1083%26epage%3D1093%26doi%3D10.1038%2Fonc.2014.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Saito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefor, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span> </span><span class="NLM_article-title">The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="refDoi"> DOI: 10.1186/s12885-015-1065-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1186%2Fs12885-015-1065-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=82&author=S.+Saitoauthor=K.+Morishimaauthor=T.+Uiauthor=H.+Hoshinoauthor=D.+Matsubaraauthor=S.+Ishikawaauthor=H.+Aburataniauthor=M.+Fukayamaauthor=Y.+Hosoyaauthor=N.+Sataauthor=A.+K.+Leforauthor=Y.+Yasudaauthor=T.+Niki&title=The+role+of+HGF%2FMET+and+FGF%2FFGFR+in+fibroblast-derived+growth+stimulation+and+lapatinib-resistance+of+esophageal+squamous+cell+carcinoma&doi=10.1186%2Fs12885-015-1065-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1065-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1065-8%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DK.%26aulast%3DUi%26aufirst%3DT.%26aulast%3DHoshino%26aufirst%3DH.%26aulast%3DMatsubara%26aufirst%3DD.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DFukayama%26aufirst%3DM.%26aulast%3DHosoya%26aufirst%3DY.%26aulast%3DSata%26aufirst%3DN.%26aulast%3DLefor%26aufirst%3DA.%2BK.%26aulast%3DYasuda%26aufirst%3DY.%26aulast%3DNiki%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520HGF%252FMET%2520and%2520FGF%252FFGFR%2520in%2520fibroblast-derived%2520growth%2520stimulation%2520and%2520lapatinib-resistance%2520of%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D82%26doi%3D10.1186%2Fs12885-015-1065-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Turner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Garcia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natrajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iorns, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2094</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F0008-5472.CAN-09-3746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=20179196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=2085-2094&author=N.+Turnerauthor=A.+Pearsonauthor=R.+Sharpeauthor=M.+Lambrosauthor=F.+Geyerauthor=M.+A.+Lopez-Garciaauthor=R.+Natrajanauthor=C.+Marchioauthor=E.+Iornsauthor=A.+Mackayauthor=C.+Gillettauthor=A.+Grigoriadisauthor=A.+Tuttauthor=J.+S.+Reis-Filhoauthor=A.+Ashworth&title=FGFR1+amplification+drives+endocrine+therapy+resistance+and+is+a+therapeutic+target+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-09-3746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer</span></div><div class="casAuthors">Turner, Nicholas; Pearson, Alex; Sharpe, Rachel; Lambros, Maryou; Geyer, Felipe; Lopez-Garcia, Maria A.; Natrajan, Rachael; Marchio, Caterina; Iorns, Elizabeth; Mackay, Alan; Gillett, Cheryl; Grigoriadis, Anita; Tutt, Andrew; Reis-Filho, Jorge S.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2085-2094</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Amplification of fibroblast growth factor receptor 1 (FGFR1) occurs in ∼10% of breast cancers and is assocd. with poor prognosis.  However, it is uncertain whether overexpression of FGFR1 is causally linked to the poor prognosis of amplified cancers.  Here, we show that FGFR1 overexpression is robustly assocd. with FGFR1 amplification in two independent series of breast cancers.  Breast cancer cell lines with FGFR1 overexpression and amplification show enhanced ligand-dependent signaling, with increased activation of the mitogen-activated protein kinase and phosphoinositide 3-kinase-AKT signaling pathways in response to FGF2, but also show basal ligand-independent signaling, and are dependent on FGFR signaling for anchorage-independent growth.  FGFR1-amplified cell lines show resistance to 4-hydroxytamoxifen, which is reversed by small interfering RNA silencing of FGFR1, suggesting that FGFR1 overexpression also promotes endocrine therapy resistance.  FGFR1 signaling suppresses progesterone receptor (PR) expression in vitro, and likewise, amplified cancers are frequently PR neg., identifying a potential biomarker for FGFR1 activity.  Furthermore, we show that amplified cancers have a high proliferative rate assessed by Ki67 staining and that FGFR1 amplification is found in 16% to 27% of luminal B-type breast cancers.  Our data suggest that amplification and overexpression of FGFR1 may be a major contributor to poor prognosis in luminal-type breast cancers, driving anchorage-independent proliferation and endocrine therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbsQ_wPmoftLVg90H21EOLACvtfcHk0lisNkBRidCm9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWis7s%253D&md5=d14ce3b47614b090c4f7bfa7e4ce8a38</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3746%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DN.%26aulast%3DPearson%26aufirst%3DA.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DLambros%26aufirst%3DM.%26aulast%3DGeyer%26aufirst%3DF.%26aulast%3DLopez-Garcia%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DMarchio%26aufirst%3DC.%26aulast%3DIorns%26aufirst%3DE.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DGillett%26aufirst%3DC.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFGFR1%2520amplification%2520drives%2520endocrine%2520therapy%2520resistance%2520and%2520is%2520a%2520therapeutic%2520target%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D2085%26epage%3D2094%26doi%3D10.1158%2F0008-5472.CAN-09-3746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machajewski, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonios-McCrea, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menezes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aardalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernette-Hammond, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">Design, structure-activity relationships and <i>in vivo</i> characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1021/jm800790t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800790t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=278-292&author=P.+A.+Renhoweauthor=S.+Pecchiauthor=C.+M.+Shaferauthor=T.+D.+Machajewskiauthor=E.+M.+Jazanauthor=C.+Taylorauthor=W.+Antonios-McCreaauthor=C.+M.+McBrideauthor=K.+Frazierauthor=M.+Wiesmannauthor=G.+R.+Lapointeauthor=P.+H.+Feuchtauthor=R.+L.+Warneauthor=C.+C.+Heiseauthor=D.+Menezesauthor=K.+Aardalenauthor=H.+Yeauthor=M.+Heauthor=V.+Leauthor=J.+Voraauthor=J.+M.+Jansenauthor=M.+E.+Wernette-Hammondauthor=A.+L.+Harris&title=Design%2C+structure-activity+relationships+and+in+vivo+characterization+of+4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones%3A+a+novel+class+of+receptor+tyrosine+kinase+inhibitors&doi=10.1021%2Fjm800790t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Structure-Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Renhowe, Paul A.; Pecchi, Sabina; Shafer, Cynthia M.; Machajewski, Timothy D.; Jazan, Elisa M.; Taylor, Clarke; Antonios-McCrea, William; McBride, Christopher M.; Frazier, Kelly; Wiesmann, Marion; Lapointe, Gena R.; Feucht, Paul H.; Warne, Robert L.; Heise, Carla C.; Menezes, Daniel; Aardalen, Kimberly; Ye, Helen; He, Molly; Le, Vincent; Vora, Jayesh; Jansen, Johanna M.; Wernette-Hammond, Mary Ellen; Harris, Alex L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of key receptor tyrosine kinases (RTKs) that are implicated in tumor vasculature formation and maintenance, as well as tumor progression and metastasis, has been a major focus in oncol. research over the last several years.  Many potent small mol. inhibitors of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases have been evaluated.  More recently, compds. that act through the complex inhibition of multiple kinase targets have been reported and may exhibit improved clin. efficacy.  We report herein a series of potent, orally efficacious 4-amino-3-benzimidazol-2-ylhydroquinolin-2-one analogs as inhibitors of VEGF, PDGF, and fibroblast growth factor (FGF) receptor tyrosine kinases.  Compds. in this class, such as TKI258 (I), are reversible ATP-competitive inhibitors of VEGFR-2, FGFR-1, and PDGFRβ with IC50 values <0.1 μM.  On the basis of its favorable in vitro and in vivo properties, compd. I was selected for clin. evaluation and is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUf3qVBfCr87Vg90H21EOLACvtfcHk0lisNkBRidCm9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sl&md5=f20f564bb7dacb5a450a29dae9e04b50</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800790t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800790t%26sid%3Dliteratum%253Aachs%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DMachajewski%26aufirst%3DT.%2BD.%26aulast%3DJazan%26aufirst%3DE.%2BM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DAntonios-McCrea%26aufirst%3DW.%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DFrazier%26aufirst%3DK.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DLapointe%26aufirst%3DG.%2BR.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DWarne%26aufirst%3DR.%2BL.%26aulast%3DHeise%26aufirst%3DC.%2BC.%26aulast%3DMenezes%26aufirst%3DD.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DWernette-Hammond%26aufirst%3DM.%2BE.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DDesign%252C%2520structure-activity%2520relationships%2520and%2520in%2520vivo%2520characterization%2520of%25204-amino-3-benzimidazol-2-ylhydroquinolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D278%26epage%3D292%26doi%3D10.1021%2Fjm800790t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colbatzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handschuh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann-Lintz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4466</span><span class="NLM_x">–</span> <span class="NLM_lpage">4480</span><span class="refDoi"> DOI: 10.1021/jm900431g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900431g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFygsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4466-4480&author=G.+J.+Rothauthor=A.+Heckelauthor=F.+Colbatzkyauthor=S.+Handschuhauthor=J.+Kleyauthor=T.+Lehmann-Lintzauthor=R.+Lotzauthor=U.+Tontsch-Gruntauthor=R.+Walterauthor=F.+Hilberg&title=Design%2C+synthesis%2C+and+evaluation+of+indolinones+as+triple+angiokinase+inhibitors+and+the+discovery+of+a+highly+specific+6-methoxycarbonyl-substituted+indolinone+%28BIBF+1120%29&doi=10.1021%2Fjm900431g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)</span></div><div class="casAuthors">Roth, Gerald J.; Heckel, Armin; Colbatzky, Florian; Handschuh, Sandra; Kley, Jorg; Lehmann-Lintz, Thorsten; Lotz, Ralf; Tontsch-Grunt, Ulrike; Walter, Rainer; Hilberg, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4466-4480</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncol.  Preclin. findings suggest that blockade of addnl. pro-angiogenic kinases, such as fibroblast and platelet-derived growth factor receptors (FGFR and PDGFR), may improve the efficacy of pharmacol. cancer treatment.  Indolinones substituted in position 6 were identified as selective inhibitors of VEGF-, PDGF-, and FGF-receptor kinases.  In particular, 6-methoxycarbonyl-substituted indolinones showed a highly favorable selectivity profile.  Optimization identified potent inhibitors of VEGF-related endothelial cell proliferation with addnl. efficacy on pericyctes and smooth muscle cells.  In contrast, no direct inhibition of tumor cell proliferation was obsd.  Compds. 2 (BIBF 1000) and 3 (BIBF 1120) are orally available and display encouraging efficacy in in vivo tumor models while being well tolerated.  The triple angiokinase inhibitor 3 (I) is currently in phase III clin. trials for the treatment of nonsmall cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvcX-_HYCS7Vg90H21EOLACvtfcHk0ljJDGpDvN9XtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFygsL4%253D&md5=1b8af461631ae3117520fc4811130bb3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900431g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900431g%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3DColbatzky%26aufirst%3DF.%26aulast%3DHandschuh%26aufirst%3DS.%26aulast%3DKley%26aufirst%3DJ.%26aulast%3DLehmann-Lintz%26aufirst%3DT.%26aulast%3DLotz%26aufirst%3DR.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DHilberg%26aufirst%3DF.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520indolinones%2520as%2520triple%2520angiokinase%2520inhibitors%2520and%2520the%2520discovery%2520of%2520a%2520highly%2520specific%25206-methoxycarbonyl-substituted%2520indolinone%2520%2528BIBF%25201120%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4466%26epage%3D4480%26doi%3D10.1021%2Fjm900431g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brave, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilburn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgensmeier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span> </span><span class="NLM_article-title">AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4389-4400&author=S.+R.+Wedgeauthor=J.+Kendrewauthor=L.+F.+Hennequinauthor=P.+J.+Valentineauthor=S.+T.+Barryauthor=S.+R.+Braveauthor=N.+R.+Smithauthor=N.+H.+Jamesauthor=M.+Dukesauthor=J.+O.+Curwenauthor=R.+Chesterauthor=J.+A.+Jacksonauthor=S.+J.+Boffeyauthor=L.+L.+Kilburnauthor=S.+Barnettauthor=G.+H.+Richmondauthor=P.+F.+Wadsworthauthor=M.+Walkerauthor=A.+L.+Bigleyauthor=S.+T.+Taylorauthor=L.+Cooperauthor=S.+Beckauthor=J.+M.+Jurgensmeierauthor=D.+J.+Ogilvie&title=AZD2171%3A+a+highly+potent%2C+orally+bioavailable%2C+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DValentine%26aufirst%3DP.%2BJ.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DBrave%26aufirst%3DS.%2BR.%26aulast%3DSmith%26aufirst%3DN.%2BR.%26aulast%3DJames%26aufirst%3DN.%2BH.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DChester%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DJ.%2BA.%26aulast%3DBoffey%26aufirst%3DS.%2BJ.%26aulast%3DKilburn%26aufirst%3DL.%2BL.%26aulast%3DBarnett%26aufirst%3DS.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%26aulast%3DWadsworth%26aufirst%3DP.%2BF.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DBigley%26aufirst%3DA.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%2BT.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DJurgensmeier%26aufirst%3DJ.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DAZD2171%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4389%26epage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Izzedine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhaescu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rixe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deray, G.</span><span> </span><span class="NLM_article-title">Sunitinib malate</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1007/s00280-006-0376-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs00280-006-0376-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=17136543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=357-364&author=H.+Izzedineauthor=I.+Buhaescuauthor=O.+Rixeauthor=G.+Deray&title=Sunitinib+malate&doi=10.1007%2Fs00280-006-0376-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sunitinib malate</span></div><div class="casAuthors">Izzedine, Hassane; Buhaescu, Irina; Rixe, Olivier; Deray, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-364</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Recently, there has been a growing interest in understanding the role of receptor tyrosine kinases (RTK), such as vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), stem cell factor receptor (KIT), and fms-like tyrosine kinase 3 (FLT3), in promoting tumor angiogenesis, tumor growth and metastasis.  Sunitinib (sunitinib malate; SU11248; SUTENT; Pfizer Inc, New York, NY, USA) is a novel, orally bio-available, oxindole, multi-targeted tyrosine kinase inhibitor with high binding affinity for VEGFR and PDGFR which has shown anti-tumor and anti-angiogenic activities.  This drug recently received approval from the US Food and Administration (FDA) in two indications simultaneously: advanced renal cell carcinoma (adRCC) and gastrointestinal stromal tumors (GIST), in patients who are resistant or intolerant to the treatment with imatinib.  The present article reviews the recent pharmacol. and clin. data related to the use of this new promising drug in the field of oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaJ5uxPevVALVg90H21EOLACvtfcHk0ljJDGpDvN9XtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsVKqu7c%253D&md5=251c65b0f915633c9f735c8b33b46988</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00280-006-0376-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-006-0376-5%26sid%3Dliteratum%253Aachs%26aulast%3DIzzedine%26aufirst%3DH.%26aulast%3DBuhaescu%26aufirst%3DI.%26aulast%3DRixe%26aufirst%3DO.%26aulast%3DDeray%26aufirst%3DG.%26atitle%3DSunitinib%2520malate%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D60%26spage%3D357%26epage%3D364%26doi%3D10.1007%2Fs00280-006-0376-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ahmad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span> </span><span class="NLM_article-title">Kinase inhibition with BAY 43–9006 in renal cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">6388S</span><span class="NLM_x">–</span> <span class="NLM_lpage">6392S</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-040028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1078-0432.CCR-040028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=6388S-6392S&author=T.+Ahmadauthor=T.+Eisen&title=Kinase+inhibition+with+BAY+43%E2%80%939006+in+renal+cell+carcinoma&doi=10.1158%2F1078-0432.CCR-040028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-040028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-040028%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DT.%26atitle%3DKinase%2520inhibition%2520with%2520BAY%252043%25E2%2580%25939006%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D6388S%26epage%3D6392S%26doi%3D10.1158%2F1078-0432.CCR-040028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harris, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boloor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Ward, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperly, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkle, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R. N.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knick, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudeman, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczyk, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span> </span><span class="NLM_article-title">Discovery of 5-[[4-[(2,3-dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4632</span><span class="NLM_x">–</span> <span class="NLM_lpage">4640</span><span class="refDoi"> DOI: 10.1021/jm800566m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800566m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4632-4640&author=P.+A.+Harrisauthor=A.+Boloorauthor=M.+Cheungauthor=R.+Kumarauthor=R.+M.+Crosbyauthor=R.+G.+Davis-Wardauthor=A.+H.+Epperlyauthor=K.+W.+Hinkleauthor=R.+N.+Hunterauthor=J.+H.+Johnsonauthor=V.+B.+Knickauthor=C.+P.+Laudemanauthor=D.+K.+Luttrellauthor=R.+A.+Mookauthor=R.+T.+Nolteauthor=S.+K.+Rudolphauthor=J.+R.+Szewczykauthor=A.+T.+Truesdaleauthor=J.+M.+Vealauthor=L.+Wangauthor=J.+A.+Stafford&title=Discovery+of+5-%5B%5B4-%5B%282%2C3-dimethyl-2H-indazol-6-yl%29methylamino%5D-2-pyrimidinyl%5Damino%5D-2-methyl-benzenesulfonamide+%28Pazopanib%29%2C+a+novel+and+potent+vascular+endothelial+growth+factor+receptor+inhibitor&doi=10.1021%2Fjm800566m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor</span></div><div class="casAuthors">Harris, Philip A.; Boloor, Amogh; Cheung, Mui; Kumar, Rakesh; Crosby, Renae M.; Davis-Ward, Ronda G.; Epperly, Andrea H.; Hinkle, Kevin W.; Hunter, Robert N., III; Johnson, Jennifer H.; Knick, Victoria B.; Laudeman, Christopher P.; Luttrell, Deirdre K.; Mook, Robert A.; Nolte, Robert T.; Rudolph, Sharon K.; Szewczyk, Jerzy R.; Truesdale, Anne T.; Veal, James M.; Wang, Liping; Stafford, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4632-4640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the vascular endothelial growth factor (VEGF) signaling pathway has emerged as one of the most promising new approaches for cancer therapy.  We describe herein the key steps starting from an initial screening hit leading to the discovery of pazopanib, N4-(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl-N2-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine, a potent pan-VEGF receptor (VEGFR) inhibitor under clin. development for renal-cell cancer and other solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIb4UT-IbEi7Vg90H21EOLACvtfcHk0ljJDGpDvN9XtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVGrtL4%253D&md5=a8737a6e003a3f6002575b4b96712fc9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm800566m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800566m%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DDavis-Ward%26aufirst%3DR.%2BG.%26aulast%3DEpperly%26aufirst%3DA.%2BH.%26aulast%3DHinkle%26aufirst%3DK.%2BW.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DLaudeman%26aufirst%3DC.%2BP.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DRudolph%26aufirst%3DS.%2BK.%26aulast%3DSzewczyk%26aufirst%3DJ.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25205-%255B%255B4-%255B%25282%252C3-dimethyl-2H-indazol-6-yl%2529methylamino%255D-2-pyrimidinyl%255Damino%255D-2-methyl-benzenesulfonamide%2520%2528Pazopanib%2529%252C%2520a%2520novel%2520and%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4632%26epage%3D4640%26doi%3D10.1021%2Fjm800566m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musgrove, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, E. S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span> </span><span class="NLM_article-title">ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4645</span><span class="NLM_x">–</span> <span class="NLM_lpage">4655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4645-4655&author=S.+R.+Wedgeauthor=D.+J.+Ogilvieauthor=M.+Dukesauthor=J.+Kendrewauthor=R.+Chesterauthor=J.+A.+Jacksonauthor=S.+J.+Boffeyauthor=P.+J.+Valentineauthor=J.+O.+Curwenauthor=H.+L.+Musgroveauthor=G.+A.+Grahamauthor=G.+D.+Hughesauthor=A.+P.+Thomasauthor=E.+S.+E.+Stokesauthor=B.+Curryauthor=G.+H.+P.+Richmondauthor=P.+F.+Wadsworthauthor=A.+L.+Bigleyauthor=L.+F.+Hennequin&title=ZD6474+inhibits+vascular+endothelial+growth+factor+signaling%2C+angiogenesis%2C+and+tumor+growth+following+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DChester%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DJ.%2BA.%26aulast%3DBoffey%26aufirst%3DS.%2BJ.%26aulast%3DValentine%26aufirst%3DP.%2BJ.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DMusgrove%26aufirst%3DH.%2BL.%26aulast%3DGraham%26aufirst%3DG.%2BA.%26aulast%3DHughes%26aufirst%3DG.%2BD.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DStokes%26aufirst%3DE.%2BS.%2BE.%26aulast%3DCurry%26aufirst%3DB.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%2BP.%26aulast%3DWadsworth%26aufirst%3DP.%2BF.%26aulast%3DBigley%26aufirst%3DA.%2BL.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DZD6474%2520inhibits%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%252C%2520angiogenesis%252C%2520and%2520tumor%2520growth%2520following%2520oral%2520administration%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4645%26epage%3D4655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Cohen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudard, S.</span><span> </span><span class="NLM_article-title">Antiangiogenic therapy for advanced renal cell carcinoma: management of treatment-related toxicities</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2066</span><span class="NLM_x">–</span> <span class="NLM_lpage">2079</span><span class="refDoi"> DOI: 10.1007/s10637-012-9796-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs10637-012-9796-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=2066-2079&author=R.+B.+Cohenauthor=S.+Oudard&title=Antiangiogenic+therapy+for+advanced+renal+cell+carcinoma%3A+management+of+treatment-related+toxicities&doi=10.1007%2Fs10637-012-9796-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs10637-012-9796-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-012-9796-8%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%2BB.%26aulast%3DOudard%26aufirst%3DS.%26atitle%3DAntiangiogenic%2520therapy%2520for%2520advanced%2520renal%2520cell%2520carcinoma%253A%2520management%2520of%2520treatment-related%2520toxicities%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26spage%3D2066%26epage%3D2079%26doi%3D10.1007%2Fs10637-012-9796-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Herbst, R. S.</span><span> </span><span class="NLM_article-title">Toxicities of antiangiogenic therapy in non-small-cell lung cancer</span> <span class="citation_source-journal">Clin. Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">S23</span><span class="NLM_x">–</span> <span class="NLM_lpage">S30</span><span class="refDoi"> DOI: 10.3816/CLC.2006.s.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.3816%2FCLC.2006.s.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=S23-S30&author=R.+S.+Herbst&title=Toxicities+of+antiangiogenic+therapy+in+non-small-cell+lung+cancer&doi=10.3816%2FCLC.2006.s.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3816%2FCLC.2006.s.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLC.2006.s.010%26sid%3Dliteratum%253Aachs%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26atitle%3DToxicities%2520of%2520antiangiogenic%2520therapy%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DClin.%2520Lung%2520Cancer%26date%3D2006%26volume%3D8%26spage%3DS23%26epage%3DS30%26doi%3D10.3816%2FCLC.2006.s.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tuder, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chacon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taraseviciene-Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cool, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacoub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polak, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelkel, N. F.</span><span> </span><span class="NLM_article-title">Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1002/path.953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1002%2Fpath.953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=11673836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2001&pages=367-374&author=R.+M.+Tuderauthor=M.+Chaconauthor=L.+Algerauthor=J.+Wangauthor=L.+Taraseviciene-Stewartauthor=Y.+Kasaharaauthor=C.+D.+Coolauthor=A.+E.+Bishopauthor=M.+Geraciauthor=G.+L.+Semenzaauthor=M.+Yacoubauthor=J.+M.+Polakauthor=N.+F.+Voelkel&title=Expression+of+angiogenesis-related+molecules+in+plexiform+lesions+in+severe+pulmonary+hypertension%3A+evidence+for+a+process+of+disordered+angiogenesis&doi=10.1002%2Fpath.953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis</span></div><div class="casAuthors">Tuder, Rubin M.; Chacon, Mati; Alger, Lori; Wang, Jun; Taraseviciene-Stewart, Laimute; Kasahara, Yasunori; Cool, Carlyne D.; Bishop, Anne E.; Geraci, Mark; Semenza, Gregg L.; Yacoub, Magdi; Polak, Julia M.; Voelkel, Norbert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Pulmonary arteries of patients with severe pulmonary hypertension (SPH) presenting in an idiopathic form (primary PH-PPH) or assocd. with congenital heart malformations or collagen vascular diseases show plexiform lesions.  It is postulated that in lungs with SPH, endothelial cells in plexiform lesions express genes encoding for proteins involved in angiogenesis, in particular, vascular endothelial growth factor (VEGF) and those involved in VEGF receptor-2 (VEGFR-2) signaling.  On immunohistochem. and in situ hybridization, endothelial cells in the plexiform lesions expressed VEGF mRNA and protein and overexpressed the mRNA and protein of VEGFR-2, and the transcription factor subunits HIF-1α and HIF-1β of hypoxia inducible factor, which are responsible for the hypoxia-dependent induction of VEGF.  When compared with normal lungs, SPH lungs showed decreased expression of the kinases PI3 kinase and src, which, together with Akt, relay the signal transduction downstream of VEGFR-2.  Because markers of angiogenesis are expressed in plexiform lesions in SPH, it is proposed that these lesions may form by a process of disordered angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWFxm-dZMILVg90H21EOLACvtfcHk0li7iVemYFKg9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlGqu7s%253D&md5=57c426e30ba09a9d99c556432c0eb2d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fpath.953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.953%26sid%3Dliteratum%253Aachs%26aulast%3DTuder%26aufirst%3DR.%2BM.%26aulast%3DChacon%26aufirst%3DM.%26aulast%3DAlger%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTaraseviciene-Stewart%26aufirst%3DL.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DCool%26aufirst%3DC.%2BD.%26aulast%3DBishop%26aufirst%3DA.%2BE.%26aulast%3DGeraci%26aufirst%3DM.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DYacoub%26aufirst%3DM.%26aulast%3DPolak%26aufirst%3DJ.%2BM.%26aulast%3DVoelkel%26aufirst%3DN.%2BF.%26atitle%3DExpression%2520of%2520angiogenesis-related%2520molecules%2520in%2520plexiform%2520lesions%2520in%2520severe%2520pulmonary%2520hypertension%253A%2520evidence%2520for%2520a%2520process%2520of%2520disordered%2520angiogenesis%26jtitle%3DJ.%2520Pathol.%26date%3D2001%26volume%3D195%26spage%3D367%26epage%3D374%26doi%3D10.1002%2Fpath.953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Douget, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graus Porta, D.</span><span> </span><span class="NLM_article-title">Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7066</span><span class="NLM_x">–</span> <span class="NLM_lpage">7083</span><span class="refDoi"> DOI: 10.1021/jm2006222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2006222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7066-7083&author=V.+Guagnanoauthor=P.+Furetauthor=C.+Spankaauthor=V.+Bordasauthor=M.+Le+Dougetauthor=C.+Stammauthor=J.+Brueggenauthor=M.+R.+Jensenauthor=C.+Schnellauthor=H.+Schmidauthor=M.+Wartmannauthor=J.+Berghausenauthor=P.+Drueckesauthor=A.+Zimmerlinauthor=D.+Bussiereauthor=J.+Murrayauthor=D.+Graus+Porta&title=Discovery+of+3-%282%2C6-dichloro-3%2C5-dimethoxy-phenyl%29-1-%7B6-%5B4-%284-ethyl-piperazin-1-yl%29-phenylamino%5D-pyrimidin-4-yl%7D-1-methyl-urea+%28NVP-BGJ398%29%2C+a+potent+and+selective+inhibitor+of+the+fibroblast+growth+factor+receptor+family+of+receptor+tyrosine+kinase&doi=10.1021%2Fjm2006222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase</span></div><div class="casAuthors">Guagnano, Vito; Furet, Pascal; Spanka, Carsten; Bordas, Vincent; Le Douget, Mickael; Stamm, Christelle; Brueggen, Josef; Jensen, Michael R.; Schnell, Christian; Schmid, Herbert; Wartmann, Markus; Berghausen, Joerg; Drueckes, Peter; Zimmerlin, Alfred; Bussiere, Dirksen; Murray, Jeremy; Graus Porta, Diana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7066-7083</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of N-aryl-N'-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring.  On the basis of its in vitro profile, compd. 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3.  These results support the potential therapeutic use of 1h as a new anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSC1v0A_6I_bVg90H21EOLACvtfcHk0lgliB6AMlZZsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvK&md5=f9a2d742294cd3814e872bdd8add1ffa</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2006222%26sid%3Dliteratum%253Aachs%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSpanka%26aufirst%3DC.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DLe%2BDouget%26aufirst%3DM.%26aulast%3DStamm%26aufirst%3DC.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DH.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DZimmerlin%26aufirst%3DA.%26aulast%3DBussiere%26aufirst%3DD.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DGraus%2BPorta%26aufirst%3DD.%26atitle%3DDiscovery%2520of%25203-%25282%252C6-dichloro-3%252C5-dimethoxy-phenyl%2529-1-%257B6-%255B4-%25284-ethyl-piperazin-1-yl%2529-phenylamino%255D-pyrimidin-4-yl%257D-1-methyl-urea%2520%2528NVP-BGJ398%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor%2520family%2520of%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7066%26epage%3D7083%26doi%3D10.1021%2Fjm2006222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gavine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgour, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Kadhimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinowska, T.</span><span> </span><span class="NLM_article-title">AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2045</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F0008-5472.CAN-11-3034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=22369928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1Wgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2045-2056&author=P.+R.+Gavineauthor=L.+Mooneyauthor=E.+Kilgourauthor=A.+P.+Thomasauthor=K.+Al-Kadhimiauthor=S.+Beckauthor=C.+Rooneyauthor=T.+Colemanauthor=D.+Bakerauthor=M.+J.+Mellorauthor=A.+N.+Brooksauthor=T.+Klinowska&title=AZD4547%3A+an+orally+bioavailable%2C+potent%2C+and+selective+inhibitor+of+the+fibroblast+growth+factor+receptor+tyrosine+kinase+family&doi=10.1158%2F0008-5472.CAN-11-3034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family</span></div><div class="casAuthors">Gavine, Paul R.; Mooney, Lorraine; Kilgour, Elaine; Thomas, Andrew P.; Al-Kadhimi, Katherine; Beck, Sarah; Rooney, Claire; Coleman, Tanya; Baker, Dawn; Mellor, Martine J.; Brooks, A. Nigel; Klinowska, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2045-2056</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fibroblast growth factor (FGF) signaling axis is increasingly implicated in tumorigenesis and chemoresistance.  Several small-mol. FGF receptor (FGFR) kinase inhibitors are currently in clin. development; however, the predominant activity of the most advanced of these agents is against the kinase insert domain receptor (KDR), which compromises the FGFR selectivity.  Here, we report the pharmacol. profile of AZD4547, a novel and selective inhibitor of the FGFR1, 2, and 3 tyrosine kinases.  AZD4547 inhibited recombinant FGFR kinase activity in vitro and suppressed FGFR signaling and growth in tumor cell lines with deregulated FGFR expression.  In a representative FGFR-driven human tumor xenograft model, oral administration of AZD4547 was well tolerated and resulted in potent dose-dependent antitumor activity, consistent with plasma exposure and pharmacodynamic modulation of tumor FGFR.  Importantly, at efficacious doses, no evidence of anti-KDR-related effects were obsd., confirming the in vivo FGFR selectivity of AZD4547.  Taken together, our findings show that AZD4547 is a novel selective small-mol. inhibitor of FGFR with potent antitumor activity against FGFR-deregulated tumors in preclin. models.  AZD4547 is under clin. investigation for the treatment of FGFR-dependent tumors.  Cancer Res; 72(8); 2045-56.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnpExryJc9xbVg90H21EOLACvtfcHk0lgliB6AMlZZsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1Wgsrs%253D&md5=cba90ad8f9b9e51cd10288868bbcc85e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3034%26sid%3Dliteratum%253Aachs%26aulast%3DGavine%26aufirst%3DP.%2BR.%26aulast%3DMooney%26aufirst%3DL.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DAl-Kadhimi%26aufirst%3DK.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DRooney%26aufirst%3DC.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DBrooks%26aufirst%3DA.%2BN.%26aulast%3DKlinowska%26aufirst%3DT.%26atitle%3DAZD4547%253A%2520an%2520orally%2520bioavailable%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520family%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2045%26epage%3D2056%26doi%3D10.1158%2F0008-5472.CAN-11-3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nakanishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isobe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebiike, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span> </span><span class="NLM_article-title">The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2547</span><span class="NLM_x">–</span> <span class="NLM_lpage">2558</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1535-7163.MCT-14-0248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=25169980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGju73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2547-2558&author=Y.+Nakanishiauthor=N.+Akiyamaauthor=T.+Tsukaguchiauthor=T.+Fujiiauthor=K.+Sakataauthor=H.+Saseauthor=T.+Isobeauthor=K.+Morikamiauthor=H.+Shindohauthor=T.+Mioauthor=H.+Ebiikeauthor=N.+Takaauthor=Y.+Aokiauthor=N.+Ishii&title=The+fibroblast+growth+factor+receptor+genetic+status+as+a+potential+predictor+of+the+sensitivity+to+CH5183284%2FDebio+1347%2C+a+novel+selective+FGFR+inhibitor&doi=10.1158%2F1535-7163.MCT-14-0248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor</span></div><div class="casAuthors">Nakanishi, Yoshito; Akiyama, Nukinori; Tsukaguchi, Toshiyuki; Fujii, Toshihiko; Sakata, Kiyoaki; Sase, Hitoshi; Isobe, Takehito; Morikami, Kenji; Shindoh, Hidetoshi; Mio, Toshiyuki; Ebiike, Hirosato; Taka, Naoki; Aoki, Yuko; Ishii, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2547-2558</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The FGF receptors (FGFR) are tyrosine kinases that are constitutively activated in a subset of tumors by genetic alterations such as gene amplifications, point mutations, or chromosomal translocations/rearrangements.  Recently, small-mol. inhibitors that can inhibit the FGFR family as well as the VEGF receptor (VEGFR) or platelet-derived growth factor receptor (PDGFR) family displayed clin. benefits in cohorts of patients with FGFR genetic alterations.  However, to achieve more potent and prolonged activity in such populations, a selective FGFR inhibitor is still needed.  Here, we report the identification of CH5183284/Debio 1347, a selective and orally available FGFR1, FGFR2, and FGFR3 inhibitor that has a unique chem. scaffold.  By interacting with unique residues in the ATP-binding site of FGFR1, FGFR2, or FGFR3, CH5183284/Debio 1347 selectively inhibits FGFR1, FGFR2, and FGFR3 but does not inhibit kinase insert domain receptor (KDR) or other kinases.  Consistent with its high selectivity for FGFR enzymes, CH5183284/Debio 1347 displayed preferential antitumor activity against cancer cells with various FGFR genetic alterations in a panel of 327 cancer cell lines and in xenograft models.  Because of its unique binding mode, CH5183284/Debio 1347 can inhibit FGFR2 harboring one type of the gatekeeper mutation that causes resistance to other FGFR inhibitors and block FGFR2 V564F-driven tumor growth.  CH5183284/Debio 1347 is under clin. investigation for the treatment of patients harboring FGFR genetic alterations.  Mol Cancer Ther; 13(11); 2547-58. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGIBEnK21337Vg90H21EOLACvtfcHk0lgliB6AMlZZsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGju73F&md5=35629d891a421582022b0f6ae0496479</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0248%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DN.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DSase%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DShindoh%26aufirst%3DH.%26aulast%3DMio%26aufirst%3DT.%26aulast%3DEbiike%26aufirst%3DH.%26aulast%3DTaka%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26atitle%3DThe%2520fibroblast%2520growth%2520factor%2520receptor%2520genetic%2520status%2520as%2520a%2520potential%2520predictor%2520of%2520the%2520sensitivity%2520to%2520CH5183284%252FDebio%25201347%252C%2520a%2520novel%2520selective%2520FGFR%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D2547%26epage%3D2558%26doi%3D10.1158%2F1535-7163.MCT-14-0248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zia-Ebrahimi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloem, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, D. J.</span><span> </span><span class="NLM_article-title">A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2200</span><span class="NLM_x">–</span> <span class="NLM_lpage">2210</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F1535-7163.MCT-11-0306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=21900693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVeltb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2200-2210&author=G.+Zhaoauthor=W.+Y.+Liauthor=D.+Chenauthor=J.+R.+Henryauthor=H.+Y.+Liauthor=Z.+Chenauthor=M.+Zia-Ebrahimiauthor=L.+Bloemauthor=Y.+Zhaiauthor=K.+Hussauthor=S.+B.+Pengauthor=D.+J.+McCann&title=A+novel%2C+selective+inhibitor+of+fibroblast+growth+factor+receptors+that+shows+a+potent+broad+spectrum+of+antitumor+activity+in+several+tumor+xenograft+models&doi=10.1158%2F1535-7163.MCT-11-0306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models</span></div><div class="casAuthors">Zhao, Genshi; Li, Wei-ying; Chen, Daohong; Henry, James R.; Li, Hong-Yu; Chen, Zhaogen; Zia-Ebrahimi, Mohammad; Bloem, Laura; Zhai, Yan; Huss, Karen; Peng, Sheng-bin; McCann, Denis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2200-2210</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fibroblast growth factor receptors (FGFR) are tyrosine kinases that are present in many types of endothelial and tumor cells and play an important role in tumor cell growth, survival, and migration as well as in maintaining tumor angiogenesis.  Overexpression of FGFRs or aberrant regulation of their activities has been implicated in many forms of human malignancies.  Therefore, targeting FGFRs represents an attractive strategy for development of cancer treatment options by simultaneously inhibiting tumor cell growth, survival, and migration as well as tumor angiogenesis.  Here, we describe a potent, selective, small-mol. FGFR inhibitor, (R)-(E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-1H-indazol-3yl)vinyl)-1H-pyrazol-1-yl)ethanol, designated as LY2874455.  This mol. is active against all 4 FGFRs, with a similar potency in biochem. assays.  It exhibits a potent activity against FGF/FGFR-mediated signaling in several cancer cell lines and shows an excellent broad spectrum of antitumor activity in several tumor xenograft models representing the major FGF/FGFR relevant tumor histologies including lung, gastric, and bladder cancers and multiple myeloma, and with a well-defined pharmacokinetic/pharmacodynamic relationship.  LY2874455 also exhibits a 6- to 9-fold in vitro and in vivo selectivity on inhibition of FGF- over VEGF-mediated target signaling in mice.  Furthermore, LY2874455 did not show VEGF receptor 2-mediated toxicities such as hypertension at efficacious doses.  Currently, this mol. is being evaluated for its potential use in the clinic.  Mol Cancer Ther; 10(11); 2200-10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLrzAyZQK_grVg90H21EOLACvtfcHk0lgsBrhFP0eceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVeltb7N&md5=eaf08fd213a836f48da2055e01bd9c29</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0306%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DW.%2BY.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZia-Ebrahimi%26aufirst%3DM.%26aulast%3DBloem%26aufirst%3DL.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DHuss%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26atitle%3DA%2520novel%252C%2520selective%2520inhibitor%2520of%2520fibroblast%2520growth%2520factor%2520receptors%2520that%2520shows%2520a%2520potent%2520broad%2520spectrum%2520of%2520antitumor%2520activity%2520in%2520several%2520tumor%2520xenograft%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2200%26epage%3D2210%26doi%3D10.1158%2F1535-7163.MCT-11-0306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoon, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4653</span><span class="refDoi"> DOI: 10.1021/jm0500931</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0500931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4628-4653&author=A.+M.+Thompsonauthor=A.+M.+Delaneyauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=T.+A.+Spoonauthor=S.+M.+Creanauthor=H.+D.+Showalterauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+relationships+of+soluble+7-substituted+3-%283%2C5-dimethoxyphenyl%29-1%2C6-naphthyridin-2-amines+and+related+ureas+as+dual+inhibitors+of+the+fibroblast+growth+factor+receptor-1+and+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinases&doi=10.1021%2Fjm0500931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0500931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500931%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DSpoon%26aufirst%3DT.%2BA.%26aulast%3DCrean%26aufirst%3DS.%2BM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520soluble%25207-substituted%25203-%25283%252C5-dimethoxyphenyl%2529-1%252C6-naphthyridin-2-amines%2520and%2520related%2520ureas%2520as%2520dual%2520inhibitors%2520of%2520the%2520fibroblast%2520growth%2520factor%2520receptor-1%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4628%26epage%3D4653%26doi%3D10.1021%2Fjm0500931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseenkova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5896</span><span class="NLM_x">–</span> <span class="NLM_lpage">5904</span><span class="refDoi"> DOI: 10.1093/emboj/17.20.5896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Femboj%2F17.20.5896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=9774334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=5896-5904&author=M.+Mohammadiauthor=S.+Froumauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=R.+L.+Panekauthor=G.+H.+Luauthor=A.+V.+Eliseenkovaauthor=D.+Greenauthor=J.+Schlessingerauthor=S.+R.+Hubbard&title=Crystal+structure+of+an+angiogenesis+inhibitor+bound+to+the+FGF+receptor+tyrosine+kinase+domain&doi=10.1093%2Femboj%2F17.20.5896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span></div><div class="casAuthors">Mohammadi, Moosa; Froum, Scott; Hamby, James M.; Schroeder, Mel C.; Panek, Robert L.; Lu, Gina H.; Eliseenkova, Anna V.; Green, David; Schlessinger, Joseph; Hubbard, Stevan R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5896-5904</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is an essential physiol. process in development, yet also plays a major role in the progression of human diseases such as diabetic retinopathy, atherosclerosis and cancer.  The effects of the most potent angiogenic factors, vascular endothelial growth factor (VEGF), angiopoietin and fibroblast growth factor (FGF) are mediated through cell surface receptors that possess intrinsic protein tyrosine kinase activity.  In this report, the authors describe a synthetic compd. of the pyrido[2,3-d]pyrimidine class, designated PD 173074, that selectively inhibits the tyrosine kinase activities of the FGF and VEGF receptors.  The authors show that systemic administration of PD 173074 in mice can effectively block angiogenesis induced by either FGF or VEGF with no apparent toxicity.  To elucidate the determinants of selectivity, the authors have detd. the crystal structure of PD 173074 in complex with the tyrosine kinase domain of FGF receptor 1 at 2.5 Å resoln.  A high degree of surface complementarity between PD 173074 and the hydrophobic, ATP-binding pocket of FGF receptor 1 underlies the potency and selectivity of this inhibitor.  PD 173074 is thus a promising candidate for a therapeutic angiogenesis inhibitor to be used in the treatment of cancer and other diseases whose progression is dependent upon new blood vessel formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zdEklzyMx7Vg90H21EOLACvtfcHk0lgsBrhFP0eceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D&md5=a76b085ddc9d352878a2c6bc9d1cd6ff</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.20.5896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.20.5896%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DFroum%26aufirst%3DS.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DEliseenkova%26aufirst%3DA.%2BV.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DCrystal%2520structure%2520of%2520an%2520angiogenesis%2520inhibitor%2520bound%2520to%2520the%2520FGF%2520receptor%2520tyrosine%2520kinase%2520domain%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D5896%26epage%3D5904%26doi%3D10.1093%2Femboj%2F17.20.5896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Grygielewicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunerka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamparska-Przybysz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieczorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzwonek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdzalik, D.</span><span> </span><span class="NLM_article-title">Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells</span> <span class="citation_source-journal">Gastric Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1007/s10120-014-0444-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs10120-014-0444-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=53-62&author=P.+Grygielewiczauthor=B.+Dymekauthor=A.+Bujakauthor=P.+Gunerkaauthor=A.+Stanczakauthor=M.+Lamparska-Przybyszauthor=M.+Wieczorekauthor=K.+Dzwonekauthor=D.+Zdzalik&title=Epithelial-mesenchymal+transition+confers+resistance+to+selective+FGFR+inhibitors+in+SNU-16+gastric+cancer+cells&doi=10.1007%2Fs10120-014-0444-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10120-014-0444-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10120-014-0444-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrygielewicz%26aufirst%3DP.%26aulast%3DDymek%26aufirst%3DB.%26aulast%3DBujak%26aufirst%3DA.%26aulast%3DGunerka%26aufirst%3DP.%26aulast%3DStanczak%26aufirst%3DA.%26aulast%3DLamparska-Przybysz%26aufirst%3DM.%26aulast%3DWieczorek%26aufirst%3DM.%26aulast%3DDzwonek%26aufirst%3DK.%26aulast%3DZdzalik%26aufirst%3DD.%26atitle%3DEpithelial-mesenchymal%2520transition%2520confers%2520resistance%2520to%2520selective%2520FGFR%2520inhibitors%2520in%2520SNU-16%2520gastric%2520cancer%2520cells%26jtitle%3DGastric%2520Cancer%26date%3D2016%26volume%3D19%26spage%3D53%26epage%3D62%26doi%3D10.1007%2Fs10120-014-0444-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Javidi-Sharifi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlap, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span> </span><span class="NLM_article-title">Crosstalk between KIT and FGFR3 promotes gastrointestinal stromal tumor cell growth and drug resistance</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1158%2F0008-5472.CAN-14-0573" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=880-891&author=N.+Javidi-Sharifiauthor=E.+Traerauthor=J.+Martinezauthor=A.+Guptaauthor=T.+Taguchiauthor=J.+Dunlapauthor=M.+C.+Heinrichauthor=C.+L.+Corlessauthor=B.+P.+Rubinauthor=B.+J.+Drukerauthor=J.+W.+Tyner&title=Crosstalk+between+KIT+and+FGFR3+promotes+gastrointestinal+stromal+tumor+cell+growth+and+drug+resistance&doi=10.1158%2F0008-5472.CAN-14-0573"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0573%26sid%3Dliteratum%253Aachs%26aulast%3DJavidi-Sharifi%26aufirst%3DN.%26aulast%3DTraer%26aufirst%3DE.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DTaguchi%26aufirst%3DT.%26aulast%3DDunlap%26aufirst%3DJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DCorless%26aufirst%3DC.%2BL.%26aulast%3DRubin%26aufirst%3DB.%2BP.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26atitle%3DCrosstalk%2520between%2520KIT%2520and%2520FGFR3%2520promotes%2520gastrointestinal%2520stromal%2520tumor%2520cell%2520growth%2520and%2520drug%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D880%26epage%3D891%26doi%3D10.1158%2F0008-5472.CAN-14-0573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Byron, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartside, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehkhoda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, P. M.</span><span> </span><span class="NLM_article-title">The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1593/neo.121106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1593%2Fneo.121106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=975-988&author=S.+A.+Byronauthor=H.+Chenauthor=A.+Wortmannauthor=D.+Lochauthor=M.+G.+Gartsideauthor=F.+Dehkhodaauthor=S.+P.+Blaisauthor=T.+A.+Neubertauthor=M.+Mohammadiauthor=P.+M.+Pollock&title=The+N550K%2FH+mutations+in+FGFR2+confer+differential+resistance+to+PD173074%2C+dovitinib%2C+and+ponatinib+ATP-competitive+inhibitors&doi=10.1593%2Fneo.121106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1593%2Fneo.121106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.121106%26sid%3Dliteratum%253Aachs%26aulast%3DByron%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWortmann%26aufirst%3DA.%26aulast%3DLoch%26aufirst%3DD.%26aulast%3DGartside%26aufirst%3DM.%2BG.%26aulast%3DDehkhoda%26aufirst%3DF.%26aulast%3DBlais%26aufirst%3DS.%2BP.%26aulast%3DNeubert%26aufirst%3DT.%2BA.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DPollock%26aufirst%3DP.%2BM.%26atitle%3DThe%2520N550K%252FH%2520mutations%2520in%2520FGFR2%2520confer%2520differential%2520resistance%2520to%2520PD173074%252C%2520dovitinib%252C%2520and%2520ponatinib%2520ATP-competitive%2520inhibitors%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D975%26epage%3D988%26doi%3D10.1593%2Fneo.121106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span> </span><span class="NLM_article-title">Design and structure-activity relationship of 3-benzimidazol-2-yl-1<i>H</i>-indazoles as inhibitors of receptor tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3595</span><span class="NLM_x">–</span> <span class="NLM_lpage">3599</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.03.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2Fj.bmcl.2006.03.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3595-3599&author=C.+M.+McBrideauthor=P.+A.+Renhoweauthor=C.+Heiseauthor=J.+M.+Jansenauthor=G.+Lapointeauthor=S.+Maauthor=R.+Pinedaauthor=J.+Voraauthor=M.+Wiesmannauthor=C.+M.+Shafer&title=Design+and+structure-activity+relationship+of+3-benzimidazol-2-yl-1H-indazoles+as+inhibitors+of+receptor+tyrosine+kinases&doi=10.1016%2Fj.bmcl.2006.03.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.03.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.03.069%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DLapointe%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DPineda%26aufirst%3DR.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDesign%2520and%2520structure-activity%2520relationship%2520of%25203-benzimidazol-2-yl-1H-indazoles%2520as%2520inhibitors%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3595%26epage%3D3599%26doi%3D10.1016%2Fj.bmcl.2006.03.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span><span class="refDoi"> DOI: 10.1021/jm2007613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.+P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29&doi=10.1021%2Fjm2007613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0lgbAxlk_jCruQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6342%26epage%3D6363%26doi%3D10.1021%2Fjm2007613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ho, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhe, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aung, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1016/j.jhep.2008.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2Fj.jhep.2008.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=19008009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A280%3ADC%252BD1cjotVOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=118-127&author=H.+K.+Hoauthor=S.+Pokauthor=S.+Streitauthor=J.+E.+Ruheauthor=S.+Hartauthor=K.+S.+Limauthor=H.+L.+Looauthor=M.+O.+Aungauthor=S.+G.+Limauthor=A.+Ullrich&title=Fibroblast+growth+factor+receptor+4+regulates+proliferation%2C+anti-apoptosis+and+alpha-fetoprotein+secretion+during+hepatocellular+carcinoma+progression+and+represents+a+potential+target+for+therapeutic+intervention&doi=10.1016%2Fj.jhep.2008.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention</span></div><div class="casAuthors">Ho Han Kiat; Pok Sharon; Streit Sylvia; Ruhe Jens E; Hart Stefan; Lim Kah Suan; Loo Hooi Linn; Aung Myat Oo; Lim Seng Gee; Ullrich Axel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-27</span>
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  FGFR4, a member of the fibroblast growth factor receptor family, has been recently associated with progression of melanoma, breast and head and neck carcinoma.  Given its uniquely high expression in the liver, we investigated its contributory role to hepatocellular carcinoma (HCC).  METHODS:  We performed a comprehensive sequencing of full-length FGFR4 transcript in 57 tumor/normal HCC tissue pairs, and quantified their mRNA expressions.  Notable mutations and expression patterns were correlated with patient data.  Clinically significant trends were examined in in vitro models.  RESULTS:  We found eight genetic alterations including two highly frequent polymorphisms (V10I and G338R).  Secretion of alpha-fetoprotein (AFP), a HCC biomarker, was increased among patients bearing homozygous Arg388 alleles.  One-third of these patients exhibited increased FGFR4 mRNA expression in the matched tumor/normal tissue.  Subsequent in vitro perturbation of FGFR4 signaling through both FGF19-stimulation and FGFR4 silencing confirmed a mechanistic link between FGFR4 activities and tumor aggressiveness.  More importantly, inhibition of FGFR activity with PD173074 exquisitely blocked HuH7 (high FGFR4 expression) proliferation as compared to control cell lines.  CONCLUSIONS:  FGFR4 contributes significantly to HCC progression by modulating AFP secretion, proliferation and anti-apoptosis.  Its frequent overexpression in patients renders its inhibition a novel and much needed pharmacological approach against HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgZzOqmNA8JynGiHuhFGv8fW6udTcc2eb9g-ggKpFu8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjotVOksg%253D%253D&md5=3196fd73fe899f09292e6ef773dcfd16</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DPok%26aufirst%3DS.%26aulast%3DStreit%26aufirst%3DS.%26aulast%3DRuhe%26aufirst%3DJ.%2BE.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DK.%2BS.%26aulast%3DLoo%26aufirst%3DH.%2BL.%26aulast%3DAung%26aufirst%3DM.%2BO.%26aulast%3DLim%26aufirst%3DS.%2BG.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25204%2520regulates%2520proliferation%252C%2520anti-apoptosis%2520and%2520alpha-fetoprotein%2520secretion%2520during%2520hepatocellular%2520carcinoma%2520progression%2520and%2520represents%2520a%2520potential%2520target%2520for%2520therapeutic%2520intervention%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3D118%26epage%3D127%26doi%3D10.1016%2Fj.jhep.2008.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Buchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannenbaum, S. R.</span><span> </span><span class="NLM_article-title">Direct acting, highly mutagenic, α-hydroxy <i>N</i>-nitrosamines from 4-chloroindoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">4115</span><span class="NLM_x">–</span> <span class="NLM_lpage">4119</span><span class="refDoi"> DOI: 10.1021/ja00274a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00274a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=1986&pages=4115-4119&author=G.+Buchiauthor=G.+C.+Leeauthor=D.+Yangauthor=S.+R.+Tannenbaum&title=Direct+acting%2C+highly+mutagenic%2C+%CE%B1-hydroxy+N-nitrosamines+from+4-chloroindoles&doi=10.1021%2Fja00274a043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja00274a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00274a043%26sid%3Dliteratum%253Aachs%26aulast%3DBuchi%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DG.%2BC.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DTannenbaum%26aufirst%3DS.%2BR.%26atitle%3DDirect%2520acting%252C%2520highly%2520mutagenic%252C%2520%25CE%25B1-hydroxy%2520N-nitrosamines%2520from%25204-chloroindoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1986%26volume%3D108%26spage%3D4115%26epage%3D4119%26doi%3D10.1021%2Fja00274a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Mizuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekine, M.</span><span> </span><span class="NLM_article-title">Fluorescent pyrimidopyrimidoindole nucleosides: control of photophysical characterizations by substituent effects</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">5046</span><span class="NLM_x">–</span> <span class="NLM_lpage">5055</span><span class="refDoi"> DOI: 10.1021/jo070206j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo070206j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt12htb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=5046-5055&author=M.+Mizutaauthor=K.+Seioauthor=K.+Miyataauthor=M.+Sekine&title=Fluorescent+pyrimidopyrimidoindole+nucleosides%3A+control+of+photophysical+characterizations+by+substituent+effects&doi=10.1021%2Fjo070206j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent Pyrimidopyrimidoindole Nucleosides: Control of Photophysical Characterizations by Substituent Effects</span></div><div class="casAuthors">Mizuta, Masahiro; Seio, Kohji; Miyata, Kenichi; Sekine, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5046-5055</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">10-(2-Deoxy-β-D-ribofuranosyl)pyrimido[4',5':4,5]pyrimido[1,6-a]indole-6,9(7H)-dione (I) and its derivs. were synthesized via the Suzuki-Miyaura coupling reaction of 5-iododeoxycytidine with 5-substituted N-Boc-indole-2-borates and characterized by UV-vis and fluorescence spectroscopy.  The new fluorescent nucleosides showed rather large Stokes shifts (116-139 nm) in an aq. buffer.  The fluorescent intensities were dependent on the nature of the substituents on the indole rings.  The electron-withdrawing groups increased the fluorescent intensity while the electron-donating groups having lone pairs decreased it.  Among the substituted I derivs. tested, the trimethylammonium deriv. of I was found to emit the brightest fluorescent light.  The solvatochromism of I and its derivs. was also studied.  Some of the I derivs. showed interesting solvent-dependent fluorescence enhancement and could be useful as new fluorescent structural probes for nucleic acids.  The Lippert-Mataga analyses of the Stokes shift were also carried out to obtain estd. values of the dipole moment of the excited states of some of the derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2SRQLbXqDI7Vg90H21EOLACvtfcHk0lhXrIV37ntdUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt12htb4%253D&md5=cf5084a569a994f96ed717f4032a8a6b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo070206j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo070206j%26sid%3Dliteratum%253Aachs%26aulast%3DMizuta%26aufirst%3DM.%26aulast%3DSeio%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DK.%26aulast%3DSekine%26aufirst%3DM.%26atitle%3DFluorescent%2520pyrimidopyrimidoindole%2520nucleosides%253A%2520control%2520of%2520photophysical%2520characterizations%2520by%2520substituent%2520effects%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D5046%26epage%3D5055%26doi%3D10.1021%2Fjo070206j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chen, D. H.; Li, H. Y.; Zhao, G. S.</span><span> </span><span class="NLM_article-title">Vinyl indazolyl compounds</span>. Patent WO2010129509,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+H.+Chen&author=H.+Y.+Li&author=G.+S.+Zhao&title=Vinyl+indazolyl+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%2BH.%26atitle%3DVinyl%2520indazolyl%2520compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ramachandran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameed, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanbhag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morayya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautela, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panduga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saralaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanduri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raichurkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menasinakai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn-Flynn, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosagrahara, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span> </span><span class="NLM_article-title"><i>N</i>-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6642</span><span class="NLM_x">–</span> <span class="NLM_lpage">6652</span><span class="refDoi"> DOI: 10.1021/jm500715u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500715u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6642-6652&author=S.+Ramachandranauthor=P.+S.+Hameedauthor=A.+Srivastavaauthor=G.+Shanbhagauthor=S.+Morayyaauthor=N.+Rautelaauthor=D.+Awasthyauthor=S.+Kavanaghauthor=S.+Bharathauthor=J.+Reddyauthor=V.+Pandugaauthor=K.+R.+Prabhakarauthor=R.+Saralayaauthor=R.+Nanduriauthor=A.+Raichurkarauthor=S.+Menasinakaiauthor=V.+Acharauthor=M.+B.+Jimenez-Diazauthor=M.+S.+Martinezauthor=I.+Angulo-Barturenauthor=S.+Ferrerauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=S.+Duffyauthor=V.+M.+Averyauthor=D.+Watersonauthor=M.+C.+S.+Leeauthor=O.+Coburn-Flynnauthor=D.+A.+Fidockauthor=P.+S.+Iyerauthor=S.+Narayananauthor=V.+Hosagraharaauthor=V.+K.+Sambandamurthy&title=N-aryl-2-aminobenzimidazoles%3A+novel%2C+efficacious%2C+antimalarial+lead+compounds&doi=10.1021%2Fjm500715u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds</span></div><div class="casAuthors">Ramachandran, Sreekanth; Hameed P., Shahul; Srivastava, Abhishek; Shanbhag, Gajanan; Morayya, Sapna; Rautela, Nikhil; Awasthy, Disha; Kavanagh, Stefan; Bharath, Sowmya; Reddy, Jitendar; Panduga, Vijender; Prabhakar, K. R.; Saralaya, Ramanatha; Nanduri, Robert; Raichurkar, Anandkumar; Menasinakai, Sreenivasaiah; Achar, Vijayashree; Jimenez-Diaz, Maria Belen; Martinez, Maria Santos; Angulo-Barturen, Inigo; Ferrer, Santiago; Sanz, Laura Maria; Gamo, Francisco Javier; Duffy, Sandra; Avery, Vicky M.; Waterson, David; Lee, Marcus C. S.; Coburn-Flynn, Olivia; Fidock, David A.; Iyer, Pravin S.; Narayanan, Shridhar; Hosagrahara, Vinayak; Sambandamurthy, Vasan K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6642-6652</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From the phenotypic screening of the AstraZeneca corporate compd. collection, N-aryl-2-aminobenzimidazoles have emerged as novel hits against the asexual blood stage of Plasmodium falciparum (Pf).  Medicinal chem. optimization of the potency against Pf and ADME properties resulted in the identification of 12 as a lead mol.  Compd. 12 was efficacious in the P. berghei (Pb) model of malaria.  This compd. displayed an excellent pharmacokinetic profile with a long half-life (19 h) in rat blood.  This profile led to an extended survival of animals for over 30 days following a dose of 50 mg/kg in the Pb malaria model.  Compd. 12 retains its potency against a panel of Pf isolates with known mechanisms of resistance.  The fast killing obsd. in the in vitro parasite redn. ratio (PRR) assay coupled with the extended survival highlights the promise of this novel chem. class for the treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkMoylS1KmbbVg90H21EOLACvtfcHk0lhXrIV37ntdUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr3I&md5=73b596070bb83ea1b7c557deb24bb3bd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm500715u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500715u%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DHameed%26aufirst%3DP.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DShanbhag%26aufirst%3DG.%26aulast%3DMorayya%26aufirst%3DS.%26aulast%3DRautela%26aufirst%3DN.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DNanduri%26aufirst%3DR.%26aulast%3DRaichurkar%26aufirst%3DA.%26aulast%3DMenasinakai%26aufirst%3DS.%26aulast%3DAchar%26aufirst%3DV.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26atitle%3DN-aryl-2-aminobenzimidazoles%253A%2520novel%252C%2520efficacious%252C%2520antimalarial%2520lead%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6642%26epage%3D6652%26doi%3D10.1021%2Fjm500715u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Young, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yudkovitz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mount, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, M. T.</span><span> </span><span class="NLM_article-title">2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00026-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2FS0960-894X%2802%2900026-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=11859012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlKqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=827-832&author=J.+R.+Youngauthor=S.+X.+Huangauthor=T.+F.+Walshauthor=M.+J.+Wyvrattauthor=Y.+T.+Yangauthor=J.+B.+Yudkovitzauthor=J.+Cuiauthor=G.+R.+Mountauthor=R.+N.+Renauthor=T.+J.+Wuauthor=X.+Shenauthor=K.+A.+Lyonsauthor=A.+H.+Maoauthor=J.+R.+Carlinauthor=B.+V.+Karanamauthor=S.+H.+Vincentauthor=K.+Chengauthor=M.+T.+Goulet&title=2-Arylindoles+as+gonadotropin+releasing+hormone+%28GnRH%29+antagonists%3A+optimization+of+the+tryptamine+side+chain&doi=10.1016%2FS0960-894X%2802%2900026-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain</span></div><div class="casAuthors">Young, Jonathan R.; Huang, Song X.; Walsh, Thomas F.; Wyvratt, Matthew J.; Yang, Yi Tien; Yudkovitz, Joel B.; Cui, Jisong; Mount, George R.; Ren, Rena Ning; Wu, Tsuei-Ju; Shen, Xiaolan; Lyons, Kathryn A.; Mao, An-Hua; Carlin, Josephine R.; Karanam, Bindhu V.; Vincent, Stella H.; Cheng, Kang; Goulet, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-832</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 2-arylindoles contg. novel heteroarom. substituents on the tryptamine tether, based on compd. I, was prepd. and evaluated for their ability to act as gonadotropin releasing hormone antagonists.  Successful modifications of I included chain length variation (redn.) and replacement of the pyridine with heteroarom. groups.  These alterations culminated in the discovery of a compd. which had excellent in vitro potency and oral efficacy in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIqPJ3Xnah2rVg90H21EOLACvtfcHk0ljpRXhfzOdwIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlKqsLY%253D&md5=6416a665673dc33876ff3f1e5277cb64</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900026-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900026-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26aulast%3DHuang%26aufirst%3DS.%2BX.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DY.%2BT.%26aulast%3DYudkovitz%26aufirst%3DJ.%2BB.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DMount%26aufirst%3DG.%2BR.%26aulast%3DRen%26aufirst%3DR.%2BN.%26aulast%3DWu%26aufirst%3DT.%2BJ.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%2BH.%26aulast%3DCarlin%26aufirst%3DJ.%2BR.%26aulast%3DKaranam%26aufirst%3DB.%2BV.%26aulast%3DVincent%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DM.%2BT.%26atitle%3D2-Arylindoles%2520as%2520gonadotropin%2520releasing%2520hormone%2520%2528GnRH%2529%2520antagonists%253A%2520optimization%2520of%2520the%2520tryptamine%2520side%2520chain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D827%26epage%3D832%26doi%3D10.1016%2FS0960-894X%2802%2900026-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chinchilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nájera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heumann, A.</span><span> </span><span class="NLM_article-title">Kinetic resolution of racemic alcohols with chiral carboxylic acids and dicyclohexylcarbodiimide</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1016/S0957-4166(00)82271-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2FS0957-4166%2800%2982271-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1990&pages=851-854&author=R.+Chinchillaauthor=C.+N%C3%A1jeraauthor=M.+Yusauthor=A.+Heumann&title=Kinetic+resolution+of+racemic+alcohols+with+chiral+carboxylic+acids+and+dicyclohexylcarbodiimide&doi=10.1016%2FS0957-4166%2800%2982271-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2800%2982271-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252800%252982271-5%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DN%25C3%25A1jera%26aufirst%3DC.%26aulast%3DYus%26aufirst%3DM.%26aulast%3DHeumann%26aufirst%3DA.%26atitle%3DKinetic%2520resolution%2520of%2520racemic%2520alcohols%2520with%2520chiral%2520carboxylic%2520acids%2520and%2520dicyclohexylcarbodiimide%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1990%26volume%3D1%26spage%3D851%26epage%3D854%26doi%3D10.1016%2FS0957-4166%2800%2982271-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span> </span><span class="NLM_article-title">Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">–</span> <span class="NLM_lpage">1804</span><span class="refDoi"> DOI: 10.1016/j.bmc.2005.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2Fj.bmc.2005.10.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1792-1804&author=N.+Foloppeauthor=L.+M.+Fisherauthor=G.+Francisauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potter&title=Identification+of+a+buried+pocket+for+potent+and+selective+inhibition+of+Chk1%3A+prediction+and+verification&doi=10.1016%2Fj.bmc.2005.10.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520buried%2520pocket%2520for%2520potent%2520and%2520selective%2520inhibition%2520of%2520Chk1%253A%2520prediction%2520and%2520verification%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1792%26epage%3D1804%26doi%3D10.1016%2Fj.bmc.2005.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Chang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S. F.</span><span> </span><span class="NLM_article-title">Synthesis of 2-arylbenzoxazoles via DDQ promoted oxidative cyclization of phenolic Schiff bases—a solution-phase strategy for library synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)02302-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1016%2FS0040-4039%2801%2902302-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=951-954&author=J.+B.+Changauthor=K.+Zhaoauthor=S.+F.+Pan&title=Synthesis+of+2-arylbenzoxazoles+via+DDQ+promoted+oxidative+cyclization+of+phenolic+Schiff+bases%E2%80%94a+solution-phase+strategy+for+library+synthesis&doi=10.1016%2FS0040-4039%2801%2902302-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-arylbenzoxazoles via DDQ promoted oxidative cyclization of phenolic Schiff bases-a solution-phase strategy for library synthesis</span></div><div class="casAuthors">Chang, Junbiao; Zhao, Kang; Pan, Shifeng</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">951-954</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The Schiff base derived from the condensation of o-aminophenol with benzaldehydes was induced to undergo oxidative cyclization in the presence of DDQ.  The resulting 2-arylbenzoxazoles were sepd. from the reduced DDQ byproduct (4,5-dichloro-3,6-dihydroxy-1,2-benzenedicarbonitrile ) by treatment of reaction mixt. with a strongly basic ion-exchange resin (e.g. Amberlite IRA-900).  The applicability of this chem. to spatially sep. library synthesis is demonstrated by the prepn. of a 352-member library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe80bdAUGZi7Vg90H21EOLACvtfcHk0liik1DVhosq4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslKjtA%253D%253D&md5=7ac23ca1805f6afcc3df1916d4ea7a33</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902302-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902302-4%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BB.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DPan%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520of%25202-arylbenzoxazoles%2520via%2520DDQ%2520promoted%2520oxidative%2520cyclization%2520of%2520phenolic%2520Schiff%2520bases%25E2%2580%2594a%2520solution-phase%2520strategy%2520for%2520library%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D951%26epage%3D954%26doi%3D10.1016%2FS0040-4039%2801%2902302-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Moir, D. T.; Aiello, D.; Peet, N. P.; Williamms, J. D.</span><span> </span><span class="NLM_article-title">Inhibitors of bacterial type III secretion system</span>. Patent WO2010118046,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+T.+Moir&author=D.+Aiello&author=N.+P.+Peet&author=J.+D.+Williamms&title=Inhibitors+of+bacterial+type+III+secretion+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoir%26aufirst%3DD.%2BT.%26atitle%3DInhibitors%2520of%2520bacterial%2520type%2520III%2520secretion%2520system%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0liik1DVhosq4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span> <span class="citation_source-book">Maestro</span>, version 9.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span> <span class="citation_source-book">Glide</span>, version 5.5; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span><span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein%E2%80%93ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0liik1DVhosq4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span> <span class="citation_source-book">LigPrep</span>, version 2.3; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span> </span><span class="NLM_article-title">Integrated modeling program, applied chemical theory (IMPACT)</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1780</span><span class="refDoi"> DOI: 10.1002/jcc.20292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1002%2Fjcc.20292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=16211539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1752-1780&author=J.+L.+Banksauthor=H.+S.+Beardauthor=Y.+Caoauthor=A.+E.+Choauthor=W.+Dammauthor=R.+Faridauthor=A.+K.+Feltsauthor=T.+A.+Halgrenauthor=D.+T.+Mainzauthor=J.+R.+Mapleauthor=R.+Murphyauthor=D.+M.+Philippauthor=M.+P.+Repaskyauthor=L.+Y.+Zhangauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=E.+Gallicchioauthor=R.+M.+Levy&title=Integrated+modeling+program%2C+applied+chemical+theory+%28IMPACT%29&doi=10.1002%2Fjcc.20292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated modeling program, applied chemical theory (IMPACT)</span></div><div class="casAuthors">Banks, Jay L.; Beard, Hege S.; Cao, Yixiang; Cho, Art E.; Damm, Wolfgang; Farid, Ramy; Felts, Anthony K.; Halgren, Thomas A.; Mainz, Daniel T.; Maple, Jon R.; Murphy, Robert; Philipp, Dean M.; Repasky, Matthew P.; Zhang, Linda Y.; Berne, Bruce J.; Friesner, Richard A.; Gallicchio, Emilio; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1752-1780</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  We provide an overview of the IMPACT mol. mechanics program with an emphasis on recent developments and a description of its current functionality.  With respect to core mol. mechanics technologies we include a status report for the fixed charge and polarizable force fields that can be used with the program and illustrate how the force fields, when used together with new atom typing and parameter assignment modules, have greatly expanded the coverage of org. compds. and medicinally relevant ligands.  As we discuss in this review, explicit solvent simulations have been used to guide our design of implicit solvent models based on the generalized Born framework and a novel nonpolar estimator that have recently been incorporated into the program.  With IMPACT it is possible to use several different advanced conformational sampling algorithms based on combining features of mol. dynamics and Monte Carlo simulations.  The program includes two specialized mol. mechanics modules: Glide, a high-throughput docking program, and QSite, a mixed quantum mechanics/mol. mechanics module.  These modules employ the IMPACT infrastructure as a starting point for the construction of the protein model and assignment of mol. mechanics parameters, but have then been developed to meet specialized objectives with respect to sampling and the energy function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZX2FzcGWGM7Vg90H21EOLACvtfcHk0ljrUS2wBSSooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI&md5=0094f15727c7fb77a0fae16ccf8292f0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20292%26sid%3Dliteratum%253Aachs%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BK.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DIntegrated%2520modeling%2520program%252C%2520applied%2520chemical%2520theory%2520%2528IMPACT%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1752%26epage%3D1780%26doi%3D10.1002%2Fjcc.20292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span> <span class="citation_source-book">Epik</span>, version 2.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+2.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DEpik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Shelley, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholleti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timlin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchimaya, M.</span><span> </span><span class="NLM_article-title">Epik: a software program for pK<sub>a</sub> prediction and protonation state generation for drug-like molecules</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1007/s10822-007-9133-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=10.1007%2Fs10822-007-9133-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=17899391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKrtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=681-691&author=J.+C.+Shelleyauthor=A.+Cholletiauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=M.+R.+Timlinauthor=M.+Uchimaya&title=Epik%3A+a+software+program+for+pKa+prediction+and+protonation+state+generation+for+drug-like+molecules&doi=10.1007%2Fs10822-007-9133-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Epik: a software program for pKa prediction and protonation state generation for drug-like molecules</span></div><div class="casAuthors">Shelley, John C.; Cholleti, Anuradha; Frye, Leah L.; Greenwood, Jeremy R.; Timlin, Mathew R.; Uchimaya, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">681-691</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Epik is a computer program for predicting pKa values for drug-like mols.  Epik can use this capability in combination with technol. for tautomerization to adjust the protonation state of small drug-like mols. to automatically generate one or more of the most probable forms for use in further mol. modeling studies.  Many medicinal chems. can exchange protons with their environment, resulting in various ionization and tautomeric states, collectively known as protonation states.  The protonation state of a drug can affect its soly. and membrane permeability.  In modeling, the protonation state of a ligand will also affect which conformations are predicted for the mol., as well as predictions for binding modes and ligand affinities based upon protein-ligand interactions.  Despite the importance of the protonation state, many databases of candidate mols. used in drug development do not store reliable information on the most probable protonation states.  Epik is sufficiently rapid and accurate to process large databases of drug-like mols. to provide this information.  Several new technologies are employed.  Extensions to the well-established Hammett and Taft approaches are used for pKa prediction, namely, mesomer standardization, charge cancellation, and charge spreading to make the predicted results reflect the nature of the mol. itself rather just for the particular Lewis structure used on input.  In addn., a new iterative technol. for generating, ranking and culling the generated protonation states is employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6PRLT1xT8LVg90H21EOLACvtfcHk0ljrUS2wBSSooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKrtbzP&md5=f4f429ea3894e1ad2519cdf3333a5645</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs10822-007-9133-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-007-9133-z%26sid%3Dliteratum%253Aachs%26aulast%3DShelley%26aufirst%3DJ.%2BC.%26aulast%3DCholleti%26aufirst%3DA.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DTimlin%26aufirst%3DM.%2BR.%26aulast%3DUchimaya%26aufirst%3DM.%26atitle%3DEpik%253A%2520a%2520software%2520program%2520for%2520pKa%2520prediction%2520and%2520protonation%2520state%2520generation%2520for%2520drug-like%2520molecules%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2007%26volume%3D21%26spage%3D681%26epage%3D691%26doi%3D10.1007%2Fs10822-007-9133-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span> <span class="citation_source-book">The PyMOL molecular graphics system</span>, version 1.7.0; <span class="NLM_publisher-name">Schrodinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+molecular+graphics+system%2C+version+1.7.0%3B+Schrodinger%2C+LLC%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DThe%2520PyMOL%2520molecular%2520graphics%2520system%26pub%3DSchrodinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WJ6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WJ6','PDB','3WJ6'); return false;">PDB: 3WJ6</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00056">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_60166"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00056">10.1021/acs.jmedchem.6b00056</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of intermediates <b>30</b>–<b>31</b>; analytical data for compounds <b>24</b>–<b>27</b>, <b>32</b>–<b>33</b>, <b>40</b>, (<i>S</i>)-<b>21c</b>, (<i>R</i>)-<b>22</b>, and (<i>S</i>)-<b>22</b>; supplementary kinase inhibition profile of (<i>R</i>)-<b>21c</b>; HPLC analysis of all target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_001.pdf">jm6b00056_si_001.pdf (198.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00056/suppl_file/jm6b00056_si_002.csv">jm6b00056_si_002.csv (4.49 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00056&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00056%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00056" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a995f9a541234","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
